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Studies were undertaken using transesophageal Doppler echocardiography to
monitor left ventricular systolic function in anaesthetised horses. A 3.5 MHz
transoesophageal probe was specifically developed in collaboration with Vingmed
Sound for equine use. The indices of systolic function investigated were maximum
acceleration of aortic blood flow (dv/dt^J, maximum blood flow velocity, (V^J,
cardiac output (CO), left ventricular pre-ejection period (PEP) and left ventricular
ejection time (ET).
The feasibility of the technique was demonstrated in a group of 8 healthy
Thoroughbred horses anaesthetised using a standard protocol. It was established that
two dimensional transoesophageal echocardiography provided a reference view of the
left ventricular outflow tract and aorta that consistently allowed high quality Doppler
echocardiographic measurement of aortic blood flow velocity. The flow envelopes
obtained were suitable for measurement of indices of left ventricular systolic function.
The repeatability of the measured indices was similar to that of the maximum rate of rise
of left ventricular pressure (LVdp/dt^J, obtained simultaneously by cardiac
catheterisation.
Cardiac output estimations made using transoesophageal Doppler
echocardiography were compared with those obtained by thermodilution in the same
group of horses under general anaesthesia. Cardiac output was altered by infusions of
the sympathomimetic amine, dobutamine. Aortic velocity spectra obtained both by high
pulse repetition frequency and continuous wave insonation modes were used to obtain
the velocity time integral for calculation of cardiac output. The measurements derived
from transoesophageal echocardiography agreed well with those obtained by
thermodilution. Both correlation coefficients and limits of agreement between the two
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techniques were better than those obtained from similar studies in standing horses using
transthoracic echocardiography.
The sensitivity of the Doppler derived indices of left ventricular function to
inotropic intervention was assessed in the final sequence of studies. As these indices
are derived during the ejection period they are load dependent, so their response to
changes in ventricular loading was also assessed and compared with the most
commonly used index of myocardial contractility in horses, LVdp/dt^. Three drugs
were administered to the anaesthetised horses in a randomised sequence during three
separate anaesthetic episodes. The drugs, dobutamine, dopamine and dopexamine were
selected because of their relatively different effects on afterload, preload and
contractility. Maximum acceleration of aortic blood flow was as sensitive to the
changes in ventricular performance as LVdp/dt^. Maximum aortic blood velocity
showed the same qualitative response to infusion of the drugs but the changes were
quantitatively less than in dv/dt^ and LVdp/dt^. The systolic time intervals, PEP and
ET, were also responsive to drug infusion; pre-ejection period shortened with each
drug, whilst ET increased after dopamine and dopexamine, but was reduced by
dobutamine.
These studies have shown that dv/dt^ is as sensitive as the invasive index
LVdp/dt^ for detecting changes in left ventricular performance. In addition dv/dt^
and appear to be no more affected by changes in ventricular loading conditions than
the isovolumic index LVdp/dtmM. It is concluded that transoesophageal Doppler
echocardiography provides a minimally invasive technique for assessment of left
ventricular systolic function in anaesthetised horses.
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Chapter 1
REVIEW OF THE LITERATURE
GENERAL ANAESTHESIA AND CARDIOVASCULAR FUNCTION IN HORSES
General anaesthesia in horses produces cardiac depression and systemic
hypotension (Gillespie, Tyler and Hall, 1969; Eberly, Gillespie, Tyler and Fowler,
1968). These adverse cardiovascular sequalae have been implicated in the higher
incidence of intraoperative mortality in horses compared to other species (Johnston,
Taylor, Holmes and Wood, 1995), and in the postoperative lameness which not
infrequently accompanies general anaesthesia in horses (Richey, Hollans, McGrath,
Dodman, Marshall, Court, Norman and Seeler, 1990; Lindsay, Robinson, Brunson
and Majors, 1989; Grandy, Steffey, Hodgson and Woliner, 1987). Steffey and
Howland (1978) showed that the equine cardiovascular system is more susceptible to
the depressant effects of halothane than that in other species. Cardiovascular
monitoring during equine anaesthesia is generally restricted to recording cardiac rate,
rhythm and arterial blood pressure (Hubbel, 1991; Lumb and Wynn-Jones, 1985), and
information concerning the mechanisms of cardiovascular dysfunction which occurs
under general anaesthesia in this species has been limited by the invasive nature of the
monitoring techniques that were previously available. However the availability of non¬
invasive echocardiography has removed many of these limitations. Two-dimensional
echocardiography permits recording of dynamic images of the heart non-invasively
(Feigenbaum, 1993), whilst techniques employing the Doppler principle can be used to
record blood flow velocity from targeted areas of the heart and great vessels (Goldberg,
Allen, Marx and Donnerstein, 1988). In human medicine ultrasound technology is
being increasingly used for evaluation of left ventricular function under general
anaesthesia (Skarvan, 1993; Shively, 1992).
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The studies which form the basis of this thesis evaluate Doppler
echocardiography for monitoring left ventricular function in anaesthetised horses. The
studies were performed using an ultrasonic transducer sited in the oesophagus, a
position, which from anatomic considerations, should provide optimal alignment with
aortic blood flow for Doppler echocardiographic studies in this species (Ghoshal,
1975).
CARDIAC ULTRASOUND
Since its introduction in 1954 cardiac ultrasound has become an invaluable
diagnostic tool in veterinary and human medicine. The history and development of 2-
dimensional (2-D) transthoracic echocardiography in human medicine has been
reviewed by Weyman (1994b) and Edler (1990). Long (1993) has reviewed the




The principle that the frequency of a wave could be altered after reflection off a
moving target was first enunciated by the Austrian mathematician and physicist
Christian Doppler (1803 - 1853). A biography of Christian Andreas Doppler and a
description of the early history and development of the effect that subsequently bore his
name is provided by Long (1993) and Eden (1985).
The first reported use of Doppler ultrasound to detect blood flow was by
Satomoto (1956). The early devices recorded the intensity of the Doppler signal, not its
frequency shift, and were therefore unable to quantify velocity. The goal throughout
early development of Doppler devices was the determination of volumetric flow
(Weyman, 1994e). The first true measurement of the Doppler shift frequency was
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made by Franklin, Schlegal and Rushmer (1961). Their device employed continuous
wave ultrasound and, whilst capable of measuring flow velocity, could not detect flow
direction. As transducer technology advanced methods used in radio communication,
were adapted to separate the forward and reverse components of the flow signal
(Weyman, 1994e). The first Doppler transducers were developed commercially, not
for cardiac use, but for detection of peripheral blood flow after pulse occlusion (Baker,
Stegal and Schlegal, 1964). Doppler detection of aortic blood flow was a little slower
to develop since the available continuous wave devices were sensitive to movement all
the way along the beam path. This resulted in unwanted interference from
neighbouring moving structures around the aorta. Light (1969) succeeded in recording
blood flow velocity in the human aorta using continuous wave ultrasound. He
suggested that the instrument might prove useful for assessment of the acceleration of
aortic blood which had recently been proposed as an index of myocardial strength
(Noble, Gabe, Trenchard and Guz, 1965; Rushmer, 1964). He also recommended the
technique for diagnosis of aortic stenosis, a condition which resulted in an increase in
maximum velocity of blood flow.
The velocity of the aortic blood flow was calculated from the Doppler frequency
shift using the formula
V = c AF
2F0 cosf)
c speed of ultrasound in tissue
AF Doppler frequency shift
F0 frequency of emitted ultrasound
cost) cosine of the angle between the ultrasound beam and direction of
flow
The problem of interference from neighbouring structures and failure to target
specific vessel locations continued to hamper the long-term objective of flow
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quantification. To achieve this aim, it is necessary not only to measure flow direction
and mean flow velocity, but also to identify the point in the vessel to which that velocity
applies and to measure the vessel's cross sectional area at that point. Only maximum
velocity can be measured from a continuous wave signal and the area of the heart or
vessel to which the maximum velocity applies cannot be established.
Development of pulsed Doppler echocardiography
In 1970 Baker described an ultrasound technique that allowed velocity to be
measured at a specific depth (range-gating) and from a specific sampling site (the
sample volume). To achieve this the transducer transmitted a short burst of sound and
then switched to receiving mode to await the return of the reflected back-scattered
ultrasound. Because the velocity of ultrasound in tissue is fixed, the delay between
transmission of the pulse of ultrasound and its return to the transducer is related directly
to the distance between the transducer and the target. Range-gated systems adjust the
time between transmission and reception of ultrasound pulses to accommodate the target
depth selected by the operator. This ensures that only echoes reflected from structures
at the target depth are recorded. The sound pulse transmitted from a pulsed Doppler
device has both length and width. At any instant in time echoes can arise only from
structures that lie in the volume of tissue occupied by the pulse (the sample volume)
(Weyman, 1994c). Its length is determined by the wavelength of the sound and the
number of cycles constituting a pulse. At least 5 cycles are generally transmitted in each
pulse, which at a frequency of 3.0 MHz represents a pulse length of 2.5 mm (X = 0.5
mm) (Feigenbaum, 1993). The width of the pulse, and therefore the sample volume,
depends upon transducer size and frequency, and the extent that it is focused (Weyman,
1994c).
Devices utilising pulsed Doppler ultrasound allowed blood velocity information
to be acquired from selected depths or areas in a vessel, satisfying one criterion for flow
quantification. The angle of incidence between ultrasound beam and blood flow could
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not be quantified, an important factor in estimating the accuracy of Doppler derived
velocity estimations (Goldberg, Allen, Marx and Donnerstein, 1988), and the technique
could not provide a means for measurement of the cross-sectional area of the vessel at
the site of velocity recording. Early prototypes combining real time 2-D imaging with
pulsed Doppler were unsuitable for cardiac work as they incorporated two separate
transducers aligned to intersect at a selected depth within the scan plane (Weyman,
1994c). The two modalities were soon incorporated using the same transducer and 2-D
guided, targeted Doppler echocardiography became possible, permitting flow recording
from the heart and great arteries (Moritz, Shreve and Mace, 1976). Alignment of the
ultrasound beam with flow could be visually appraised in two perpendicular planes thus
improving the accuracy of velocity measurement (Griffith and Henry, 1978). In human
cardiology the technical advances in data processing and the realisation that Doppler
derived velocities could be used to estimate trans-valvular pressure gradients has
elevated Doppler echocardiographic techniques to a position of major diagnostic
importance. The Doppler techniques provide additional data which are complementary
to that derived from standard imaging echocardiography and have established the
echocardiogram as the definitive non-invasive diagnostic tool for cardiology (Weyman,
1994e).
Colour Flow Doppler echocardiography
In recent years a system has been developed for displaying Doppler information
superimposed upon a 2-D or M-mode image. Doppler Colour flow mapping is a pulsed
technique in which multiple sample volumes are used to record Doppler information
from different areas of the heart (Sutherland and Fraser, 1989). Flow velocity is colour
coded and displayed on the 2-D or M-mode image. Most instruments code flow
towards the ultrasound transducer in red and away from the transducer in blue
(Simpson and Sahn, 1984). These colours were selected because they give the greatest
contrast with the surrounding endocardial borders and cardiac chambers, giving optimal
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definition to the human eye in real time (Weyman, 1994d). The convention is
somewhat contrary to Doppler's original concept that light from stars moving away
from earth was shifted to the red end of the spectrum, and probably arose from early
studies imaging human carotid arteries (Kisslo, Adams and Belkin, 1988). In these
studies the workers arbitarily chose red to code the carotid arterial blood flow moving
towards an ultrasound transducer in the suprasternal notch.
In addition to coding flow direction, the magnitude is also represented by
varying the hues of the two primary direction colours; higher velocities being coded in
lighter shades of red or blue (Goldberg, Allen, Marx and Donnerstein, 1988). Many
machines also use the third primary colour, green, to code for variance in the flow
signal (Nishimura, Miller, Callahan, Benassi, Seward and Tajik, 1985). The use of
multiple velocity pulses along a single sight line allows the machine to calculate the
variance of each sample relative to the mean velocity. Laminar flow should show little
variance, whilst turbulent flow should have variance that is directly related to the degree
of flow disturbance. Variance about the mean also occurs when flow within the sample
volume is accelerating or decelerating, even when the flow is essentially laminar
(Weyman, 1994d). The limits of variability at which a green colouration is assigned
varies between manufacturers, as does the method used to determine variance
(Goldberg, Allen, Marx and Donnerstein, 1988). As a result the use of variance in
colour flow mapping in human cardiology remains controversial.
Colour flow mapping has revolutionised clinical diagnostic echocardiography
(Simpson and Sahn, 1984). The technique allows rapid screening of cardiac chambers
for evidence of abnormal blood flow and is non-invasive (Cooper, Nanda, Philpot and
Fan, 1989). It is especially useful in neonates and children with congenital heart
disease, and in adults for the semi-quantitative assessment of valve regurgitation, or the
description of flow patterns in complex acquired disease (Sutherland and Fraser, 1989).
The technique provides spatial orientation of regurgitant signals which can be used to
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guide placement of a pulsed Doppler sample volume, or continuous wave ultrasound,
for optimal velocity determination and accurate calculation of trans-valvular pressure
gradients (Monoghan and Mills, 1989). Small eccentric regurgitant signals that are
easily missed by pulsed or continuous wave techniques are readily identified by colour
flow mapping.
Limitations of pulsed Doppler echocardiography
Range specificity by pulsed Doppler techniques, including colour flow
mapping, imposes limitations on the maximum velocity that can be measured. Because
the transducer must wait for the reflected echoes to return before the next pulse can be
transmitted, the period between pulses is much longer than the pulse duration. As a
result during the period when the pulse interacts with the target, the target moves only a
fraction of a wavelength, so that the frequency shift cannot be calculated. Meanwhile in
the period between pulses the target has moved much further and measurable changes in
phase can have occurred (Weyman, 1994d). In pulsed techniques the Doppler
waveform is reconstructed from a series of samples taken at regular intervals (the pulse
repetition frequency). The upper limit of velocity detection is constrained by the pulse
repetition frequency which imposes a maximum value to the highest velocity that can be
detected unambiguously (the Nyquist limit) (Feigenbaum, 1993).
If higher velocities occur the frequency waveform cannot be reconstructed
accurately, and the phenomenon of "aliasing" occurs (Goldberg, Allen, Marx and
Donnerstein, 1988). Because of an insufficient pulse repetition frequency the Doppler
shift frequency is under-sampled, i.e. the target moves faster than the systems ability to
record its velocity (Weyman, 1994d). When this ocurs the velocity is coded as if it
were occurring in the opposite direction (Feigenbaum, 1993). Quantitatively sampling
frequency must be double the shift frequency to avoid velocity aliasing, as a result to
measure high velocities unambiguously a high pulse repetition frequency is needed
(Angelsen and Brubakk, 1976). The further a vessel is from the skin surface, the
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longer will be the wait period required for the pulse of ultrasound to return to the
receiver, thus the pulse repetition frequency is limited by the speed of sound in tissues.
As a result the deeper the artery the lower is the velocity that can be measured by a
pulsed system, adding a further range limitation.
High pulse repetition frequency Doppler systems (HPRF) sacrifice range
specificity to increase the frequency of interrogation of distant targets. In this system
multiple pulses are travelling through the tissue at any one time. This multiplies the
sampling frequency by a factor of 2 or more, depending on the number of simultaneous
pulses. The maximum velocity that can be measured is therefore increased, but at the
expense of target ambiguity (Weyman, 1994d).
TRANSOESOPHAGEAL ECHOCARDIOGRAPHY
Transoesophageal echocardiography is the term used to describe the
ultrasonographic study of the heart from the oesophagus using two-dimensional, M-
mode, or Doppler echocardiography (Weyman, 1994a). The human oesophageal
lumen is separated from the posterior pericardium by a thin muscular wall which causes
minimal attenuation of an ultrasound beam allowing almost unrestricted access to the
cardiac chambers.
HISTORY AND DEVELOPMENT
In contrast to transthoracic ultrasound early development of transoesophageal
echocardiography began with studies which evaluated blood flow. Development of
Doppler ultrasonics was primarily directed at quantification of volumetric flow (Baker,
Stegal and Schlegal, 1964). Use of the oesophageal route was prompted by difficulties
encountered in determining aortic blood flow velocity with transcutaneous continuous
wave Doppler (See page 9). In an attempt to eliminate interference from moving
structures around the aorta Side and Gosling (1971) measured thoracic aortic blood
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flow by continuous wave Doppler from a transducer sited in the oesophagus. Daigle,
Miller, Histand and Hokanson (1975) used pulsed Doppler from a oesophageal probe
to measure blood velocity, volume flow and arterial wall motion. These workers
validated the flow determinations obtained by the oesophageal probe against
measurements obtained with implanted electromagnetic and ultrasonic flow cuffs and
concluded that the simplicity, accuracy and non-traumatic nature of the probe gave it
great potential for research and clinical applications. In 1979 pulsed Doppler from
oesophageal ultrasound transducers was used to measure aortic blood velocity and to
assess aortic haemodynamics in humans (Histand, Wells, Reeves, Sodal, Adamson and
Willson, 1979; Wells, Histand, Reeves, Sodal and Adamson, 1979).
During the mid 1970s although 2-D and M-mode transthoracic
echocardiography had gained widespread acceptance in human cardiology, severe
limitations in the technique were discovered in patients with chronic obstructive
pulmonary disease, barrel chests or obesity (Segal, Konecke, Kawai, Kotler and
Linhart, 1976). The need for an alternative window from which to image the heart in
these patients redirected interest to the oesophageal route. At about this time the
previous emphasis on development of transoesophageal ultrasonography shifted from
Doppler echocardiography to M-mode and 2-D imaging techniques. Frazin, Talano,
Stephanides, Loeb, Kopel and Gunnar (1976) reported the use of a single element
transducer for transoesophageal M-mode studies in humans. The end of the probe was
fixed so there was only limited control of the ultrasound beam by the operator. The
first 2-D images of the heart were recorded from the transoesophageal route by Hisanga
and colleagues (1977), their transducer consisted of a single rotating element encased in
an oil bag and mounted on a fixed gastroscope.
A major breakthrough in transoesophageal echocardiography came with the
arrival of phased array technology. Schluter, Langenstein, Polster, Kremer, Souquet,
Engel and Hanrath (1982) incorporated a miniature phased array transducer into the tip
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of a commercially available gastroscope. Unlike the earlier mechanical
transoesophageal transducers the phased array device no longer vibrated, increasing
patient comfort. The oil bag which had ensured contact with the oesophageal wall in
the early prototypes was no longer needed, as the end of the probe was flexible and the
direction of the ultrasound beam could be steered by the endoscopic controls.
During the 1980s pulsed, continuous wave and colour flow Doppler were added
to the basic 2-D imaging format of human transoesophageal echocardiography probes.
Currently biplane transducers have become standard in human cardiology. These
probes contain a second more proximal transducer array which is mounted parallel to
the long axis of the probe and thus orthogonal to the distal transducer. The images
from both transducers can be displayed simultaneously on the ultrasound screen greatly
improving the three dimensional visualisation of cardiac anatomy and regional wall
motion abnormalities (Pearson and Pasierski, 1991). Most recently transoesophageal
transducers have been developed that allow the scan plane to be rotated around a central
axis. The transducer is mechanically rotated through an arc of 180° and displays the
angle of rotation on the screen. The first generation multiplane probes are large in
diameter which currently limits their usefulness, but advances in technology may soon
resolve this problem (Weyman, 1994a).
Applications of transoesophageal echocardiography in human
medicine
In a recent position statement by the American College of Cardiologists
transoesophageal echocardiography was officially recognised as an acceptable clinical
procedure in the diagnosis of heart disease (Seward, Labovitz, Lewis, Martin, Pollick,
Quinones, Ritchies, Snider and Stewart, 1992). The close anatomical proximity of the
oesophagus to the heart, coupled with the use of near-focused, high frequency
transducers permits superior images of many intracardiac structures to be obtained
(Fisher, Stahl, Budd and Goldman, 1991). The quality of the 2-D images obtained is
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better than with conventional transthoracic echocardiography because there is better
spatial resolution of structures from the higher frequency transducer. Acoustic
interference from the lungs and chest wall is avoided because the transducer is
physically closer to posterior structures such as the left atrium, interatrial septum, mitral
valve and descending aorta (Roelandt and Sutherland, 1988). Fifteen 2-D standard
imaging planes of the heart obtainable by transoesophageal echocardiography have been
described by the Echocardiography Committee of the American College of
echocardiography (Seward, Khandheria, Oh, Abel, Hughes, Edwards, Nichols,
Freeman and Tajik, 1988). Transoesophageal echocardiography also provides the
opportunity to examine virtually the whole length of the thoracic aorta in long and short
axis (Weyman, 1994a) and has gained widespread acceptance for emergency diagnosis
of aortic aneurism where it offers significant advantages over other methods (Ballal,
Nanda, Gatewood, Darcy, Samdarshi, Holman, Kirklin and Pacifico, 1991; Erbel,
Engberging, Daniel, Roelandt, Visser and Rennollet, 1989). The technique is being
increasingly used for detection of mitral chord rupture where superiority over
conventional techniques has also been demonstrated (Alam and Sun, 1991; Sochowski,
Chan, Ascah and Bedard, 1991). Transoesophageal echocardiography allows
examination of native and prosthetic valves (Dittrich, McCann, Walsh, Blanchard,
Oppenheim, Waack, Donahey and Wheeler, 1990). The latter create a particular
problem for external scanning techniques because the prosthetic material produces
intense echoes which severely limit their visualisation. Mitral regurgitation is readily
visualised by transoesophageal echocardiography (Castello, Lenzen, Aguirre and
Labovitz, 1992; Kisslo, 1989) although the ability of the technique to quantify the
severity of regurgitation is the source of some debate (Khandheria and Oh, 1992;
Kleinman, Czer, DeRobertis, Chaux and Maurer, 1989). The technique has also been
used for examination of aortic and tricuspid valves and for diagnosis of infective
endocarditis (Milchak and Plehn, 1991) and for diagnosis of embolic disease
(Nagelhout, Pearson and Labovitz, 1991) and intracardiac masses (Fisher, Stahl, Budd
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and Goldman, 1991). It is estimated that between 2 and 5 % of all echocardiograms
being performed in major institutions in the USA are oesophageal (Khandheria and Oh,
1992; Weyman, 1994a).
The technique has been introduced into others areas in human medicine;
transoesophageal echocardiography has been employed in stress echocardiography to
detect coronary artery disease (Geiser, 1992; Zabalgoitia, Gandhi, Abi-Mansour,
Yarnold, Moushmoush and Rosenblum, 1991) and to examine left ventricular function
during exercise (Matsumoto, Hanrath, Kremer, Tams, Langenstein, Schluter, Weiter
and Bleifeld, 1982).
Safety of transoesophageal echocardiography
At present there are no known risks to the human patient following an
oesophageal ultrasound examination. The risk of bacteraemia has been shown to be
slight (Steckelberg, Khandheria, Anhalt, Ballard, Seward, Click and Wilson, 1991;
Melendez, Chan, Cheung, Sochowski, Wong and Austin, 1991; Daniel, Erbel, Kasper,
Visser, Engberding, Sutherland, Grube, Hanrath, Maisch, Dennig and Schartl,
Kremer, Angerman, Iliceto, Curtius and Mugge, 1991), the risk of oesophageal
damage minimal (O'Shea, Southern, D'Ambra, Magro, Guerrero, Marshall, Vlahakes,
Levine and Weyman, 1991) and the incidence of post-operative dysphagia was not
increased after transoesophageal echocardiographic examination in anaesthetised human
patients (Messina, Paranicas, Fiamengo, Yao, Krieger, Isom and Devereux, 1991).
Intraoperative use of transoesophageal echocardiography
In transoesophageal echocardiography the transducer is fixed in the oesophagus
and controlled from a site distant to the patient, which makes it ideal for the intensive
care unit or operating theatre (Bjerke, 1992). Matsumoto, Oka, Strom, Frishman,
Kadish, Becker, Frater and Sonnenblick (1980) demonstrated that an ultrasound
transducer sited in the oesophagus offered a stable location for continuous cardiac
19
examination in patients undergoing cardiac surgery. These authors concluded that the
technique offered a new approach to continuous monitoring of ventricular performance
during anaesthesia and surgery. The technique is particularly suited to cardiothoracic
procedures since the heart lies directly on the oesophagus and echocardiography is still
possible when the chest is open and the anterior pericardium is exposed to air. The
stability of the transducer in the oesophagus also permits continuous recording of the
same area for monitoring. The oesophageal position ensures that the transducer does
not interfere with surgery and precludes the need for aseptic precautions. The
development of intra-operative echocardiography continued during the 1980s. Kremer,
Cahalan, Beaupre, Schroder, Hanrath, heinrich, Ahnefield, Bleifield and Hamilton
(1985) used the technique to monitor left ventricular filling and contractility in 400
patients undergoing general surgery. They concluded that transoesophageal
echocardiography had three fundamental advantages over existing monitoring systems
in that it was inherently safer than cardiac catheterisation and allowed both direct
assessment of left ventricular filling and provided direct information on global and
regional left ventricular wall motion.
Two-dimensional transoesophageal echocardiography is now used most
frequently for assessment of segmental wall motion abnormalities for detection of
regional ischaemia (Skarvan, 1993; Shiveiy, 1992; Milchak and Plehn, 1991). As a
result the technique is now recognised as an important adjunct to anaesthesia for
cardiothoracic procedures (Skarvan, 1993; Shiveiy, 1992; Thys, Hillel, Konstadt and
Goldman, 1987). Colour flow mapping from oesophageal transducers has also been
exploited for intraoperative evaluation of valve repair (Shah and Shapiro, 1991) and in
the surgical management of congenital heart disease (Hsu, Santulli, Wong, Drinkwater,
Laks and Williams, 1991). The technique also provides a very sensitive technique for
detection of air embolus (Cucchiara, Nugent, Seward and Messick, 1984).
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The slow uptake of cardiological technology into anaesthesic monitoring largely
results from lack of cross-disciplinary training in echocardiographic techniques
(Skarvan, 1993) and the large capital outlay required (Bjerke, 1992). In the few
centres where the technology has been adopted the echocardiographic converts have
been vocal in their appreciation (Bjerke, 1992).
Transoesophageal echocardiography for measuring haemodynamic
effects of anaesthetic agents
Transoesophageal echocardiography can be used to assess the effects of
anaesthetic agents on cardiac function (Cahalan, Lurz and Schiller, 1988). For example
the technique has been used to evaluate the effect of thiopentone during induction of
anaesthesia in humans (Coriat, Bruere, Benammar, Houissa, Letouzey and Viars,
1987) and to compare the haemodynamic effects of propofol with other induction
agents (Heinrich and Wilder-Smith, 1991; Mulier, Wouters, Van Aken, Vermaut and
Vendermeersch, 1991). Echocardiographic techniques have also been used to evaluate
the cardiovascular effects of the volatile agents, isoflurane, enflurane and halothane in
humans (Heinrich, Fontaine, Fosel, Spilker, Winter and Ahnefeld, 1986). However,
despite being ideally suited for monitoring haemodynamic effects of anaesthetic drugs
transoesophageal echocardiography is still relatively under-used in this field.
Transoesophageal echocardiography in veterinary species
The first reports of transoesophageal echocardiography in dogs appeared in
1978, when the technique was compared with the transthoracic route for evaluation of
valve function in beagles (Dennis, Nealeigh, Pyle, Gilbert, Leee and Miller, 1978).
The technique received little further attention, and it was widely held that the canine
heart imaged poorly via the transoesophageal route (Vandenberg and Kerber, 1990).
Bashein and Martin (1991) countered this view in a letter to the editor of
Anesthesiology stating that excellent long axis views of the left ventricle could be
obtained from dogs. These authors concluded their correspondence by encouraging the
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more widespread use of transoesophageal echocardiography for haemodynamic
monitoring in experimental animals. Recently biplane transoesophageal
echocardiography has been used in dogs (Loyer and Thomas, 1995) and cats (Kienle,
Thomas and Rishniw, 1995). In dogs the technique provides superior visualisation of
heart base structures and offers advantages over transthoracic techniques in the
diagnosis of subaortic stenosis, pulmonic stenosis and patent ductus arteriosus
(Thomas, 1994). Thomas and coworkers also noted that Doppler examination of left
ventricular outflow yielded high quality signals which resulted from better alignment of
the ultrasound beam with aortic blood flow. There have been no reports on the use of
transoesophageal echocardiography in horses.
ASSESSMENT OF CARDIAC FUNCTION
The heart's main function is to deliver oxygenated blood to meet the metabolic
requirements of the tissues. As a result, measurement of cardiac output has become a
time-honoured method of assessing cardiac performance (Braunwald, 1992). Whilst
determination of cardiac output provides a useful insight into the pumping ability of the
heart, it is critically dependent on preload and afterload (Braunwald, 1971). The output
of the heart is an ejection-phase index of cardiac performance since it is measured after
the aortic or pulmonary valves have opened. In the normal animal cardiac output is
regulated more by the loading conditions of the heart than by the fundamental contractile
activity of the myocardium (inotropy / contractility). Only when myocardial function
becomes compromised, in heart failure, or by the influence of negative inotropes, does
inotropy become the major determining factor of cardiac output (Braunwald, 1971).
Thus measurement of cardiac output alone may not be the best indicator of myocardial
function.
Cardiac contractility is dependent on the fundamental properties of cardiac
muscle cells including the rate of cross-bridge formation and the rapidity with which
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they are recycled (Braunwald, 1992). Enhancement of myocardial cell excitation-
contraction coupling results in an increase in force development for a given initial fibre
length (Sonnenblick, 1962a). Contractility has been defined as "the performance of the
heart if it were freed from the constraints of afterload and preload i.e what the heart is
capable of doing rather than what it actually does" (Milnor, 1990c). For any given level
of contractility myocardial fibre shortening varies directly with preload (initial fibre
length) and indirectly with afterload (Ross, 1983). The increased force generation
caused by increasing initial fibre length is well known as the Frank-Starling
mechanism. It arises because of a sarcomere length-dependent availability of calcium
ions and more optimal contractile filament overlap which enhances the developed force
during contraction (Milnor, 1990c). In the intact animal afterload is closely related to
aortic impedance (Milnor, 1990a), which is defined as the sum of the external factors
that oppose ventricular ejection (Milnor, 1990a). Aortic impedance is the ratio of
pressure to flow in the aorta. It is determined by the physical properties of blood and
the vasculature, including blood viscosity and density, aortic diameter and elasticity,
and the reflected pressure and flow waves generated in the distal systemic arteries
(Nichols and O'Rourke, 1990a). When aortic impedance is raised an increasing
proportion of the heart muscle's contractile activity is used to generate tension and a
corresponding smaller fraction to shorten myocardial fibres. In the extreme case if
afterload exceeds the maximum force generating capacity of the ventricle, ejection
ceases (Braunwald, 1992).
To measure contractility requires a distinction between changes in mechanical
performance caused by the Frank-Starling mechanism and those which are independent
of muscle length. To achieve this in practice involves obtaining a variable generated by
cardiac contraction that is independent of initial fibre length (heart size) and that is not
affected by changes in ventricular afterload (aortic impedance) (Van den Bos, Elzinga,
Westerhof and Noble, 1973). There has been an unrelenting search for such indices
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able to reflect contractility in the intact heart (Lambert, Nichols and Pepine, 1983). It
has been suggested that the large number that have been described indicates that no
single measure is completely satisfactory (Milnor, 1990a).
ISOVOLUMIC INDICES OF MYOCARDIAL CONTRACTILITY
Maximum rate of rise of intraventricular pressure (LVdp/dt^)
The early search for indices of contractility focused upon the rate of rise of
intraventricular pressure and peak developed pressure by the left ventricle (Milnor,
1990a). The theoretical basis for use of intraventricular pressure is derived from its
relationship with ventricular wall force through ventricular dimensions (Hefner,
Sheffield, Cobbs and Klip, 1962). Before the aortic valve opens the rate of change of
ventricular pressure is closely related to the simultaneous rate of change of wall tension
(Wallace, Skinner and Mitchell, 1963). Provided that the increased force caused by
increased heart size is balanced by an increased chamber diameter it is theoretically
possible that LVdp/dt^ may be independent of changes in preload (Van den Bos,
Elzinga, Westerhof and Noble, 1973). However it was soon demonstrated that the
increased force caused by increased fibre length and the Frank-Starling mechanism
dominated the reduction in wall tension by the Laplace effect (Wallace, Skinner and
Mitchell, 1963). Since LVdp/dt^ occurs before the aortic valve opens it has been
generally accepted that the index, being isovolumic, should be independent of afterload
(Braunwald, 1992; Milnor, 1990a). In fact increases in aortic diastolic pressure have
been shown to influence LVdp/dt^ independent of alterations in contractility or left
ventricular end diastolic pressure in dogs (Wallace, Skinner and Mitchell, 1963) and
humans (Borow, Neumann, Marcus, Sareli and Lang, 1992; Mason, 1969).
Wildenthal, Mierzwiak and Mitchell (1969) concluded that LVdp/dt^ cannot be used
confidently to evaluate ventricular performance unless changes in aortic pressure and
the time of aortic valve opening are considered. Maximum rate of rise of left ventricular
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pressure is also sensitive to changes in heart rate, increasing with increasing frequency
of stimulation (Wallace, Skinner and Mitchell, 1963; Gleason and Braunwald, 1962).
Despite these limitations the index is widely used in human medicine, since it
shows sensitivity to agents known to produce acute changes in contractility
(Braunwald, 1992; Milnor, 1990a). The index is relatively simple to obtain, requiring
only a high fidelity intracardiac micromanometer and an analogue differentiator. The
index has also been used in horses (Brown and Holmes, 1979a) and has been
employed to assess the effects of therapeutic agents and anaesthetic agents (Muir,
1992b; Hillidge and Lees, 1976). Brown and Holmes (1979a) showed that the peak
dp/dt reliably occurred before aortic valve opening in the left ventricle of horses. It is
therefore justifiable to use LVdp/dt,nM for evaluation of left ventricular function in this
species provided its dependence on preload, afterload and heart rate are considered. In
the right ventricle LVdp/dt™* occurred after the pulmonary valve had opened in 5/8
horses in the study by Brown and Holmes (1979a), therefore use of LVdp/dt™* as an
index of right ventricular contractility is ill-advised, as it is not invariably an isovolumic
event in this species (Van den Bos, Elzinga, Westerhof and Noble, 1973). Hillidge and
Lees (1976) demonstrated that general anaesthesia with either ether or halothane
reduced LVdp/dt^from resting values in ponies.
Other pressure related indices
Time to attain LVdp/dt™* was advocated as a measure of left ventricular
contractility in humans after studies in open-chest dogs revealed that dp/dt™* was
increased by stretch and contractility. However time to peak dp/dt was unaffected by
stretching the ventricle and was decreased with infusions of epinephrine (Reeves and
Hefner, 1963). This index has been used in humans (Mason, Sonnenblick, Ross,
Covell and Braunwald, 1967) and horses (Brown and Holmes, 1979b), but it appears
to have few advantages over LVdp/dt™* since only when alterations in the two variables
are inversely related do they reflect absolute changes in contractility (Mason, 1969).
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Studies by Nejad, Klein, Mirsky and Lown (1971) demonstrated that the peak
value of the second differential of intraventricular pressure was essentially devoid of
afterload and preload dependence, but sensitive to infusions of isoprenaline. The index
was evaluated in horses by Brown and Holmes (1979a) who found great variability
between horses and between cardiac cycles in individual horses. They concluded that
because of the wide beat to beat variation the index would have limited sensitivity. The
index never gained widespread popularity in human medicine, although Lambert,
Nichols and Pepine (1983) showed that the peak second differential of left ventricular
pressure ranked above LVdp/dt^ in their sensitivity and specificity evaluation of 24
individual indices of myocardial contractility in anaesthetised dogs.
Relationships between dp/dt and developed pressure
The problem of preload dependence was thought to be alleviated by relating
dp/dt to the developed pressure, where developed pressure is the left ventricular
pressure - the end-diastolic pressure (Milnor, 1990a). Use of the value of dp/dt at a
developed pressure of 40 mmHg was used since this value invariably occurred during
isovolumic systole in most clinical circumstances (Braunwald, 1992). The index is less
sensitive than simple LVdp/dt^, but is useful for monitoring changes in individuals
(Mason, Braunwald, Covell, Sonnenblick and Ross, 1971). The index is said to be
relatively insensitive to changes in afterload and to be only mildly affected by moderate
changes in preload (Mahler, Ross, O'Rourke and Covell, 1975). A similar index using
dp/dt at an intraventricular pressure of 30 mmHg in horses has been described by
Brown and Holmes (1979a), but there have been no further reports of its use in this
species.
Indices based on calculated contractile element force-velocity
relationships
The extent and maximum velocity of shortening for each myocardial contraction
depends upon the load imposed on the muscle; the inverse relationship between the
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tension developed and the velocity of shortening is known as the force-velocity relation
(Braunwald, Sonnenblick and Ross, 1992). When the load is maximum the muscle
fails to shorten and develops maximal tension during isometric contraction, conversely
when there is no load the muscle shortens at its maximum velocity. It is not possible to
measure the velocity of shortening at zero load, however multiple assessments made at
different loads allows the resultant force velocity curve to be extrapolated back to zero
(Sonnenblick, 1962b). Theoretically the maximum velocity of shortening of the
unloaded contractile elements (CEVmaJ provides an index of contractility that is
independent of preload and afterload. However there is controversy surrounding the
determination of CEVIIiax in isolated muscle and this is compounded for the intact heart
(Braunwald, 1992). In an intact heart it is difficult to impose changes in afterload or
study purely isometric beats. However a technique for measuring a mathematical
relative of CEV^, VCE has been described which is derived using only the isometric
period of systole (Van den Bos, Elzinga, Westerhof and Noble, 1973). This involves
plotting dp/dt divided by developed pressure against the developed pressure and then
extrapolating the curve to zero pressure. This extrapolation is beyond the range of the
data and the sigmoid shape of the curve makes the extrapolation difficult. Van den Bos,
Elzinger, Westerhof and Noble (1973) suggested that use of developed pressure was
only feasible in open-chest preparations when intrapleural pressure could be assumed to
be zero. Otherwise great fluctuations in transmural pressure rendered division by
intraventricular pressure meaningless. Effectively this rules out use of this index in
closed chest subjects, although the index was evaluated by Brown and Holmes (1979a)
in horses when transmural pressure was not measured. These authors experienced
similar difficulties to Van den Bos, Elzinger, Westerhof and Noble (1973) in
extrapolating a sigmoid curve back to zero. They also suggested that the index was
dependent on left ventricular end-diastolic pressure. A study in humans which evaluated
a number of isovolumic indexes in humans under different loading conditions and
inotropy concluded that Vce lacked sufficient stability during acute changes in loading
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conditions to warrent its use in the quantitative assessment of acute changes in inotropic
state (Quinones, Gaasch and Alexander, 1976).
Overview of indices derived from intraventricular pressure
Although the value ofLVdp/dt^ is limited by heart rate and preload and
afterload dependence, the index has been shown to be useful in the assessment of acute
changes in inotropic state in humans (Mason, 1969; Gleason and Braunwald, 1962).
Van den Bos, Elzinger, Westerhof and Noble (1973) concluded that LVdp/dt^ was the
only pressure-derived index that was feasible in closed chest subjects because of
difficulty in measuring pressure across the left ventricular wall. The more complex
derived indices appear to confer no real advantage over the first differential of left
ventricular pressure in humans (Mahler, Ross, O'Rourke and Covell, 1975) or horses
(Brown and Holmes, 1979a). It is generally accepted that indices are not suitable for
comparison of myocardial contractility between individuals, but are useful for detection
of directional changes within an individual (Braunwald, 1992; Van den Bos, Elzinga,
Westerhof and Noble, 1973; Mason, 1969). Changes in LVdp/dt^ can only be
attributed to increased inotropy when end-diastolic pressure, aortic diastolic pressure
and heart rate remain unchanged (Mason, 1969; Wallace, Skinner and Mitchell, 1963).
EJECTION PHASE INDICES OF LEFT VENTRICULAR FUNCTION
Maximum acceleration of aortic blood flow (dv/dtmax)
In 1964 Rushmer used the term "initial ventricular impulse" to describe the
dynamic properties of left ventricular ejection. Impulse was defined as the product of
force and time, and was manifested by the peak velocity imparted to the aortic blood
(Rushmer, 1964). Rushmer showed that ventricular impulse was increased by
exercise, sympathetic stimulation and after long diastolic intervals, but was decreased
by premature ventricular contractions, exsanguination hypotension, acute coronary
occlusion and general anaesthesia. Maximum force exerted by the ventricle on the
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blood is proportional to its maximum acceleration according to Newton's second law of
motion (Noble, Trenchard and Guz, 1966). Use of maximum acceleration is only valid
provided that the whole column of blood moves from the ventricle in a single mass i.e.
there is true bulk flow of blood in the aorta (Noble, 1965). Theoretically this is likely
when pulsatile flow occurs in a tube, since when the diameter of the tube increases the
liquid begins to move more like a solid mass. The lateral variations in velocity in the
liquid occur closer and closer to the boundary of the tube so that the velocity profile
across the tube is essentially flat (Nichols and O'Rourke, 1990b). A flat aortic blood
velocity profile has been demonstrated using hot film anemometers in dogs (Falsetti,
Caroll, Swope and Chen, 1977; Seed and Wood, 1971). It is therefore considered
justifiable to apply the laws of mass acceleration to the movement of blood from the
myocardium (Noble, 1965).
Of equal importance in the assumption that dv/dt^ is proportional to the total
force exerted by the contracting myocardium is the stipulation that at the time dv/dt^
occurs, force is being expended by the heart to accelerate the column of blood and not
to overcome resistance (Noble, 1965). Throughout ventricular ejection, force is
expended not only to accelerate blood, but also to distend the arteries and force blood
through the peripheral vessels (Spencer, Johnston and Denison, 1958). However in
the early stages of ventricular ejection, at the time of dv/dt^, the left ventriclular
contraction achieves high peak blood velocity and momentum before much blood has
left the ventricle, thus producing the rapid initial ventricular impulse described by
Rushmer (1964). In fact when dv/dt^ occurs only 5% of the stroke volume has been
ejected, implying that opposition to left ventricular contraction is inductive and
contraction is directed to overcoming inertia at this time (Noble, Gabe, Trenchard and
Guz, 1965). Rushmer had suggested that both peak acceleration (dv/dt,,^) and rate of
rise of intraventricular pressure reflected the magnitude of the impulse generated by the
contracting left ventricle, but it was the experimental work of Noble (1965) that
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established dv/dt^ for evaluation of left ventricular contractility. He developed an
implantable electromagnetic flowmeter for conscious dogs and demonstrated in a series
of studies that dv/dt^ was more sensitive than stroke volume and LVdp/dt,^ for
detecting changes in left ventricular function after coronary artery occlusion and after
intracoronary injection of isoprenaline or calcium (Noble, Trenchard and Guz, 1966).
The theoretical basis of the use of dv/dt^ has been reviewed by Van den Bos,
Elzinger, Westerhof and Noble (1973), who suggested that the index would not be
independent of preload unless the increase in force produced by the Frank Starling
mechanism was counteracted by an increase in mass of blood to be ejected. The index
cannot be independent of afterload, since in the most extreme instance dv/dtrmx is zero
during an isovolumic beat. In a more physiological range of aortic pressures it is
possible that maximum aortic acceleration might not be influenced by small changes in
afterload since they may be insufficient to alter the mass of blood to be ejected (Van den
Bos, Elzinga, Westerhof and Noble, 1973). In the studies by Lambert, Nichols and
Pepine (1983) dv/dt^ showed increased inotropic sensitivity and less afterload and
preload dependence than LVdp/dt,nax.
Maximum acceleration has been used for assessing ventricular performance in
humans with coronary artery disease (Bennet, Else, Miller, Sutton, Miller and Noble,
1974), although it failed to differentiate patients with heart failure grouped according to
conventional LVdp/dt^ in a study by Kolettis, Jenkins and Webb-Peploe (1976).
Until the development of Doppler echocardiography measurement of dv/dt^ required
implantation of electromagnetic flowmeters, so the technique had limited applications
outside the laboratory. With increasing availability of Doppler technology, reports of
the use of dv/dt^ appeared in the medical literature. Sabbah, Khaja, Brymer,
McFarland, Albert, Snyder, Goldstein and Stein (1986) found that the index could be
used to classify the severity of left ventricular failure in human patients.
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In humans dv/dt^ was inversely related to afterload (Harrison, Clifton, Berk
and DeMaria, 1989) and directly related to preload (Bedotto, Eichhorn and Grayburn,
1989). This led some workers to conclude that, along with other ejection phase
indices, dv/dt^ was unable to differentiate changes in contractility from changes in
loading conditions (Borow, Neumann, Marcus, Sareli and Lang, 1992). However
other studies indicated that moderate increases in preload which increased stroke
volume caused minimal changes to dv/dfim compared to the very large increases in the
variable that occurred after inotropes were administered (Bennett, Barclay, Davis,
Mannering and Mehte, 1984). Similarly in anaesthetised dogs the index was more
sensitive to changes in inotropy than preload (Wallmeyer, Wann, Sagar, Kalbfleisch
and Kloppfenstein, 1986) and afterload (Wallmeyer, Wann, Sagar, Czakanski,
Kalbfleish and Klopfenstein, 1988). Maximum acceleration measured from
transthoracic Doppler echocardiography in standing horses was sensitive to changes in
inotropy caused by administration of inotropic and sedative agents (Young, Long,
Darke and Jones, 1993).
Maximum aortic acceleration clearly provides a useful index of myocardial
performance, but it is subject to the same limitations as LVdp/dt,rax imposed upon it by
dependence upon loading conditions (Bedotto, Eichhorn and Grayburn, 1989; Gardin,
1989), This led Wallmeyer, Wann, Segar, Kalbfleish, Kloppfenstien (1986) to
conclude that aortic acceleration was as sensitive as conventional indices to alterations in
myocardial contractility, but that it was no better at defining inotropic state in absolute
terms. In agreement with the conclusions of Van den Bos, Elzinger, Westerhof and
Noble (1973) they also suggested that dv/dfmx was of value in detecting changes in
cardiac function within an individual but not for comparing cardiac performance
between individuals
Although Doppler echocardiography provides a method for measurement of
aortic blood flow velocity, the maximum acceleration, as assessed from the velocity
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spectra (See General methods: page 49) is not representative of the true maximum
acceleration obtained by differentiation of the signal from a high fidelity flowmeter
(Bedotto, Eichhom and Grayburn, 1989). To obtain true maximum aortic acceleration
requires special instrumentation capable of differentiating the early up-stroke portion of
the flow envelope; most commercially available ultrasound systems are not equipped
with this facility. The mean acceleration can be obtained by measuring from zero to
peak velocity on the velocity spectra (Bedotto, Eichhom and Graybum, 1989).
Although errors in determination of the time taken to attain peak velocity are believed to
contribute to the high intra and inter-observer variability detected for this index (Gardin,
Bum, Childs and Henry, 1984). It has also been suggested that mean acceleration is
less sensitive to changes in inotropy than peak acceleration (Wallmeyer, Wann, Sagar,
Kalbfleisch and Kloppfenstein, 1986). Alternatively an estimate of maximum
acceleration can be obtained by measuring the steepest gradient on the early up-stroke of
the velocity spectra (See General methods: Figure 5). This was the technique adopted
for these studies, however, it is accepted that the value obtained does not represent the
true maximum acceleration as described by Nobel (1965).
Peak aortic velocity (Vmax)
The maximum velocity attained by the aortic blood flow was believed to reflect
the magnitude of the initial ventricular impulse (Rushmer, 1964). Lambert, Nichols
and Pepine (1983) showed that in anaesthetised dogs the index was similar in inotropic
sensitivity and load dependence to LVdp/dt^ and dv/dt^. The relative sensitivities of
Vmax and dv/dt,nax in reflecting changes in ventricular performance are unclear. Some
workers considered that dv/dt^ was the most sensitive indicator (Sabbah, Khaja,
Brymer, McFarland, Albert, Snyder, Goldstein and Stein, 1986; Noble, 1965), whilst
others favoured use of (Wallmeyer, Wann, Sagar, Kalbfleisch and Kloppfenstein,
1986; Gardin, Iseri, Elkayam, Tobis, Childs, Bum and Henry, 1983). In common
with dv/dt,n!U(, VnKX is inversely dependent on afterload (Bedotto, Eichhorn and
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Grayburn, 1989; Wallmeyer, Wann, Sagar, Czakanski, Kalbfleish and Klopfenstein,
1988; Elkayam, Gardin, Berkley, Hughes and Henry, 1983) and directly related to
preload (Wallmeyer, Wann, Sagar, Kalbfleisch and Kloppfenstein, 1986). As a result
the ability of either index to reflect absolute changes in contractility is similarly limited
(Bedotto, Eichhorn and Grayburn, 1989), it seems likely therefore that both indices are
of equal merit.
Velocity Time Interval (VTI)
The velocity time integral is derived by calculating the area under the median
velocity of the aortic velocity flow envelope. The index is closely related to stroke
volume (Mehte and Bennet, 1986; Haites, McLennan, Mowat and Rawles, 1984), and
can be multiplied by vessel area and heart rate to provide an estimate of cardiac output
(Hatle and Angelsen, 1985a). The limitations of stroke volume and cardiac output in
assessing global ventricular performance have been discussed previously (See page
22). Velocity time integral, like stroke volume, is directly dependent on preload and is
inversely influenced by afterload (Bedotto, Eichhorn and Grayburn, 1989).
The systolic time intervals
The systolic time intervals of the left ventricle (pre-ejection period and ejection
time) have been used in the evaluation of ventricular performance (Lewis, Rittgers,
Forester and Boudoulas, 1977; Filner and Karliner, 1976; Weissler and Schoenfeld,
1970; Weissler, Harris and Schoenfeld, 1969). The left ventricular ejection time (ET)
is the interval during which the contracting ventricle exerts sufficient pressure to
maintain the aortic valve open (Weissler and Schoenfeld, 1970). Ejection time is
therefore dependent not only on both the duration of active contraction and the amount
of myocardial tension developed, but also on the rate that pressure is elevated to aortic
diastolic pressure during the pre-ejection period (PEP) (Lewis, Rittgers, Forester and
Boudoulas, 1977). In general inotropic stimulation shortens PEP, whilst it is increased
by myocardial failure (Weissler, Harris and Schoenfeld, 1968). In contrast both
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negative and positive inotropy tend to decrease ET. An increase in inotropy increases
the rate of development of pressure and the extent of fibre shortening, which have
opposing effects on ET. Generally the increased velocity of shortening is predominant
and overrides the effect of increased stroke volume thus shortening ejection time
(Lewis, Rittgers, Forester and Boudoulas, 1977). Because of the opposite changes in
PEP compared to ET, use of the ratio PEP/ET has become increasingly used in human
cardiology, since it may identify left ventricular dysfunction when both ET and PEP are
within normal limits. Ejection time is highly influenced by heart rate (Weissler, Peeler
and Roahll, 1961) and various correction factors have been applied to normalise ET for
heart rate in humans (Weissler, Harris and White, 1963). Pre-ejection period appears
to be less influenced by heart rate than ET (Spodick, Doi, Bishop and Hashimoto,
1984), but both indices are affected by ventricular loading conditions in humans
(Spodick, Doi, Bishop and Hashimoto, 1984) and dogs (Talley, Meyer and McNay,
1971). Pre-ejection period and ET, measured by transthoracic Doppler
echocardiography, changed in response to inotropic and sedative agents in conscious
horses (Young, Long, Darke and Jones, 1993).
OVERVIEW OF THE INDICES OF MYOCARDIAL CONTRACTILITY
From the preceding discussion it is clear that neither indices derived from
cardiac catheterisation, nor those from Doppler echocardiography are capable of
providing an absolute measure of ventricular contractility. Whichever index is selected
it is necessary to consider both the loading conditions of the heart and the heart rate
before any conclusions can be drawn regarding the effects of any intervention in an
individual. However the problem of measuring muscle mechanics in the intact heart has
been recognised for many years (Braunwald, 1992; Milnor, 1990a; Van den Bos,
Elzinga, Westerhof and Noble, 1973). A rational approach to the problem involves
using as complete a collection of data on flow, pressure and cardiac performance as
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possible, not a single number (Milnor, 1990a). As was pointed out by Binks and
Jewell (1972) "if an index is really simple, it's informational content is unlikely to be
adequate".
Multiple indices of myocardial performance are provided by Doppler
echocardiography. This confers great advantages for elucidation of ventricular
performance, therefore if the variables are considered as an integrated group they
should provide a more complete means of assessment of heart function.
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AIMS OF THESE STUDIES
1. To investigate the feasibility of using transoesophageal Doppler
echocardiography for noninvasive haemodynamic monitoring in anaesthetised
horses.
2. To establish the repeatability of the indices of left ventricular
performance derived from transoesophageal Doppler echocardiography in
anaesthetised horses, and to compare their repeatability with that of maximum
rate of rise of left ventricular pressure, systemic arterial blood pressure and heart
rate obtained simultaneously from the same animals.
3. To compare cardiac output estimations obtained by transoesophageal
Doppler echocardiography with those obtained by thermodilution in
anaesthetised horses.
4. To assess the sensitivity of transoesophageal Doppler derived indices of
left ventricular function in horses anaesthetised with halothane by changing





Studies were performed on eight Thoroughbred horses (four mares and four
geldings), aged between three and six years (Appendix 1). The horses were bred for
flat or National Hunt racing and were registered with the British Thoroughbred stud
book authority1 . Their mean weights over the duration of the studies ranged from 490
kg to 615 kg. At the time of purchase the horses were subject to a standard clinical
examination and were judged healthy and fit for normal work. Cardiac auscultation
was performed on each horse before its acceptance, and valvular dysfunction was not
detected in seven horses. A grade 2, late systolic murmur characteristic of tricuspid
regurgitation was detected in horse 8. Since mild tricuspid regurgitation is a common
finding in horses bred for National Hunt racing (Patteson and Cripps, 1993) and the
studies to be performed would involve the left ventricle only, the horse was included in
the group. The studies took place between October 1992 and June, 1994 for mares and
between December, 1993 and September, 1994, for geldings. Incoming horses were
immunised against tetanus using a commercially available tetanus toxoid (duvaxyn T2).
Two doses, separated by one month, were administered by intramuscular injection.
Animal Husbandry
The horses were housed indoors, in loose boxes, throughout the studies. Daily
grazing was permitted in summer. Horses 1, 3 and 8 were broken to saddle and had
been racing before they were purchased. The remaining animals (horses 2, 4, 5, 6, 7)
were unbroken at the time of purchase and were broken to saddle before the studies
began.
1 Wetherbys, Sanders Road, Wellinborough, Northamptonshire, UK.
2 duvaxyn T, Solvay-Duphar Veterinary, Solvay House, Flanders Road, Hedge End Southampton, UK
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All horses were kept in moderate work, and each performed ridden or lungeing
exercise at a level appropriate to it's age and stage of training. This amounted to
approximately 45 minutes of ridden or lungeing work at least 5 times per week. On
days when the horses were not worked they were loose schooled in pairs for 20
minutes in a covered indoor arena.
Horses were exercised normally the day before each procedure and resumed
normal work within 48 hours.
Surgical Preparation
The right carotid artery of each horse was raised to a subcutaneous position
under general anaesthesia. Prophylactic antibiosis was provided by intramuscular
administration of 6.0 mg.kg"1 procaine penicillin and 10 mg.kg"1 dihydrostreptomycin
(Depomycin3). Drug administration was continued on a daily basis for a further 5 days
after the day of surgery. Horses were premedicated with 100 fig.kg"1 romifidine
(Sedivet4) administered by intravenous injection. Five minutes later general anaesthesia
was induced with an intravenous bolus of 2.2 mg.kg"1 ketamine (Vetalar5). Anaesthesia
was maintained by halothane (Halothane-M&B6) delivered in oxygen. The horses
breathed spontaneously from a large animal circle system7.
The skin was incised just dorsal to the jugular vein, at the level of the 4th
cervical vertebra. Elevation of the skin prevented damage to the jugular vein when the
incision was made. The cutaneous muscle and omohyoid muscles were split to gain
access to the carotid artery and 7 cm length of the artery was then dissected free. It was
then anchored in a subcutaneous position by raising it above the omohyoid muscle and
suturing the muscle below it. The subcutaneous layer was closed with sutures and the
3 Depomycin, Mycofarm UK Ltd, Science Park, Milton Road, Cambridge, UK.
"Sedivet, Boehringer Ingelheim(Vetmedica), Ellesfield Avenue, Bracknell, Herts, England, UK.
5 Vetalar, Parke Davis Company (Veterinary), Usk Road, Pontypool, Gwent, Wales, UK.
6 Halothane-M&B, Rhone Merieux Limited, Spire Green Centre, Harlow, Essex, England, UK.
7 Large Animal Anesthesia Control Centre, North American Drager, 148, Quarry Road, Telford, PA.
USA.
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overlying skin opposed with surgical staples, these staples were removed 7-10 days
later, then at least eight weeks were allowed to elapse for resolution of the surgical
wound, before catheterisation was attempted.
Small subcutaneous suture abscesses developed in Horse 1, two weeks after
surgery. Bacterial culture revealed a heavy growth of Staphylococcus aureus which
was completely resistant to penicillin, but sensitive to trimethoprim and tetracycline.
The problem resolved rapidly when affected sutures were removed and 30 mg.kg"1
trimethoprim and sulphadiazine (Uniprim for Horses8) was administered daily in feed
for 5 days.
Complete occlusion of the raised right carotid artery occurred at the site of
relocation in Horse 7. The surgical wound had healed without problems in this animal
and the relocation surgery was uncomplicated. However at the first cardiac
catheterisation attempt, 3 months after the original surgery, palpation of the raised
vessel revealed total absence of an arterial pulse. Feeling down the length of the artery
after it had been surgically exposed confirmed that the vessel was occluded as far as the
thoracic inlet. There was no evidence of infection nor abnormalities of the exterior of
the vessel which could explain why a thrombus had formed. Since there was no blood
flowing within the lumen, the subcutaneous tissues and skin incision were closed,
without returning the occluded vessel to it's original site. Surgical relocation of the
contra-lateral carotid artery was considered to constitute too great a risk to the horse,
and was not performed. Horse 7 was not used in any studies involving left heart
catheterisation.
8 Uniprim for Horses, Cheminex Laboratories Ltd, 7, Godwin Road, Earlstrees Industrial Estate, Corby,
Northants, UK.
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ANAESTHETIC PROTOCOL FOR EXPERIMENTAL STUDIES
Preoperative Preparation
Food, but not water, was withheld from the horses from 20.00 hr of the day
preceding the study. The skin overlying the left jugular vein was anaesthetised by
surface application of Emla cream9, followed by subcutaneous deposition of 2%
lignocaine10. A 13 gauge over-the-needle catheter11 was placed in the jugular vein
through the desensitised skin.
Induction of General Anaesthesia
In a padded induction area 100 pg.kg1 romifidine (Sedivet12) were
administered by intravenous injection through the pre-placed jugular catheter.
Anaesthesia was induced by intravenous administration of 2.2 mg.kg1 ketamine
(Vetalar13). The trachea was intubated with a 25 or 30 mm cuffed endotracheal tube
which was adapted to allow collection of gas from its distal end.
Maintenance of General Anaesthesia
Anaesthesia was maintained by halothane (Halothane-M&B14), delivered from
an out of circuit precision vaporiser (Vapor 1915), initially breathing was spontaneous
from a large animal circle system. Once an adequate depth of anaesthesia was obtained
the horse was transferred to a padded operating table and ventilation was controlled
using intermittent positive pressure16. Initially ventilation rate and tidal volume were set
at 10 breaths per minute and 7 litres respectively. A commercial blood gas analyser17
9 Emla Cream, Astra Pharmaceuticals Ltd, Kings Langley, UK.
10 Xylocaine 2%, Astra Pharmaceuticals Ltd, Kings Langley, UK.
11 Intaflon, Vygon Ltd, Cirencester, UK.
12Sedivet, Boehringer Ingelheim(Vetmedica), Ellesfield Avenue, Bracknell, Herts, England, UK.
13 Vetalar, Parke Davis Company (Veterinary), Usk Road, Pontypool, Gwent, Wales, UK.
14 Halothane-M&B, Rhone Merieux Limited, Spire Green Centre, Harlow, Essex, England, UK.
15 Drage-Vapor 19.1, Dragerwerk, Aktiengesellschaft, Postfach 13 39, Moisinger Allee 53 55, D-2400,
Lubeck, Der Bundesrepublik, Deutschland.
16
Large Animal Anesthesia Control Centre, North American Drager, 148, Quarry Road, Telford, PA.
USA.
17 283 pH - blood gas analyzer, Ciba-Corning Limited, Colchester Road, Halstead, Essex, UK.
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was used to monitor arterial partial pressure of CO2 (PaC02). Samples of arterial blood
were withdrawn into heparinised syringes through a 20 gauge (1 mm external diameter)
teflon catheter18 placed in the right great metatarsal artery. The maximum interval
between samples was 20 minutes and the blood was always analysed immediately after
withdrawal, the value of PaC02 obtained was then corrected for the horse's body
temperature. Minor adjustments of the ventilator controls were used to maintain arterial
partial pressure of CO2 (PaC02) between 35 and 45 mmHg. Halothane concentration
was measured from end-expired gas sampled from the end of the endotracheal tube,
using a calibrated anaesthetic gas monitor19. The vaporiser was adjusted throughout the
procedure to maintain an end-tidal halothane concentration of 0.9%. If the anaesthetist
noticed a 0.01% change in end tidal halothane concentration the vaporiser was adjusted
accordingly. A base-apex electrocardiogram was continuously displayed on an
oscilloscope20 (See page 47 for lead configuration).
A minimum of three people was required for all studies. An anaesthetist (R.E.
Clutton) supervised the well being of the horse and maintained end-tidal halothane and
PaC02 at target levels. Cardiac catheterisation (see page 53) was performed by a
second operator (K.J. Blissitt) assisted by a theatre nurse. The second operator was
also responsible for catheter positioning and pressure data acquisition. The third
operator (L.E.Young) positioned the transoesophageal echocardiography probe (see
page 47), performed all echocardiographic studies and provided 2-D echocardiographic
guidance for positioning micromanometers (see page 53).
18 Venflon 2, Viggo Spectramed, Faraday Road, Swindon, Wiltshire, UK.
19 Servo Gas Monitor 120, Siemens pic, 26- 28 Napier Court,Wardpark North, Cumberauld, UK.





A transoesophageal probe, suitable for use in horses, was developed by
Vingmed Sound21 in association with the Royal (Dick) School of Veterinary Studies.
The probe was a high frequency annular phased array transducer designed according to
the methods of Angelsen, Hoem, Dorum, Chapman, Grube, Gerckens, Visser and
Vanndenbogaerde (1989). The ultrasound images were obtained from a 3.0 MHz
transducer mounted at the end of a 160 cm human colonoscope (Figure 1). To avoid
risk of thermal injury to the oesophagus when the probe was used for extended periods
(Savino and Weiss, 1990), it was fitted with an integral thermistor and its internal
temperature was displayed in the top left quadrant of the ultrasound monitor (Figure 2).
The first equine transoesophageal transducer was similar to a standard human
transoesophageal probe, the distal end being manoeuvrable for 15 cm, by endoscopic
controls. In human cardiology this manoeuvrability of the end of the probe is important
as it allows acquisition of the multiple standard transoesophageal images (Fisher, Stahl,
Budd and Goldman, 1991). However in horses during early studies, advancing the
flexible probe against the resistance of the pharynx resulted in it bending, and in one
case complete retroflexion of the distal end occurred. The 'U' bend produced was then
unwittingly advanced through the pharynx into the oesophagus (Figure 3), once in the
oesophagus the bend could not be straightened using the endoscopic controls. When
the probe was withdrawn through the nose and the U bend approached the pharynx, it
stimulated violent coughing and became wedged in this position. This rare
complication of transoesophageal echocardiography has been reported only once in the
medical literature (Kronzon, 1992). In human medicine if a gastroscope becomes
retroflexed, it can be advanced into the stomach, where it can be easily straightened
21 Vingmed Sound, Horten, Norway.
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(Weyman, 1994a). Because of the relative lengths of the equine oesophagus and the
transoesophageal echocardiography probe this option was not available. Instead it was
necessary to insert a stomach tube into the horse's oesophagus through the contra¬
lateral nostril to the probe. The end of the stomach tube was then used to wedge the
echocardiography probe tip. With the stomach tube fixed, the body of the probe was
pulled backwards at the nostril. This technique successfully straightened the probe and
the horse recovered uneventfully, but the probe was irreversibly damaged.
Subsequent studies with a new probe showed that suitable transoesophageal
images could be obtained in horses with the endoscopic controls in the locked position.
To minimise the risk of damage to the probe, it's distal end was stiffened using heat
shrink sleeving (Figure 1). To facilitate insertion by lubrication of the oesophagus and
to ensure good echocardiographic contact, lubricating fluid was delivered to the end of
the probe through a length of vinyl tubing22 affixed to the body of the colonoscope by
adhesive tape23. Before insertion the tubing was pre-filled with lubricating fluid24 and
further fluid was instilled as the probe was advanced down the oesophagus (see page
47).
Vingmed CFM 700
All Doppler echocardiographic studies were performed using a Vingmed CFM
70025 ultrasound system, with the 3.0 MHz transoesophageal probe. A 2.25 MHz
transthoracic probe was used to derive aortic diameters (Chapter 4) and to assist in
positioning intracardiac catheters (see page 53). The ultrasound system could perform
2-dimensional and M-mode, colour flow mapping, and spectral Doppler
echocardiography. The spectral Doppler studies could be made using either high pulse
repetition frequency (HPRF) or continuous wave (CW) insonation modes.
22 800/101/250/800, Portex, Arterial Medical, Arterial House, 313 Chase Road, South Gate, London,
UK.
23 Sleek, Smith and Nephew Medical Limited, Hull, UK.
24 Vet-Lubigel, Millpledge, Whinley's Estate, Church Lane, Clarborough, Retford, Herts, UK.
25 Vingmed CFM 700, Diasonics, Sonotron, Bedford, UK.
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Two Dimensional Imaging
The maximum depth for 2-D and M-mode imaging was 24 cm. The frame
update rate varied between 19 and 55 frames per second, dependent upon the sector
angle selected and the imaging depth. For most transoesophageal 2-D
echocardiography the sector angle was 70° and the depth 20 cm, this resulted in a frame
update rate of 22 s'1. For transthoracic echocardiography an angle of 90° and depth of
24 cm resulted in an update rate of 19 s"1. The frame update rate was continuously
recorded by a digital indicator shown at the bottom right of the image sector, it was also
displayed as the lower trace at the bottom of the ultrasound screen below the
electrocardiogram (Figure 2).
The values for signal amplification (gain), and the threshold level for rejection
of low amplitude signals (reject) were adjusted to give good definition of intracardiac
structures. The temporal averaging facility of the echocardiogram was not used.
Amplification was adjustable at five depth levels. For transoesophageal studies the
amplification (gain) was minimal up to an imaging depth of 7 cm, then it was gradually
increased to a maximum beyond 15 cm. The relationship between signal amplitude and
intensity of the grey scale displayed could also be adjusted (compression). In these
studies compression was set to give high contrast between cardiac structures and
resulted in a black and white image with limited grey scale. Controls were pre-set for
initial use of the transoesophageal probe, but were individually varied to obtain the best
images in individual horses: Minimal adjustment of the gain was generally all that was
required to optimise images in individual horses.
Transthoracic 2-D echocardiography was performed using the methods
described by Long, Bonagura and Darke (1992).
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Colour Flow mapping
The Vingmed CFM 700 initially produces a 2-D image and then superimposes
the colour flow information. The colour image is constructed by designating different
flow velocities towards the transducer at each of the multiple sampling sites in shades of
red and flow velocities away from the transducer in shades of blue. Increasing mean
velocities in either direction are encoded by lighter shades of red or blue. Variance /
turbulence are depicted by adding increasing intensities of green to the velocity map.
At 20 cm, the maximum depth for colour flow mapping, the Nyquist limit was
0.6 m.s'1. Thus when mean blood flow velocity exceeded 0.6 m.s"1 aliasing of the
colour flow signal occurred (see page 14).
The angle of the colour flow sector was kept between 35 and 45° in
transoesophageal studies. Sector angle inversely influences the frame update rate of the
colour flow and 2-D image. The annular phased array transducer in the
transoesophageal echocardiography probe is mechanically steered through the sector
angle to construct the ultrasound image (Weyman, 1994b). This imposes a finite
rotational velocity on the transducer which also limits frame update rate. The rotational
velocity can be modified by the 'quality' setting on the echocardiogram, which
influences the number of ultrasound pulses per image beam. Whilst more detailed
velocity information is generated by increasing the number of insonating pulses, the
rotational velocity of the transducer is reduced, thus reducing the frame rate. A high
frame rate is required when colour flow mapping is being used to detect abnormal
short-lived regurgitant flow signals at fast heart rates. In the present transoesophageal
studies the technique was used to aid placement of the spectral Doppler sample volume
and not for detection of abnormal blood flow, thus frame update rate was of lesser
importance. High quality images were therefore used at the expense of a lower frame
update rate which varied between 9 and 12 frames s"1. Since the system was being used
to evaluate aortic blood flow velocity, not high velocity regurgitant flow, the velocity
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reject value was fixed at a low value (0.31 m.s"1). The amplification (gain) of the colour
signal was set at one level below the setting which produced colour artefacts within the
sector (Long, 1993).
Spectral Doppler echocardiography
Spectral Doppler studies were conducted using the transducer in high pulse
repetition frequency (HPRF) mode, with ultrasound emitted at a frequency of 2.5 MHz.
As for colour flow mapping studies low intensity velocity signals could be rejected
(reject) and all other signals could be amplified by a user specified control (gain).
These controls were set to ensure that the waveforms were clearly visible with minimal
artefacts. A low velocity filter was also available, which allowed low velocity, high
intensity signals, such as those emanating from slowly moving intracardiac structures,
to be filtered from the display. During spectral Doppler studies the low velocity filter
was set at 0.1 m.s"1. Sample volume length was fixed at 2.5 mm. The sample volume
was always positioned using the colour flow image to assess the area of fastest flowing
blood. Once spectral studies commenced, the colour flow Doppler image was frozen,
allowing the transducer to be dedicated to the acquisition of Doppler information (Long,
Bonagura and Darke, 1995).
The Vingmed system uses fast Fourier transform spectral analysis to provide
quantitative velocity determination. The frequencies of velocities occurring within the
sample volume are recorded using a grey scale display. The brightest white line in any
velocity envelope represents the modal velocity within the sample volume. The
maximum magnitude and phase of the velocities recorded could be modified by moving
the zero baseline of the spectral display. The maximum positive velocity that could be
registered using a single sample volume in HPRF mode was 1.5 m.s"1. By adding
additional sample volumes, higher velocities could be recorded, but range ambiguity
was introduced (see page 14). For most transoesophageal studies in anaesthetised
horses aortic blood flow velocity was less than 1.5 m.s"1, so adjustment of the scale
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was unnecessary. The horizontal sweep time was also adjustable but was pre-set at 4 s
for all Doppler studies. This sweep speed allowed at least one complete cardiac cycle
to be included on the ultrasound screen. Accurate alignment with aortic blood flow was
assumed from the clarity of the audible signal and when a complete velocity envelope
containing minimal spectral dispersion was obtained.
Data Recording by the Vingmed CFM 700
Echocardiographic studies were recorded on VHS video tape by a Panasonic
AG 6200 video recorder. Still photographs were taken using a freeze frame video
recorder26. A base apex ECG was recorded during all studies and was displayed with
the ultrasound data at the bottom of the ultrasound monitor (Figure 2). Pre-gelled
silver-silver chloride adhesive electrodes27 were used to obtain the base apex ECG, one
recording electrode being fixed to the right hemithorax at the cardiac apex, a second one
in the right jugular furrow half way up the neck, and an earth electrode high on the right
thoracic wall.
Transoesophageal Probe Insertion
Within 15 minutes of induction of anaesthesia, with the horses in lateral
recumbency, the transoesophageal probe was inserted into the uppermost nostril and
advanced through the ventral nasal meatus into the pharynx. Once the probe reached
the pharynx, the endotracheal tube was removed. One operator then placed a hand into
the pharynx through the horse's mouth, which was held open using a Varnell's gag.
From this position the end of the probe could be guided into the oesophagus and
advanced at the nares by a second operator. The endotracheal tube was then
reintroduced and it's cuff inflated. As soon as the airway was secure, 60 mis of
lubricating fluid was introduced through the lubrication tubing. The probe was then
advanced down the oesophagus until the endoscopic controls reached the nostrils.
26 Polaroid UK Limited, Ashley Road, St Albans, Herts,UK.
27 F60, Skintact ECG pads, HA West Ltd, 41, Watson Crescent, Edinburgh, UK.
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Blind introduction of the transoesophageal probe into the oesophagus was
abandoned after inadvertent transtracheal ultrasonography was performed in 3/8 horses
during pilot studies. The probe entered the larynx despite the anaesthetised horse
swallowing and the presence of a 25 or 30 mm endotracheal tube in it's trachea. The
images obtained in these horses were indistinguishable from those obtained from the
oesophagus. In retrospect difficulty advancing the probe unless the endotracheal tube
cuff was first deflated and constant leakage of anaesthetic gases were signs of probe
malpositioning, that went unrecognised at the time of the study. Affected horses then
experienced high body temperatures, lethargy and coughing for 3 - 5 days after the
procedure. Endoscopy of affected animals revealed inflamed tracheal mocosae and the
presence of food material in the airway. In the next batch of studies when the first
horse swallowed the probe, the endotracheal tube was removed and its position was
checked by introducing a hand through the horse's mouth and palpating the probe in the
pharynx; it could clearly be felt entering the larynx. Inadvertent transtracheal placement
of a transoesophageal echocardiography probe has been reported in a 74 year old
human patient with neurological deficits (Fagan, Weiss, Castello and Labovitz, 1991);
this individual also suffered inhalational pneumonia after the procedure. The same
workers then examined transtracheal echocardiography in an anaesthetised dog, and
observed that the image quality obtained was "virtually indistinguishable from that
obtained by the transoesophageal approach". Whilst inadvertent tracheal intubation is a
rare complication of human transoesophageal echocardiography, it occurred commonly
when oesophageal echocardiography was performed in anaesthetised horses. Since it is
feasible to advance the probe by hand into the oesophagus of an adult horse, the
introduction procedure was modified. Interestingly tracheal introduction had not
occurred previously when the anaesthetised horses swallowed the original probe which
had a flexible end.
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The transoesophageal ultrasound probe was positioned, by slowly withdrawing
it, until a reference view of the aorta, the left ventricular outflow tract, and the
pulmonary artery (Figure 4) was obtained. The probe occasionally had to be rotated to
bring this image into view.
Echocardiographic data measurement
Data from echocardiographic studies were measured by a single observer (L.
Young) from the video tape. Software within the CFM 700 provides two electronic
calipers and a series of automated measurement menus. During video playback the
calipers are calibrated for the ultrasound image by entering a digital calibration code
(Figure 2). The calipers have been shown to measure velocity with an accuracy of 0.01
m.s"1, time with an accuracy of 0.01 s and distance with an accuracy of 0.01 cm
(Vingmed operating manual28). In spectral Doppler mode the caliper can be guided to
any point on the display, using a tracker ball, and the integral software determines the
velocity represented by the vertical height of the caliper above the zero baseline. Use of
two calipers allows the difference in velocity and time between two points on the
display to be determined.
In these studies to determine maximum aortic velocity (Vmax), one caliper was
positioned at the peak of a single aortic velocity spectrum (Figure 5). To determine
maximum aortic acceleration (dv/dtmax) one caliper was positioned on the baseline at the
start of ejection, and the line adjoining it to the second caliper was placed parallel to the
maximum upstroke of the velocity spectra and positioned at the vertical level of the peak
velocity. Pre-ejection period (PEP) was calculated from the horizontal distance between
one caliper placed at the start of the 'Q' wave of the ECG and the other positioned at the
onset of aortic flow. Ejection time (ET) was measured similarly, but the first caliper
was transferred to the point on the baseline when aortic flow ceased. The area under
the Doppler spectrum (velocity time integral, VTI) was measured by manually tracing
28 Vingmed CFM 700: Operating Manual, Vingmed Sound, co. Sonotron Ltd, Bedford, England, UK.
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the brightest white line, or modal value, of the velocity envelope using the tracker ball.
The software within the spectral Doppler menu then measured the area below the trace
to the nearest 0.01 cm.
Anatomic measurements from 2-D images were made using a separate
measurement menu. When the anatomical structure was aligned perpendicular to the
ultrasound beam the first caliper was placed on the endocardial surface closest to the
transducer (leading edge) and the second caliper was placed on the leading endocardial
edge of the distant wall. Although use of this technique results in a measurement which
incorporates the thickness of one wall, in vivo studies have shown it is preferable,
because the first echo from the surface closest to the transducer is easiest to identify and
measure accurately (Wyatt, Haendchen, Meerbaum and Corday, 1983). When tissue
interfaces are aligned parallel to the ultrasound beam, considerable lateral broadening of
the echo always occurs (Feigenbaum, 1993). According to the studies by Wyatt,
Haendchen, Meerbaum and Corday (1983) errors in width measurement in these
circumstances are minimised when measurement is made from the middle of each band
of echoes corresponding to the anatomical boundaries.
INTRACARDIAC AND INTRA-ARTERIAL PRESSURE MEASUREMENT
Micromanometers
Left ventricular and aortic pressure measurements were made using 2 strain
gauge transducers29 mounted on a 150 cm long woven Dacron catheter with a 2.64 mm
outside diameter (size 8F). One manometer was sited at the distal end and one 12 cm
more proximal. Sensitivity of the strain gauge transducers was 5 (iV.V '.mmHg'1 and
their frequency response exceeded 12 kHz. The bridge excitation voltage from each
manometer was monitored via a high gain amplifier30. The output from each high gain
29Gaeltec Ltd, Dunvegan, Isle of Skye, Scotland, UK.
30Series 5000, No 5248. Lectromed Ltd, Unit 26, The Business Centre, Avenue One, Letchworth
Garden City, Hertfordshire, England, UK.
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amplifier was recorded simultaneously by one channel of a four channel chart recorder31
and a data acquisition system on a Macintosh Ilvi microcomputer32.
Data acquisition using the Macintosh Ilvi
The analogue outputs from the micromanometers were connected to channels 1
and 2 of a 16-bit analogue to digital converter33, which had 8 differential input
channels. The connections between the input/output board and the micromanometers
were standardised in all studies (Table 1)





The Macintosh Ilvi was upgraded by addition of a maths coprocessor, and its
random access memory (RAM) was increased from 5 to 8 MB. Calibration of
micromanometers, data acquisition and analysis were performed using a series of
programmes written using Labview 2.2.1 software34. During data acquisition, each
channel was scanned alternately at a frequency of 50 HZ
Labview 2.2.1.
Labview 2.2.1 has the power of traditional programming languages, but the
lines of code and syntax are replaced by graphical objects in a 'windows' environment.
31Multitrace 4, Lectromed Ltd, Unit 26, The Business Centre, Avenue One, Letchworth Garden City,
Hertfordshire, England, UK.
32Macintosh II VI, Scotsys, Ltd, The Apple Centre, Rigshead Industrial Park, Bellshill. Scotland,UK.
33Lab NB-MIO-16, National Instruments UK, 21, Kingfisher Court, Hambridge Road, Newbury,
Berkshire, England, UK..
34Labview, National Instruments Corporation, 6504 Bridge Point Parkway, Austin, Texas, USA.
The application programmes created in Labview are called virtual instruments (Vis).
Labview programmes are hierarchical in structure, the final VI being built up of several
linked, but discrete subVis.
The front panel is the user interface to the VI. It is built with a combination of
controls and indicators. This is illustrated by Figure 6 which shows the front panel of
the application programme, 'DVCal levels', written for calibration of the strain gauge
transducers.
Front panel indicators simulate instrument output devices, and display data
generated when the programme is executed. When a VI is used as a subVI, the controls
and indicators receive data from, and return data to, the VI at the next level in the
hierarchy.
Labview 2.2.1 has a library of standard Vis capable of performing a wide
variety of functions, which can be integrated into user defined Vis. For the present
studies standard Vis controlled the analogue to digital converter, saved and retrieved
data from hard disc and performed mathematical calculations and charting functions.
Purpose written Vis calculated heart rate and systolic and diastolic blood pressures.
Using the Labview interface, three discrete programs were developed for
invasive haemodynamic studies; the first was used for calibration of manometers
(DVCal levels), the second, for real time acquisition of four channels of pressure data,
and on-line analysis of mean, systolic, diastolic pressures and heart rate (DVpoly), and
the third, for off-line analysis of stored data (DV compute bp,hr,etc).
Micromanometer calibration
Each transducer was calibrated against 100 mmHg, using a mercury
manometer, before being inserted and again on removal. In the present studies after
removal from the horse, zero for both transducers lay within 2.5 mmHg of the pre-
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insertion zero with 95% confidence. Recorded pressures were not adjusted when
baseline drift occurred because of the difficulty of knowing when the drift started and
whether it was linear. Maximum drift detected during these studies was +3 mmHg to -
2 mmHg for the proximal manometer, and +2.5 mmHg to -3.5 mmHg for the distal
manometer.
Catheterisation technique
An arterial sheath introducer35 was placed in the raised right carotid artery using the
percutaneous Seldinger technique (Grossman, 1992). The sheath had a side arm and
proximal haemostasis valve, allowing the internal catheter to be removed, without
invoking serious haemorrhage. The dacron catheter was advanced through the
introducer until the pressure traces recorded indicated the distal transducer was located
in the left ventricle, and the proximal transducer in the aorta (Figure 7). Pressure data
was displayed throughout each study on the chart recorder and on the screen of the
microcomputer.
In human medicine fluroscopy is used to image the catheters and facilitate their
introduction into the heart (Grossman, 1992). In horses it has been suggested that
cardiac catheters can be advanced blindly into the heart (Muir, Skarda and Milne, 1976;
Carlsten, Kvart and Jeffcott, 1984). However at the end of an early study, a woven
Dacron catheter could not be withdrawn through the arterial sheath in Horse 3.
Radiography revealed that it had become kinked (Figure 8). The catheter was removed
by first removing the arterial sheath, followed immediately by the catheter.
Considerable haemorrhage resulted, but there were no long-term adverse effects to the
horse. The catheter was irreparably damaged. In the next series of studies in horses 2
and 4, the proximal micromanometer entered the left ventricle first. Two-dimensional
echocardiography was performed and a bend in the body of the catheter, proximal to the
micromanometers, was visible within the left ventricle. If the catheter was withdrawn,
"Haemaquet, 9F. Bard Ltd, Forest House, Brighton Road, Crawley, West Sussex, England, UK.
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or advanced, at the introducer, it did not uncurl, but the bend moved vertically within
the heart. Continued withdrawal resulted in the distal micromanometer entering the
aorta (Figure 9). To correct the problem, the body of the catheter was rotated in the
introducer, whilst 2-D transthoracic echocardiography was performed. If a long axis
view of the left ventricular outflow tract and aorta were obtained from either right or left
hemithorax (Long, Bonagura and Darke, 1992), the catheter loop became visible: The
image was then used to determine the direction of rotation and the amount of
withdrawal of the catheter. Once the free end of the bent catheter was pivoted away
from the intraventricular septum, there was sufficient room in the ventricle for it to
uncurl. Once this orientation was achieved, the catheter straightened when it was pulled
backwards at the arterial sheath. It could then be removed uneventfully from the horse.
In subsequent studies the catheter was inserted into the left ventricle under
ultrasonographic scrutiny. A long axis view of the aorta and left ventricular outflow
tract was obtained using either transthoracic or transoesophageal ultrasonography. The
catheter was advanced through the arterial sheath until the distal micromanometer
became visible on the ultrasound image just above the aortic valve (Figure 10). The
final advance of the catheter was then made to coincide with ventricular systole. If the
distal micromanometer failed to enter the left ventricle, becoming lodged in the sinus of
Valsalva, the catheter was withdrawn slightly and repositioned in the centre of the
vessel, and the procedure was repeated. To compensate for the natural tendency of the
end of the catheter to enter the sinus of Valsalva, it was often necessary to rotate
catheter within the arterial sheath, as it was advanced. When the catheter passed into
the ventricle the distal micromanometer could be visualised in the left ventricular
outflow tract (Figure 11).
Occasionally the catheter was already bent when it was first seen at the sinus of
Valsalva. The cause of the bend was unclear, since the insertion technique was
apparently the same. One possibility is that the end of the catheter entered one of the
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brachiocephalic arterial branches, proximal to the aortic valve which could not be
visualised using ultrasound. If the body of the catheter was advanced from the arterial
sheath this would force the body of the catheter to bend if the distal end was lodged.
Introduction of more catheter might free the fixed extremity, so that the catheter would
be advanced bend-first down the aorta. When a catheter had bent in this way there was
insufficient room in the aorta to straighten it, so the bend was deliberately advanced into
the left ventricle. The catheter was then uncurled in the ventricle using the technique
described above. On five occasions during the straightening process, rotation of the
catheter caused the distal transducer to enter the left atrium, evidenced by a left atrial
pressure trace on the chart recorder. From this position the catheter could always be
straightened. The uncurling process was monitored by transthoracic echocardiography
using a right parasternal long axis view of the aorta. Transoesophageal
echocardiography was not suitable for this purpose as the left ventricle was too far from
the ultrasound crystal to allow the whole chamber to be visualised.
Real Time Data acquisition and charting
At the start of each study session the scales and offsets for each
micromanometer obtained from the calibration program were manually entered into the
corresponding control of 'DV poly', the program written for data acquisition. When
the program was initiated the user was prompted to define a folder on the hard disk of
the Macintosh 1 lvi, all files generated during that study were then stored within it. The
program had the capacity to acquire data from four channels, allowing two additional
channels of pressure data to be collected if required.
A double buffered data acquisition system was used to allow uninterrupted
acquisition of data from the four channels. Use of a buffer carries with it the risk that
data will be overwritten if the application programme is unable to access it sufficiently
regularly. If this occurs DV poly returns an error message, registered by an indicator
on the front panel. Data was not overwritten during the course of these studies.
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DV Poly retrieved micromanometer data in 5 second blocks from the buffer.
These voltages were immediately converted into mmHg, using the previously defined
scales and offsets. Using purpose written Vis the mean, systolic and diastolic
pressures from each channel were calculated and displayed on a corresponding front
panel chart (Figure 12). The calculations were performed on the blocks of data,
extracted from the buffer, and results from the previous 15 minutes were continuously
displayed on each chart. A scroll facility allowed data from the entire study to be
accessed at the request of the operator. DV Poly also contained an on-line algorithm to
calculate heart rate. The instantaneous value of heart rate was also displayed.
The duration of each recording epoch, was set using a control on the front panel
of the program. In these studies it was 20 s, ensuring that data from at least 10 cardiac
cycles were available for analysis. Data were stored permanently on disk only when the
operator recruited a subVI of the main program by activating a front panel control.
When the store facility was activated the data were stored in a file which was
automatically identified using a label from the internal clock of the microcomputer. This
label included the date and the running time of the program, in hours, minutes and
seconds. To allow visual appraisal of the saved data, after the data had been written to
disk, the subVI displayed each channel on the Macintosh monitor. The subVI also
displayed a synopsis of the saved data from each channel on the front panel of DV
Poly. This allowed the operators to monitor trends in the data and to ensure that it had
been recorded at all time points specified in the procedure protocol.
Measurement of pressure data
The programme 'DV compute bp, hr etc' calculated the systolic, mean and
diastolic pressures from the four channels averaged from the 20 s of data recorded on
the microcomputer hard disk (Figure 13). Mean pressure from each channel was
calculated by a standard library VI, which measured the arithmetic mean of all the data
points constituting a 20 s sample from each channel. The algorithm to calculate systolic
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and diastolic pressures detected the maxima and minima of the pressure waveforms by
scanning the data to determine when the rate of change of pressure is zero. To avoid
detection of false maxima such as the dichrotic notch on the aortic pressure, the
algorithm only accepted an end point after a pre-determined change in pressure had
occurred. These values could be set by the operator. Their default values were 20 and
10 mmHg for the left ventricle and aortic pressure data respectively. For data obtained
during anaesthesia it was sometimes necessary to reduce one or both of these limits so
that the analysis programme could detect all the maxima and minima of a wave-form.
Heart rate was calculated from the number of maxima detected on channel 1 (the left
ventricular channel).
An additional standard library VI was used as a subroutine to differentiate left
ventricular pressure data from channel 1. The maxima and minima of the resultant trace
were then determined by the purpose written VI used for systolic and diastolic blood
pressure. The average value of the maxima over the 20 s period was the isovolumic
index of left ventricular contractility (LV dp/dt^)
To ensure that all maxima and minima had been correctly identified, as the
programme analysed each channel sequentially, it plotted the waveform in a full screen
window (Figure 14). Also plotted were the maxima (red crosses), minima (blue
crosses) and horizontal lines representing the calculated mean (green), systolic (red) and
diastolic (blue) blood pressures. This ensured that all computer-generated data could be
visually appraised before being accepted. The programme automatically paused at this
screen for 10 seconds for each channel, but this period could be extended by activating
an on-line pause option.
Occasionally e.g. when a micromanometer was opposed to a valve, it was
necessary to perform maxima and minima detection manually by using two electronic
cursors and increasing the scale of both axes (Figure 15). If visual inspection of the
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intermediate window for any channel showed errors in detection of end points the
manual system was also employed. Manual determination was required most often to
obtain the maxima of the differentiated left ventricular pressure waveform. In
anaesthetised horses myocardial depression by halothane reduced the amplitude of the
waveform, so that maxima were not always detected reliably by the software. As the
automated facility detected left ventricular end systolic pressure (LVesP) the cursors
were also used to measure the end diastolic left ventricular pressure (LVedP).
Files corresponding to each data point in a study were analysed sequentially.
Once analysis of each study session was completed the programme was terminated.
The programme then prompted for a result file to store the results of the automated
analysis as a text-delimited spreadsheet. The data was stored in chronological order of
analysis, each row of the spreadsheet corresponding to an individual Labview file from
a single data collection point. The appropriate time identification label was also stored
in the first column of the spreadsheet next to the analysed data. The text-delimited file
was then read into a commercial spreadsheet programme36, missing values of LVedP,
were then entered and other computed values corrected if manual measurement had been
employed.
STATISTICAL METHODS
All statistical manipulations were performed using a commercial software
package, Statgraphics Version 637 on a personal computer. Data was checked for
normality using a normal probability plot. If data showed deviation from normal non-
36 Microsoft Excel Version 5, Microsoft Ltd, Microsoft Place, Wharfedale Road, Winnersh Triangle,
Wokingham, Berkshire, England, UK.
37 Statgraphics, The Bloomsbury Software Co. Ltd, 3 - 6, Alfred Place, London. UK
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parametric statistical analyses were performed. Specific statistical methods and tests are
detailed in the appropriate chapters.
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FIGURES FOR CHAPTER 2
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Figure 1: Equine transoesophageal probe.
A 3.0 MHz, mechanically steered, annular phased array transducer,
mounted at the distal end of a 160 cm human colonoscope.
Note that the steering system of the colonoscope was locked and the
flexibility of its distal end was reduced by the application of heat shrink
material. The oesophagus was lubricated by means of 'Lubrel' delivered
through the added external tubing
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Figure 2: The screen of the vingmed CFM 700 as it appears for 2-D
transoesophageal ultrasonography
1. Displayed in the left upper corner are the pre-set controls (compression,
reject and temporal averaging) The temperature of the transoesophageal
probe is registered below
2. On the far right is a diagrammatic ramp illustrating the settings of the
adjustable gain at the five depth stages.
3. The ECG and frame update traces are displayed at the bottom of the
screen. The far right hand corner of the trace indicates the frame being
displayed in 2-D imaging modes
4. The imaging depth and the frame rate indicator are at the bottom right of
the image sector.
5. The calibration code for calibration of measurement menus during video
playback of stored data is displayed in this position
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Figure 3: Lateral radiograph of the caudo-dorsal thorax of horse 1
A 'U' bend in the transoesophageal echocardiography probe is clearly
visible against the air filled lung.
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Figure 4: Reference 2-D image obtained by transoesophageal
echocardiography
Showing the long axis of the aorta and the left ventricular outflow tract.
PA = pulmonary artery LVOT = Left ventricular outflow tract
AO = Aorta
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Figure 5 : Diagram representing the indices of left ventricular function,
outflow velocities and systolic time intervals measured from
aortic velocity spectra recorded by transoesophageal Doppler
echocardiography.
Peak velocity (V,^) is measured in ms"1. Peak acceleration (dv/dt^) in ms"
2, is measured from the gradient of the line drawn parallel to the maximum
upstroke of the spectral envelope. The line begins at the start of ejection
and stops at the vertical height of the maximum velocity. The area under
the curve (VTI) is measured in cm, and is derived by integrating under a
line traced around the brightest line of the spectral envelope (the modal
velocity). Pre-ejection period (PEP) is measured from the start of the 'Q'
wave of the ECG to the start of ejection, Ejection time (ET) is time
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Figure 6: Front panel of calibration program
The front panel of 'DV Cal Levels' as it appears on the screen of the
Macintosh Ilvi. The virtual instrument (VI) is used for calibration of the
micromanometers. The high and low digital indicators are set by the
operator, to supply the numeric values of the calibration pressures for each
micromanometer. They are used by the VI to calculate a scale and offset for
each transducer. The input channel control selects which transducer (1 or 2)
is being calibrated. The analogue to digital converter has a programmable
gain, which can be adjusted using a front panel control. This facility was
not employed here and the control was set at 1, it's default value
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Figure 7: Characteristic left ventricular and aortic pressure waveforms
Pressure measured from two micromanometers sited in the left ventricle
(upper) and aorta (lower) of a standing horse (Horse 1).
The horse is exhibiting 1 : 3 second degree atrioventricular block, a
common finding in normal Thoroughbred horses. There is a progressive
increase in systemic arterial pressure with conducted beats, which results in
baroreceptor activation and increased vagal tone. In this animal after 3
conducted beats vagal tone is sufficient to block the next beat at the
atrioventricular node.
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Figure 8: Lateral radiograph of neck of Horse 3.
A kink in the micromanometer tipped catheter within the carotid artery is
visible against the air-filled trachea. The kink prevented withdrawal of the
catheter from the arterial sheath introducer.
The catheter was removed by first removing the arterial sheath, followed
immediately by the catheter. Considerable haemorrhage resulted, but there
were no long-term adverse effects to the horse. The catheter was irreparably
damaged.
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Figure 9: Right parasternal long axis view, showing bend in woven
dacron catheter.
The distal strain gauge transducer is hyperechoic and is visible as a bright
white spot at the level of aortic valve (Ml).
AO = Aorta RV = Right ventricle
IVS = Intraventricular septum
The woven dacron catheter has entered the left ventricle with a bend. The
strain gauge transducer at the end of the woven dacron catheter is in the
aorta, whilst the transducer mounted 9 cm more proximal on the catheter
body is in the left ventricular outflow tract. A portion of the curled
catheter body can be seen above the aortic micromanometer entering the
left ventricle. Such errors in catheter positioning can be reduced by
ultrasonographic monitoring.
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Figure 10: Right parasternal long axis view showing distal strain gauge
transducer positioned above the aortic valve
LVOT = Left ventricular outflow tract AO = Aorta
RA = Right atrium RV = Right ventricle
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Figure 11: Right parasternal long axis view showing correctly
positioned strain gauge transducers.
The strain gauge transducers are now correctly positioned on either side of
the aortic valve. The woven dacron catheter was advanced through the
arterial sheath during systole and the distal micromanometer has crossed
the aortic valve.
LVOT = Left ventricular outflow tract AO = Aorta






Figure 12: Front panel of real time data acquisition program, 'DV Poly'
1. Charts used to plot heart rate and mean, systolic and diastolic pressures
from four strain gauge transducers. Each chart displays up to 15 minutes
of real time data (a scrolling facility to access the entire data is also
available). The instantaneous pressure or heart rate is also shown by the
digital indicators on the left of each chart.
2. Digital control 'Hr offset' which determines the pressure change in
mmHg that must occur before the programme counts a maximum value
from the peaks of the pressure wave-form from which to calculate heart
rate.
3. Empty summary chart which is used to store summary statistics from
pressure data saved to hard disc during program execution.
4. Slide control used to set duration of data recording periods.
5. Button to activate record facility.
6. Digital indicator showing instantaneous running time of program. Used
to time and label data acquisition in all studies.
7. Indicator showing number of seconds of pressure data still stored in the
circular data buffer.
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Figure 13: Front panel of data analysis programme, 'DV compute bp, hr
etc'
1. Chart showing first derivative of left ventricular pressure over recording
period. The data is obtained by differentiation of channel 1 by a standard
library VI, used as sub VI in the analysis program hierarchy
2. Charts showing 2 channels of pressure data plotted for recording period.
In this case the upper chart displays pressures from micromanometers in
the left ventricle (blue) and the aorta (red) of horse 4. The lower traces
are derived simultaneously from manometers in the right ventricle (black)
and the pulmonary artery (purple)
3. Offsets for maxima and minima detection are set individually for each of
the channels using a digital control array.
4. The file name of the record being analysed is identified by this indicator.
During acquisition data from each 20 s recording period were stored as
an individual Labview file in a user specified folder by 'DV poly'.
Individual files are identified by labels, corresponding to the actual date
and time the data was recorded.
5. The calculated data, for each channel can be written to a text delimited tab
file, which is displayed as a chart.
73
File Edit Operate Windows Tools





T J J \ i. i—4 i _j *
1




V f i r f in t
120 — HT Tl T 1II100 —
=L60 -
















At Time ( sees) hi? offset
|-|oojio | |-|rooe|
P*«« Veights
HRBPM Sysf BP Me*» BP Dust BP
| 37 II 154 inn I 14 I
51
•
14 58 -* o -OOI |-h' I
si
Figure 14: Intermediate window from the analysis program 'DV compute
bp hr etc'.
During execution the analysis program pauses on data from each channel
sequentially. On a chart showing the raw pressure data, the program
superimposes the maxima (red crosses) and minima (blue crosses),
detected using it's subVI. These deiived points are used by the program
to calculate the average pressure for each recording period. The resultant
calculated value for mean (green), systolic (red) and diastolic (blue)
pressure are also drawn on the chart for visual inspection.
Data shown on the left has been recorded from a micromanometer sited in
the left ventricle of horse 4. There was a premature ventricular contraction
after 15 seconds.
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Figure 15: Labview 2.2.1 charting cursors.
Use of integral cursors within the analysis program allows waveforms to
be measured manually if necessary.
The cursors are shown here, being used to measure the maximum and




ASSESSMENT OF THE REPEATABILITY OF DOPPLER INDICES OF
LEFT VENTRICULAR SYSTOLIC PERFORMANCE
AIMS
The indices of cardiac performance derived from Doppler echocardiography
have been demonstrated to be non-invasive safe methods of assessing cardiovascular
disease and responses to treatment in humans (Ihlen, Amlie, Myhre, Forfang and
Larsen, 1985; Elkayam, Gardin, Berkley, Hughes and Henry, 1983).
Transoesophageal echocardiography has potential to be a useful technique in
anaesthetised horses for monitoring cardiac output and other indices of left ventricular
performance. For the technique to be able to monitor an individual horse and to
establish an individual's response to treatment, it is necessary to determine the reliability
of the technique for detecting serial changes in cardiac performance. Before this can be
achieved it is necessary to determine the day to day, or anaesthetic to anaesthetic,
changes in cardiac performance for a single individual, as well as the range of values
that may be encountered in different individuals. The purpose of this study was to
assess the anaesthetic to anaesthetic variability of the transoesophageal Doppler-derived
indices of cardiac performance in normal horses. To reduce other sources of variation
throughout the study animal management and anaesthetic regimes were standardised.
Similar studies were not available for other more commonly used measurements
including arterial and intracardiac pressure, heart rate and cardiac output measured by
thermodilution. The study additionally assessed the repeatability of measurements of
heart rate, arterial blood pressure, and the invasive index of myocardial contractility,




General anaesthesia and instrumentation
The eight thoroughbred horses described in Appendix 1 were the subjects of
this study. Each horse was anaesthetised and instrumented for transoesophageal
echocardiography as described previously (see page 47). Once the reference 2
dimensional (2-D) long axis view of the left ventricular outflow tract and aorta had been
obtained (Chapter 2: Figure 4), colour flow Doppler echocardiography was performed.
Using the keyboard tracker-ball the sample volume for high pulse repetition frequency
(HPRF) Doppler echocardiography was then positioned in the centre of the vessel just
above the valve in the area with the fastest blood flow shown by the colour flow map.
Faster flowing blood was indicated by a paler red coloration in the colour flow map
(Figure 16), or a blue coloration which occurred when the Nyquist limit (blood flow
velocity > 0.6 m.s') had been exceeded (Figure 17). HPRF Doppler studies were then
performed with the 2-D imaging facility frozen so that the transducer was dedicated to
the acquisition of Doppler information. The Doppler spectra were displayed
continuously on the screen of the echocardiograph and were recorded onto video tape
during data collection.
Left heart catheteration was performed and a calibrated strain gauge transducer
was placed in the ascending aorta and left ventricle (see page 53). General anaesthesia
was maintained with halothane at an end-expired concentration of 0.9%. The constant
end-tidal halothane concentration was maintained for 45 minutes before data were
collected. Intermittent positive pressure ventilation was performed by a mechanical
ventilator to maintain arterial PaC02 between 35 to 45 mmHg. Each horse was
anaesthetised on four separate occasions and 1 month elapsed between each anaesthetic
episode. The allocation of horses to each group of anaesthetic episodes designated by
numeric codes 1-4 was randomised to minimise any effects of ageing or training on
cardiovascular function.
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On the day following the first anaesthetic episode in each horse, nasal and
pharyngeal endoscopy was performed to check for evidence of oesophageal damage
caused by the transoesophageal echocardiography probe.
Data collection and measurement
Mechanical ventilation was stopped at each measurement point. Because
intermittent positive pressure ventilation had maintained normocapnia in the horses,
spontaneous breathing had ceased, so data were always recorded during apnoea.
Twenty seconds of pressure data from each strain gauge transducer was stored on the
hard disk of the Macintosh computer. This was then analysed off-line using the
analysis programme described previously (see page 56). The average mean, systolic
and diastolic pressures for the aortic transducer and the average left ventricular systolic
pressure and heart rate were computed by the programme. The left ventricular end-
diastolic pressure was measured manually using electronic calipers (see page 57). The
left ventricular pressure waveform was differentiated to obtain maximum rate of rise of
left ventricular pressure (Lvdp/dtmax).
All Doppler derived data was measured from the video taped images by a single
observer by manual planimetry using electronic calipers. Measurements from the
spectra comprised; velocity time integral (VTI), maximum acceleration (dv/dtmax),
maximum velocity (Vmax), left ventricular ejection time (ET) and pre-ejection period
(PEP) (Chapter 2: Figure 5). Five consecutive velocity spectra, coinciding with the
period of blood pressure data acquisition, were averaged for each anaesthetic episode.
Cardiac output was calculated using the equation:
Cardiac output = VTI x aortic cross sectional area x heart rate
Aortic cross sectional area was calculated using the equation:
Aortic cross sectional area = 3.14 x (radius)2
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Aortic radius was measured from a 2-D standard transoesophageal image, of the
sino-tubular junction (Figure 18). In this view both walls are imaged with lateral
resolution so that the diameter measurement was performed from centre to centre of
both aortic wall images (Hatle and Angelsen, 1985a). To obtain the diameter, three
measurements were taken during systole from three consecutive cardiac cycles and an
average figure obtained. These 2-D images were recorded onto video tape immediately
before the spectral Doppler recordings.
Statistical analysis
Differences between anaesthetic episodes and horses were assessed using
analysis of variance. When the f ratio was significant (p < 0.05) an estimate of the day
to day variability and within horse variability was determined by calculating the
intraclass correlation coefficient, using the method described by Sokal and Rohlf
(1969). In this method the added variance between groups, Sa2, is first calculated
using the equation:
sa2 = sB2 - sw2
n
Sa2 = measure of the variability between individual horses, (an estimate of the variance
due to error-free variability of different horses)
sb2 = the between group mean square (measure of the variance between horses)
sw2 = the within group mean square (measure of the variance in individual horses)
n = number of horses
The intraclass correlation coefficient (q) is calculated from the equation
h = sA2
sw2 - sA2
The intraclass correlation coefficient represents the fraction of the overall
variability of the measurement that arises due to variability between individual horses.
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It therefore varies from 0 to 1. The more repeatable is a measurement in an individual
the closer q is to 1.
The coefficient of variation was calculated for each variable from pooled data by
dividing the mean value by the standard deviation and expressing the result as a
percentage. 95% confidence intervals for the error-free (or true) value of a measured
variable in a single subject was calculated using the methods described by Moulinier,
Venet, Schiller, Kurtz, Morris and Sebastian (1991). The square root of Sw2 is used to
obtain the standard deviation within individuals.
95% confidence interval for = 2 x sw
a single measurement
sw = standard deviation within individuals.
This value was then expressed as a percentage of the mean. The percentage
difference between two measurements in a single individual must therefore exceed the
95% confidence interval, if the observed difference reflects a real change (p < 0.05).
RESULTS
The probe was placed in the oesophagus successfully in each horse on every
occasion. The stiffened distal portion of the colonoscope made access to the ventral
meatus difficult in horses 2 and 4 and inadvertent introduction into the middle meatus
resulted in nasal haemorrhage on five occasions in horses 2, 4 and 8. Haemorrhage
was of limited extent and duration, and had always stopped before the horse recovered
from anaesthesia. If the probe entered the middle meatus, increased resistance to its
passage was detected before reaching the pharynx, the probe was then withdrawn and
re-introduced into the ventral meatus. On the day after each study all horses had mild
serous nasal discharge from the nostril that had housed the transoesophageal
echocardiography probe. Endoscopy revealed slight mucosal reddening of the ventral
nasal meatus but there was no evidence of inflammation along the length of the
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oesophagus. The nasal discharge had ceased within 48 hours of recovery from
anaesthesia except in one animal (Horse 3) on one occasion. Radiography of Horse 3
at this time revealed a fluid line in the left maxillary sinus and endoscopy showed
evidence of nasal mucosal inflammation. Clinical and radiographic signs had resolved
after 7 days of antibiotic treatment.
Once the oesophageal probe was fully inserted the reference 2-D view of the left
ventricular outflow tract and aorta was obtained within 5 minutes. The image was
obtained after between 130 - 145 cm of scope had been inserted in all horses: the depth
was repeatable for each individual. A long axis view of the left atrium and left
ventricular inflow was also observed, but this was not specifically studied.
Spectral Doppler recordings taken from aortic blood flow were of uniform high
quality, only minor adjustment or rotation of the probe being required to maintain clear
audible signals and velocity spectra (Figure 19).
Table 2 shows the pooled data for all measured variables. Analysis of variance
revealed significant differences between horses for heart rate, Vmax, and VTI.
Intraclass correlation coefficients were calculated for these variables. No significant
differences between anaesthetic episodes were found for any of the measured variables.
Table 3 shows data from each anaesthetic episode averaged for each horse, the
coefficient of variation indicates the variability of cardiovascular function of individual
horses. In Table 4 the data is averaged for all horses for each anaesthetic episode, the
coefficients of variation therefore reflect the variability between horses. Graphs la to
13a (Appendix Chapter 3, Page 230) are box and whisker plots of all the measured
variables plotted for individual anaesthetic episodes and Graphs lb to 13b (Appendix
Chapter 3, Page 230) are similar plots, but the variables are grouped for individual
horses.
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The present study shows that transoesophageal echocardiography is well
tolerated in anaesthetised Thoroughbred horses and although the number of two
dimensional images obtained was limited compared to human studies, a long axis view
of the left ventricular outflow tract and aorta was always obtained. Nasal haemorrhage
was an undesirable complication of probe insertion in 3 animals. Horse 2 was
consistently the most difficult to intubate, although haemorrhage did not result on every
occasion. The mare was not the smallest animal of the group, but she did have a long
face with slightly roman nose that tapered to the nares (Figure 20). This problem had
not been experienced before the distal end of the transoesophageal echocardiography
probe was stiffened. The reduction in flexibility presumably reduced access to the
ventral meatus by limiting the operator's ability to manipulate the tip of probe in the
nostril, a problem which seemed to be accentuated in certain animals because of upper
airway anatomy. This difficulty could probably be eliminated if the probe was
redesigned.
The mild serous nasal discharge which occurred consistently after
transoesophageal echocardiography was not considered to be a serious complication in
these healthy Thoroughbred horses. Nosocomial sinusitis is well recognised in human
patients after nasotracheal intubation (Rouby, Laurent and Gosnach, 1994). There is
still controversy whether poor sinus drainage, or the trauma associated with the tube are
primary causes for the maxillary sinusitis that invariably occurs in humans. The
maxillary sinus is an ideal location for resistant infections because it is shielded from
full antibiotic penetration, and can thus provide a source of bacteria for septicaemia in
critically ill humans (Heffner, 1994). Radiographic evidence of unilateral sinusitis was
obtained from Horse 3, and its presence cannot be ruled out in the other horses,
certainly evidence of mechanical trauma to the nasal mucosa was demonstrable in the
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horses 24 hours after transoesophageal echocardiography. In this study all the
symptoms were short-lived and were considered to be of little clinical consequence,
however it is possible that a larger series would reveal that significant sinusitis did
occur especially in the presence of other upper respiratory tract pathogens.
The axial alignment of the aorta and left ventricular outflow tract with the
ultrasound beam in the reference long axis transoesophageal view was ideal for Doppler
echocardiography. High quality velocity spectra, which were suitable for derivation of
ejection phase indices of left ventricular function, were readily obtained using high
pulse repetition frequency Doppler insonation.
Management of the horses in the study was controlled with respect to diet,
exercise and environment. Anaesthetic technique was standardised, and intraoperative
arterial blood gas tensions were maintained within fixed limits. The effects of these
sources of variance on the measured haemodynamic variables within each study, should
therefore have been minimised. All measured variables showed marked variation,
indicated by coefficients of variation greater than 10% and wide 95% confidence
intervals (Table 2). Since variation in a biological measurement made on a particular
animal on different occasions dictates it's sensitivity for detecting serial changes,
allowance must be made for this when the measurement is to be used to detect
responses to treatment. Variation between individuals also influences the normal range
of a measurement, and must be defined, if the measurement is to be used to help define
disease or abnormal function. For physiological data these two sources of variation can
be of differing relative importance. When haemodynamic data is considered, the
situation is complex. If the heart rate of a group of horses is measured by auscultation
considerable variation will be detected. Auscultation is expected to measure heart rate
with almost 100% accuracy, so that the observed variation must reflect differences
between individual horses. If the horses are ausculated on a second occasion, it is
unlikely that each horse will have the same heart rate as on the first examination, the
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magnitude of this variation within individuals describes the variable's repeatability. The
ability of auscultation to measure these heart rates correctly on each occasion indicates
the reliability of the auscultatory technique. With any measurement technique,
measurement errors can also contribute additional sources of variation to biological
data, so reliability is an important consideration for new methods.
In this study significant differences in measured variables between individual
horses was assessed using analysis of variance. Statistically significant differences
were detected in heart rate, Vmax, and VTI. The use of intraclass correlation coefficient,
r„ has been used as an index of measurement technique reliability (Landis and Koch,
1977). It provides a number between 0-1, for which 1 which indicates perfect
repeatability. Moulinier, Venet, Schiller, Kurtz, Morris and Sebastian (1991) reported
a very similar study of day to day reliability of Doppler derived VTI measurements in 7
conscious human volunteers kept under tight environmental control. They used
transthoracic echocardiography to obtain the aortic velocity spectra and also measured
heart rate and arterial blood pressure. If the same calculation for the correlation
coefficient, r: described by these workers is used on data from the present study the
values obtained for heart rate are very similar (0.60 for conscious humans compared to
0.57 for anaesthetised horses). The value obtained for VTI was considerably higher in
the human study (0.87 cf. 0.51), indicating that VTI measurement varies little between
days in conscious humans, whilst there was relatively more variation between different
anaesthetic episodes for horses. These workers presented similar findings for systolic
and diastolic arterial blood pressure (r, = 0.85) indicating that there is also minimal day
to day variation of blood pressure. This contrasts with findings in the present study in
anaesthetised horses when analysis of variance failed to reveal significant differences
between individual animals, because variation between anaesthetic episodes was so
great. It was therefore inappropriate to calculate an intraclass correlation coefficient for
the equine blood pressure data (Sokal and Rohlf, 1969), making direct comparison with
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the human study impossible. However the 95% confidence intervals for a single blood
pressure measurements can be compared for the two species; in conscious humans this
value was less than 10%, compared to 35% and 45% for systolic and diastolic aortic
pressure measurements in anaesthetised horses. If the errors in blood pressure
measurement technique are similar in both studies it must be concluded that general
anaesthesia in horses interferes with normal homeostatic control of arterial blood
pressure.
In the present study, heart rate, Vmax, and VTI were the only variables for
which significant differences were detected between individual horses. The source of
this variation is more clearly illustrated in Table 3 and throughout Graphs 1-13
(Appendix Chapter 3, Page 230). If Graphs la and lb are examined two horses (1 and
6) show much higher individual variation in heart rate than the rest of the group. Horse
1 was noted to have second degree atrioventricular block and a heart rate of 22 during
anaesthetic episode 2. In the other three episodes the horse was in normal sinus rhythm
with a mean rate of 30 beats per minute. Dysrhythmias have important effects on all
indices of myocardial performance and in this horse second degree atrioventricular
block was probably responsible for the very high coefficients of variation of dv/dtmax
and LVdp/dtmax- Examination of the raw data revealed this to be the case, aberrant high
values for dv/dtmax and LVdp/dtmax were also present during anaesthetic episode 2. In
Horse 6 the high coefficient of variation was not associated with a single anaesthetic
episode. Marked variation of heart rate between horses is illustrated by Horse 4 which
maintained a higher heart rate in all anaesthetic episodes. Left ventricular end-diastolic
pressure showed the highest variation of all pressure measurements. The reason for
this is unclear, measurements were always taken during apnoea, so respiratory effects
should not be responsible. Left ventricular end-diastolic pressure has been used as an
index of preload for normally compliant ventricles. The value of 47% for the 95%
confidence interval for a single measurement of left ventricular end-diastolic pressure
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(Table 2) indicates that this variable must be used with caution for assessing the effects
of treatment on preload in individual anaesthetised horses.
The main source of error in the measurement of linear velocity by Doppler
echocardiography arises from poor alignment of the ultrasound beam with the direction
of blood flow (Hatle and Angelsen, 1985b; Angelsen and Brubakk, 1976). The
measured velocity of blood flow is proportional to the cosine of the angle between the
direction of blood flow and the insonating beam. If this angle is less than 18° this will
give a maximum error of +/- 5% in velocity measurement. The standard 2-D image
obtained by transoesophageal echocardiography in horses suggested that alignment with
aortic flow in two dimensions was good (Figure 18). Alignment in the other plane is
difficult to assess but the clarity of the audible signals indicated that the beam was well
aligned to blood flow and these are the criteria accepted in human in-vivo studies (Hatle
and Angelsen, 1985a). It is therefore considered unlikely that poor alignment provided
a significant source of error in the present study.
Although operator errors associated with measurement of the Doppler-derived
indices are a possible source of error in this study, most variation was associated with
variables derived from aortic and left ventricular pressure measurement. The high
fidelity micromanometers and recording system used in these studies were calibrated
frequently and are considered to have measured pressure accurately. The greatest
coefficient of variation and widest 95% confidence intervals were found in the index of
left ventricular contractility, LVdp/dtmax. It might be expected that a similar amount of
physiological variation would occur in the indices of ventricular performance derived
simultaneously from Doppler echocardiography. In this study however the coefficient
of variation and 95% confidence intervals were narrower for the Doppler-derived
variables than for those obtained by cardiac catheterisation. Doppler indices of
ventricular performance are ejection phase indices, occurring after the aortic valve has
opened. In contrast LVdp/dtmax is an isovolumic index of left ventricular contractility.
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Marked variation in aortic diastolic pressure in these anaesthetised horses may explain
the poorer repeatability of LVdp/dtmax. Reduction in aortic diastolic pressure is known
to influence LVdp/dtmax since the aortic valve opens before maximum tension has been
produced by the contracting myocardium (Borow, Neumann, Marcus, Sareli and Lang,
1992; Wallace, Skinner and Mitchell, 1963). Marked variation in left ventricular end-
diastolic pressure, and therefore ventricular preload, also occurred in these studies
which would be expected to influence all the indices of cardiac performance (Bedotto,
Eichhorn and Grayburn, 1989). The increased variability associated with the
isovolumic index in the present study suggests that it may be more sensitive to changes
in afterload and preload than the indices derived from transoesophageal Doppler
echocardiography. Alternatively the relative increase in variability of LVdp/dtmax may
reflect increased measurement error rather than true physiological variation.
Maximum aortic acceleration showed much higher coefficient of variation than
the peak velocity (Vmax). This is in agreement with a study performed in experimental
dogs (Wallmeyer, Wann, Sagar, Czakanski, Kalbfleish and Klopfenstein, 1988).
Gardin, Dabestani, Martin, Alfie, Russel and Henry (1984) attributed a similar finding
in humans to technical difficulties in defining dv/dtmax from the velocity spectra. Peak
velocity is much easier to identify and small errors in identifying dv/dtmax are magnified
by differentiation.
In summary it appears that indices of cardiac performance derived from Doppler
echocardiography can be obtained reliably in anaesthetised horses using
transoesophageal echocardiography. At first sight the repeatability of the indices may
be considered disappointing when compared to similar studies performed in conscious
humans. However this difference may be attributable to changes in homeostatic control
of cardiovascular function imposed by general anaesthesia, rather than reflecting true
species differences, or inadequacy in the measurement techniques. In conscious
humans blood pressure data was strongly repeatable between days for given individuals
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in marked contrast to the situation in anaesthetised horses. In humans blood pressure is
kept under tight physiological control (Haites, McLennan, Mowat and Rawles, 1984)
and unpublished work in horses suggests that the situation is similar for both arterial
blood pressure and Doppler-derived indices of cardiac performance when horses are
conscious. The poor repeatability detected when the same animals were anaesthetised
could arise because the anaesthetic techniques were sufficiently different on each
occasion to change haemodynamic function. This situation cannot be ruled out, but on
a practical level the anaesthetic procedures in these studies were standardised within the
limits of currently available expertise and equipment. An alternative explanation may be
that general anaesthesia interferes with the normal homeostatic regulation of
cardiovascular performance in anaesthetised horses.
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FIGURES FOR CHAPTER 3
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Figure 16: Colour Doppler echocardiography study of the aorta.
The red colour shows flow from left ventricular outflow tract to aorta
during systole. The lighter shades of red indicate a central core of faster
flowing blood in the centre of the vessel. For high pulse repetition
frequency pulsed Doppler studies the sample volume was positioned in the
centre of the central core above the aortic valve.
The timing of this frame is represented by the ECG in the far right of the
figure.
AO = aorta LVOT = left ventricular outflow tract
PA = pulmonary artery
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Figure 17: Colour Doppler echocardiography study of the aorta.
Systolic frame showing blood flow from left ventricular outflow tract to
aorta. In this frame velocity of blood flow has exceeded the Nyquist limit
of 0.6 ms1 as a result velocity has been coded in shades of blue as if it
were moving in the opposite direction.
AO = aorta LVOT = left ventricular outflow tract
PA = pulmonary artery
In this example which is taken from a later study, the bright echo in the
lumen of the pulmonary artery is caused by reflection from the balloon of a
Swan Ganz catheter, inserted during comparative studies with
thermodilution (chapter 4)
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Figure 18: Reference 2-D image of aorta and left ventricular outflow
tract from transoesophageal echocardiography
The long axis of the aorta is parallel to the ultrasound beam which results in
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Figure 19: Typical appearance of an HPRF Doppler study of aortic blood
flow in an anaesthetised horse
The colour flow study of the aorta and left ventricular outflow tract, used to
position the Doppler sample volume, was always frozen during spectral
Doppler studies. The shrunken frozen image is displayed above the
velocity information.
The velocity scale in ms1 is depicted on the right hand axis. Because blood
is flowing towards the transducer it is plotted above the baseline.
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Figure 20: Horse 3, Vivienne.
This horse was consistently the most difficult to intubate, the
transoesophageal echocardiography probe always tended to enter the
middle, rather than ventral nasal meatus.
The horse was the largest of the group of mares, so the problem is not one
of body size. The mare has a long narrow head which tapers towards the
nostrils and this may be a guide to the confirmation of the nasal meatus.
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CHAPTER 4:
COMPARISON OF CARDIAC OUTPUT MEASUREMENTS FROM
TRANSOESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY WITH
THOSE OBTAINED BY THERMODILUTION
INTRODUCTION
Transoesophageal Doppler echocardiography provides a non-invasive
alternative for measurement of cardiac output in anaesthetised horses. Ideally if a new
measurement technique is proposed it should be compared to a standard method which
measures the variable with known accuracy (Bland and Altman, 1986). Unfortunately
no such standard exists for cardiac output measurement in the intact animal (Schuster
and Nanda, 1984). The thermodilution or dye dilution methods have gained widest
acceptance in clinical practice and both have been employed in horses (Dunlop,
Hodgson and Chapman, 1992; Muir, Skarda and Milne, 1976; Hillidge and Lees,
1975; Fisher and Dalton, 1959). Thermodilution is generally favoured over dye
dilution because use of a thermal indicator ensures that multiple measurements can be
made in a single individual without indicator accumulation compromising accuracy.
The potential for allergic reactions to the dye and the necessity to withdraw blood from
the patient are also factors which have encouraged more widespread use of
thermodilution (Schuster and Nanda, 1984).
Measurement of cardiac output by thermodilution
In this technique a known volume of cold fluid is injected into the right atrium.
A temperature sensor positioned in the pulmonary artery registers the change in
temperature caused by dilution of the thermal indicator with the blood. Measurement of
cardiac output by thermodilution was first described in anaesthetised dogs by Fegler
(1954). A flow directed pulmonary arterial catheter to facilitate thermodilution
measurements was subsequently developed by Swan, Ganz, Forrester, Marcus,
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Diamond and Chonnette (1970). The catheter contained two lumens, one opening at the
distal extremity and the other 10 cm more proximal. The proximal lumen allowed
thermal indicator to be administered into the right atrium through the same catheter as
housed the thermistor. The distal lumen allowed measurement of pulmonary artery
pressure and facilitated sampling of mixed venous blood. The catheter was introduced
into clinical use in humans a year later by the same group (Forrester, Ganz, Diamond,
McHugh, Chonnette and Swan, 1972). These balloon-tipped, flow-directed catheters
are now used extensively for thermodilution measurements in human medicine and have
become known as Swan Ganz catheters.
In the thermodilution technique temperature changes in the pulmonary artery are
recorded by an analogue computer. The computer measures the area under the blood
temperature curve after the thermal injectate has been administered. Cardiac output
(CO) is then determined using the following equation:
CO = (Blood Temp - Injectate Temp) x Injectate Volume
Integral of the dilution curve
Temperature is measured in °C
Integral is measured in degree minutes
Volume is measured in mis
Cardiac output is measured in L.min"1
The thermodilution technique relies upon accurate measurement of injectate and
blood temperature, small errors in either measurement have very large effects on
calculated cardiac output. To minimise measurement errors the pulmonary artery
temperature must be measured directly, not estimated from rectal temperature, and the
injectate temperature should be measured directly by a calibrated thermal sensor placed
in the injectate fluid (Levett and Replogle, 1979).
There is conflicting evidence to the relative merits of using iced versus room
temperature fluids in the medical literature. Traditionally injectate, cooled to between 0
99
- 4 °C was recommended as thermal indicator (Sorensen, Bille-Brahe and Engell, 1976;
Weisel, Berger and Hechtman, 1975). A large temperature difference between injectate
and blood results in increased amplitude of dilution curve. Physiological fluctuations in
pulmonary artery temperature, superimposed on the temperature changes caused by
cold fluid injection cause relatively greater errors when the curve is of low amplitude
(Elkayam, Berkley, Azen, Weber, Geva and Henry, 1983). However there are
practical and theoretical problems associated with use of iced injectate which may in
themselves cause inaccuracies and counteract the improved signal to noise ratio of the
temperature curve. When cold fluids are used the temperature of the injectate can be
reduced in the catheter before reaching the right atrium, heat being lost to the
surrounding blood and tissues. Such indicator loss is an error inherent in the
thermodilution technique, since it is impractical to measure injectate temperature directly
at the site of administration. As the temperature differential between injectate and blood
is increased by lowering the injectate temperature, the greater is the loss of thermal
indicator by this route and the greater the measurement errors (Meisner, Glanert,
Steckmeier, Gams, Hagl, Heimisch, Sebening and Messmer, 1973). Second handling
and measuring the temperature of iced indicators is more difficult. When fluid has been
stored at room temperature, temperature measurement is easily performed and usually
truly reflects the temperature of all the fluid in the injectate. In contrast Levett and
Replogle (1979) showed that at least 60 minutes are required before a 5 cc syringe
containing 5% dextrose solution reaches the same temperature as a surrounding ice
bath. The time required for larger volumes ( > 40 mis) needed in horses has not been
evaluated, but the long equilibration time needed would undoubtedly cause practical
difficulties when multiple measurements were to be made.
Both lowering injectate temperature, or increasing its volume will increase the
amount of thermal indicator and augment the temperature change registered. If the
volume of injectate is increased, the signal to noise ratio of the curve is improved, and
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acceptable "dilution curves" can be obtained from room temperature injectate in human
patients. In fact clinical studies in humans failed to demonstrate greater reproducibility,
or accuracy, in cardiac output measurements when 10 mis of room temperature injectate
were used instead of 10 mis of an iced solution (Pearl, Rossenthall, Nielson, Ashton
and Brown, 1986; Elkayam, Berkley, Azen, Weber, Geva and Henry, 1983). Use of
large injectate volumes probably explains why adequate thermodilution curves have
been obtained in adult horses when room temperature saline was used as a thermal
indicator (Long, Young, Jones, Darke and Utting, 1992). Although this finding
contradicts the findings of Muir, Skarda and Milne (1976), who demonstrated
decreased correlation of thermodilution with dye dilution when room temperature
injectate was used in horses, this discrepancy can probably be explained by the
difference in the reported ambient temperature of the two studies (27 °C for Muir,
Skarda and Milne, 1976, and 12 - 15 °C for Long, 1993).
Errors in measurement of cardiac output by thermodilution can also be caused
by inadequate mixing of injectate and blood, a situation which results in an irregular
thermodilution curves (Pavek, Pavek and Boska, 1970). As a result it is recommended
that the shape of the dilution curve should be inspected before any associated
measurement is accepted (Levett and Replogle, 1979).
Cardiac output is traditionally calculated from the mean of three individual
thermodilution measurements obtained within a period of a few minutes. It has been
demonstrated that the variability of the measurement is minimised when this approach is
adopted (Elkayam, Berkley, Azen, Weber, Geva and Henry, 1983; Stetz, Miller, Kelly
and Raffin, 1982). The optimal timing of thermodilution estimates within the
respiratory cycle is also subject to some controversy (Snyder and Powner, 1982).
Blood temperature in the pulmonary artery is known to fluctuate with respiration
(Alfonso, Herrick, Youmans, Rowe and Crumpton, 1961). This is illustrated by the
baseline variations in the early part of the lower trace of Figure 21. The trace is derived
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from a thermistor sited in the pulmonary artery of an anaesthetised horse. The
inspiratory cycle of the mechanical ventilator in this case results in an overall increase in
intrathoracic pressure which elevates the baseline of the upper pulmonary artery
pressure trace in Figure 21. From these traces it can be appreciated that the baseline
fluctuations in pulmonary artery pressure coincide with those of pulmonary arterial
blood temperature. To minimise the effect of this unstable baseline on cardiac output
measurements in the present studies the horses were mechanically ventilated and
estimates were always obtained during apnoea after the mechanical ventilator was
switched off.
The true accuracy of thermodilution for measuring absolute flow remains in
doubt. Mackenzie, Haites and Rawles (1986) demonstrated that during conditions of
pulsatile flow three commercially available cardiac output computers agreed better with
each other than with absolute flow. From this they concluded that factors resulting in
lack of accuracy with pulsatile flow affected all computers similarly. Transition from
continuous to pulsatile flow in the Mackenzie, Haites and Rawles model doubled the
confidence intervals for a single measurement for each computer. All the computers
substantially overestimated absolute flow during pulsatile flow conditions. The authors
explain this by consideration of the time base of the flow calculation. A true estimate of
flow will only be obtained if the time base used for the integration comprises a whole
number of cardiac cycles. If the sample starts and ends during a period of diastole or
static flow, cardiac output will be underestimated, the reverse occurring if computation
starts and ends during systole, a high flow period. Individual computers also differ in
the method used to integrate under the thermodilution curve, especially in defining the
tail of the curve. The shorter the time base used for integration the greater will be the
sampling errors during pulsatile flow conditions. Arrythmias provide an additional
source of error, and the high incidence of second degree atrioventricular block and
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sinus arrhythmia in thoroughbred horses can increase sampling errors for
thermodilution measurements in this species.
Despite widespread acceptance in clinical medicine studies evaluating the
accuracy of the thermodilution technique are lacking. Apart from the study performed
by Mackenzie, Haites and Rawles (1976) most in vitro studies have utilised continuous
flow models, which are likely to overestimate the accuracy and repeatability of the
technique. Accuracy of the technique in a high flow, low frequency, pulsatile model,
corresponding to the situation in horses not been addressed. Jarvis, Woliner and
Steffey (1992) evaluated a commercial thermodilution computer at flows between 8 and
50 L.min1 in an artificial circulation. However use of a continuous flow pump in their
model means their results may not represent the in-vivo situation. The majority of in-
vivo studies have evaluated the technique against estimates of cardiac output by dye
dilution in both humans (Ganz, Donoso, Marcus, Forrester and Swan, 1971) and
horses (Dunlop, Hodgson and Chapman, 1992; Muir, Skarda and Milne, 1976).
However both techniques are indicator dilution methods, and are therefore subject to
similar errors, calling the validity of this comparison into question (Stetz, Miller, Kelly
and Raffin, 1982). Despite these technical limitations many authors conclude that
provided that the sources of error are fully appreciated and the technique is
standardised, the thermodilution method provides as reasonable a means of cardiac
output measurement as the other techniques available (Schuster and Nanda, 1984;
Levett and Replogle, 1979), and therefore can be used as a reference method (Stetz,
Miller, Kelly and Raffin, 1982).
Aims of Chapter 4
Cardiac output estimations made by transoesophageal echocardiography were
compared to those obtained using thermodilution in anaesthetised horses over a range of
cardiac output. For each Doppler derived estimate two separate comparisons were
made; the first using a thermodilution estimate derived simultaneously and the second
103
using a composite mean of three thermodilution measurements made in quick
succession. Spectra were obtained using both continuous wave (CW) and high pulse




The eight thoroughbred horses described in Appendix 1 were the subjects of
this study. Each horse was anaesthetised and instrumented for transoesophageal
echocardiography as described previously. General anaesthesia was maintained with
halothane at an end expired concentration of 0.9%. Intermittent positive pressure
ventilation was performed by a mechanical ventilator to maintain arterial PaC02 between
35 to 45 mmHg.
Once positioned on the operating table two percutaneous catheter introducer
sets38 were inserted into the horse's right jugular vein, using the percutaneous Seldinger
technique (Grossman, 1992). A 150 cm long thermodilution catheter39 (OD = 2.31
mm) was inserted through one introducer until pressure recordings from it's distal port
indicated that it was situated in the pulmonary artery. Pressure waveforms were
derived by connecting the distal catheter lumen, via a fluid line, to a disposable strain
gauge transducer40. The strain gauge transducer was connected to an amplifier within
the cardiac output computer whose output was displayed on one channel of a two
channel chart recorder41 (Figure 21).
38 Haemaquet, 9F. Bard Ltd, Forest House, Brighton Road, Crawley, West Sussex, England, UK.
39 Columbus Instruments, 950N North Hague Avenue, Columbus Ohio, USA.
40 DTX Plus Transducer, Viggo-Spectramed, Faraday Road, Dorcan, Swindon, Wiltshire, UK.
41 Multitrace 2, Lectromed Ltd, Unit 26, The Business Centre, Avenue One, Letchworth Garden City,
Hertfordshire, England, UK.
104
The thermodilution catheter was equipped with a proximal port, but high
internal resistance to flow precluded it's use for thermal indicator administration. A
separate introducer catheter was made for this purpose from a 200 cm length of
polyethylene tubing42 (OD = 1.6 mm). The atrial end of the catheter was sealed closed
by heat from a Bunsen burner. Five holes (D = 0.5 mm) were then pierced along the
final 4 cm of catheter body, using a hot 14 gauge intravenous needle. The open end of
the tubing was forced over the body of 14 gauge intravenous needle. The hub of the
needle was then connected to the pressure injector. A test injection of 45 mis of fluid
was then made through the catheter using the pressure injector to ensure that flow
occurred evenly through the side holes and that injection was completed within 3
seconds. The catheter was then sterilised using ethylene oxide.
The catheter was pre-filled with heparinised saline (5 IU per ml) and introduced
into the right atrium by advancing it down the second percutaneous introducer set. For
location in the right atrium the polyethylene catheter was connected to the pressure
transducer, and advanced down the introducer until a characteristic right ventricular
pressure waveform was obtained. It was then withdrawn until the pressure trace
indicated it had just re-entered the right atrium. With the catheter in position a test
injection with 45 mis of 0.9% saline was carried out whilst observing a two
dimensional (2-D) image of the right atrium obtained by transthoracic
echocardiography. Correct catheter placement was confirmed by the sudden short-lived
appearance of multiple echogenic speckles in the right atrium, coinciding with injection.
These echoes were caused by microbubbles present in the injectate. This simple
technique to provide echogenic contrast is widely used in clinical echocardiography to
diagnose atrial septal defects and right to left intracardiac shunts (Carlsten and Nilfors,
1986). At intervals throughout each study (before each new batch of measurements
42 800/200/225, Portex, Arterial Medical, Arterial House, 313 Chase Road, South Gate, London, UK.
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began) the contrast technique was repeated to confirm that the atrial catheter was still
correctly positioned.
MEASUREMENT OF CARDIAC OUTPUT
Thermodilution technique
A Cardiomax II model 85 cardiac output computer43 was used to measure
cardiac output by thermodilution. Blood temperature was measured directly from the
thermistor situated on the indwelling pulmonary arterial catheter.
For the Cardiomax II a calorific difference of at least 100 calories is necessary to
obtain dilution curves that are adequate for integration44. Calorific difference was
calculated from the equation:
Calorific difference = (Blood Temp - Injectate Temp) x Injectate Volume
Blood temp and injectate temp are measured in °C
Injectate Volume is measured in mis
Calorific difference is measured in calories
Previous work using the same instrument demonstrated that satisfactory dilution
curves could be obtained from standing horses when 45 mis of room temperature saline
was injected using a pressure injector through a separate catheter in the right atrium
(Long, Young, Jones, Darke and Utting, 1992). This combination of injectate
temperature and volume exceeds the minimum calorific difference specified by the
manufacturers of the Cardiomax II. The pressure injector was driven by compressed
air at an operating pressure of 30 pounds per square inch (psi) which ensured that the
charge of 45 mis of injectate was delivered within 3 seconds, as recommended by Ganz
and Swan (1972). The dilution curves were displayed on the second channel of the two
channel chart recorder allowing visual inspection of each curve. Only measurements
43 Columbus Instruments, 950N North Hague Avenue, Columbus Ohio, USA.
44 Cardiomax II Model 85, Operators instruction manual, Columbus Instruments, 950N North Hague
Avenue, Columbus Ohio, USA.
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from dilution curves with a characteristic fast attack slope and a slower return to
baseline were accepted (Figure 21: lower trace). Cardiac output estimations derived
from curves which did not satisfy these criteria were excluded.
Injectate temperature was measured using a calibrated platinum thermistor
supplied with the Cardiomax II. The probe was placed in an upturned plastic 50 ml
syringe case which contained 0.9% saline solution. The syringe case was fixed to the
front of the computer unit, which was stored in the operating room throughout the
studies. The bags containing 0.9% saline, used as thermal indicator, were also stored
at the same temperature. The injectate temperature was not measured directly by the
thermistor but equilibration of both injectate fluid and the saline surrounding the
platinum probe with ambient temperature was assumed. During these studies the
ambient temperature varied between 14.4 and 19.2 °C.
Doppler echocardiography technique
Data from HPRF and CW transesophageal echocardiographic studies were measured
by a single observer from video-taped images of aortic blood velocity spectra. Cardiac
output was calculated from aortic velocity spectra using the equation:
Cardiac output = VTI x aortic cross sectional area x heart rate
VTI = Area under the velocity spectra (velocity time interval)
Area under individual velocity envelopes (VTI) was measured by manually
tracing the spectra using the keyboard track-ball. The resultant area was digitised by
software within the echocardiograph. The modal velocity or brightest line in the
velocity envelope, was used to delineate the area beneath spectra derived from HPRF
studies (Figure 22), whilst maximum velocity was used for CW envelopes (Figure 23).
Doppler signals from 5 consecutive cardiac cycles were measured for each cardiac
output estimation and the mean velocity time interval and heart rate for the group of five
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cycles was then calculated. Heart rate was calculated from the 5 corresponding RR
intervals from the electrocardiogram of the ultrasonograph.
Aortic cross-sectional area
Cross sectional area of the aorta was calculated using the equation:
Aortic cross sectional area = 3.14 x (radius)2
Three separate estimates of aortic radius were obtained by measuring the
diameter from three different 2-D echocardiographic images of the aorta. The first was
obtained at the sino-tubular junction from a standard 2-D transoesophageal image
(Figure 24). In this view the anatomical boundaries of the vessel are parallel to the
ultrasound beam, resulting in considerable lateral broadening and poor lateral resolution
(Feigenbaum, 1993). According to the recommendations of Hatle and Angelsen
(1985a) the diameter was measured perpendicular to its long axis by a line joining the
middle of the band of echoes corresponding to the vessel walls.
Since optimal resolution of anatomical structures occurs when the ultrasound
beam is perpendicular to the acoustic interface (Feigenbaum, 1993), two further
estimates of vessel diameter were obtained from transthoracic echocardiography. A
parasternal long axis view of the aorta was obtained from the right axilla using the 2.35
MHz probe (Long, Bonagura and Darke, 1992). The diameter of the vessel was
measured above the sinuses of Valsalva by a leading edge to leading edge method
(Figure 25). The final measurement was obtained from a similar right parasternal view,
angled slightly to bring the left ventricular outflow tract into long axis (Figure 26). The
diameter of the aortic valve annulus was then measured from its trailing edge to leading
edge. This methodology was employed because these interfaces were usually best
defined for caliper placement.
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To obtain each diameter, three measurements from each site were taken during
systole from three consecutive cardiac cycles and an average figure obtained. The 2-D
images needed for the measurements were recorded onto video tape immediately before
each study period. Three separate cardiac output calculations were then made using the
three estimates of vessel area for every Doppler echocardiographic recording.
Timing of cardiac output measurements
Mechanical ventilation was discontinued before each cardiac output
measurement, the ventilator was switched off in the expiratory pause just after an
inspiratory cycle was complete. Injection of thermal contrast was initiated by pressing
the pressure injector foot pedal, to coincide with the second 'p' wave of the ECG after
the ventilator was stopped. The record facility of the VHS video recorder on the
Vingmed CFM 700 was was also activated. Spectral Doppler data were recorded until a
complete thermodilution curve had been traced on the two channel chart recorder, or at
least five complete spectra had been recorded. Provided the dilution curve was
acceptable the computed thermodilution cardiac output value was labelled with a time in
hours, minutes and seconds. The time coincided with the end of the injection of cold
contrast indicated by the sound of the pressure injector barrel refilling, it was read from
the internal clock of the echocardiograph. Since this time was also recorded onto the
video tape with the velocity spectra it ensured that the measurements made later from
Doppler data were simultaneous with the corresponding measurement by
thermodilution.
According to the manufacturers instructions at least 60 seconds were allowed to
elapse between consecutive thermodilution measurements. The insonation mode of the
Doppler echocardiograph was changed from HPRF to CW and a second thermodilution
cardiac output measurement was made to coincide with recording of resultant velocity
spectra. The final, third thermodilution measurement was made without a
corresponding Doppler recording.
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In the study two separate comparisons between CW and HPRF derived cardiac
output estimations and thermodilution measurements were made. Both HPRF and CW
spectra were paired with a thermodilution measurement obtained simultaneously. This
was used to provide the instantaneous value for the first comparison (instantaneous).
For each pair of HPRF and CW spectra a total of three thermodilution cardiac output
values were available (1 simultaneous with HPRF, 1 with CW, and 1 taken in
isolation). The three thermodilution estimates were always obtained within four
minutes of each other. The three measurements were then averaged to give a mean
value, which was used for the second of the comparisons of thermodilution with both
HPRF and CW techniques (mean of 3 thermodilution).
Study protocol
A group of five sets of three thermodilution measurements with associated
Doppler recordings constituted a set of data for each horse at each cardiac output level.
After the first group of 5 sets was complete the cardiac output was increased by the
continuous infusion of the Pi adrenoreceptor agonist, dobutamine45, at 2 pg.kg-fmin-1
through a pre-placed jugular catheter. After fifteen minutes cardiac output estimations
were repeated. The infusion rate was then increased to 4 pg.kg'fmin"1, and after a
further 15 minutes, the final set of cardiac output data were collected. At the start of
each data acquisition period 2-D images were recorded from transoesophageal and
transthoracic echocardiography. This allowed vessel area to be determined at each level
of cardiac output. If the dobutamine infusion produced any disturbance to cardiac
rhythm that was considered to be a risk to the horse, the infusion was discontinued and
the procedure was terminated.
Statistical analysis
Cardiac output estimates by Doppler echocardiography were plotted against the
thermodilution estimate. The resultant scatter plots allowed the linear relationship
45 Dobutamine hydrochloride, Dobutrex, Eli Lilley & Co, Basingstoke, UK.
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between the two set of variables to be assessed as recommended by Bland and Altman
(1986). Separate plots for all 3 calculations of cardiac output by Doppler
echocardiography obtained from each vessel area and each mode of insonation (HPRF
and CW) were produced (Appendix Chapter 4: Graphs la - 12a, Page 244). The
Doppler estimates were plotted against both the instantaneous thermodilution cardiac
output measurement and the mean of three consecutive measurements. Linear
relationships between the variables were assessed by calculation of the product-moment
correlation coefficient (r). Agreement between the two techniques was assessed using
the methods of Altman and Bland (1983). This technique is used when both
measurement methods are subject to individual errors and neither measures the variable
absolutely. The best estimate of the 'true' value is considered to be the mean of the two
techniques. The difference between the two measurements is then plotted against the
mean value. Visual appraisal of the resultant plot may then indicate any relationship
between the measurement error and the true value. The bias of the Doppler technique
was calculated from the mean of the differences between Doppler and thermodilution
measurements, 95% confidence intervals for the bias were also determined. The limits
of agreement of the two techniques as defined by Bland and Altman (1986) were
calculated by adding or subtracting twice the standard deviation of the differences
between techniques to the calculated bias. To allow comparison of these results with
those from previous studies the differences between the two methods were expressed as
a percentage of the thermodilution method. The mean and standard deviation of the
percentage differences were then calculated.
The three measurements of aortic diameters were compared with each other
before and after dobutamine, using a Kruskal-Wallis test. A probability of < 0.05 was
considered to indicate a significant difference or change in the data. Where significant
differences were found a paired Wilcoxon test was used to examine differences between
individual measurements or treatments .
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RESULTS
A total of 95 comparisons of cardiac output estimations from Doppler and
thermodilution techniques were made using the various measurement methods and both
insonation modes. Only five estimates were taken from Horse 6, since supraventricular
tachycardia (rate 186 bpm) commenced 10 minutes after starting the 2 pg.kg'hmin"1
infusion of dobutamine. In Horse 7 atrial fibrillation occurred during infusion of 2
pg.kg'hmin'1 dobutamine, the heart rhythm then returned to normal sinus rhythm
during recovery from anaesthesia. Estimations made in this study were not included in
the analysis, as the study was repeated after 1 month. Supraventricular tachycardia
(rate >150 bpm) occurred in Horses 4, 5 and 8 during infusion of 4 ng.kg'hmin"1
dobutamine, before cardiac output estimates had been made, thus only ten data points
are included from each horse.
The range of cardiac outputs measured by thermodilution during the study was
between 14.1 and 65.4 L.min-1. Graphs la to 12a (Appendix Chapter 4, Page 244) are
scatter plots of the cardiac output estimations derived from Doppler echocardiography
against those obtained by thermodilution. Product moment correlation coefficients are
detailed in Table 5. There was a significant linear correlation between all Doppler
derived cardiac output estimates (both CW and HPRF modes) and thermodilution
measurements (both instantaneous and the mean of three consecutive measurements).
Estimations of cardiac output by Doppler echocardiography showed closer correlation
with thermodilution measurements when the HPRF insonation mode was employed.
The best linear relationship, r = 0.94, was achieved when aortic diameter was obtained
by transthoracic echocardiography measured at the sino-tubular junction using the
leading edge method and the comparison was made with simultaneous thermodilution
measurements.
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Graphs lb to 12b show the differences in the cardiac output estimations plotted
against the mean of the two techniques. In these figures individual data points are
coded using each horse's numeric. From these plots the differences between
techniques are most pronounced for data from Horses 4 and 8. Summary statistics of
the differences between techniques are given in Table 6. The 95% confidence intervals
for the mean (or bias) of the differences and the limits of agreement of the techniques
are shown in Table 7. Estimates of cardiac output by Doppler echocardiography tended
to overestimate those obtained by thermodilution. This is shown by the positive 95%
confidence intervals for the bias of the two techniques in all comparisons, except when
the aortic annulus diameter is used to estimate cardiac output from HPRF waveforms.
Overall the limits of agreement between the two techniques were narrower and the bias
was less when the HPRF insonation mode was used to obtain the Doppler spectra. The
limits of agreement are wider for both modes of insonation when the vessel diameter is
obtained from a transthoracic image of the aortic valve annulus. Limits of agreement
are similar when comparisons with Doppler techniques are made using either a single
simultaneous thermodilution measurement or a mean of three consecutive
measurements. The closest agreement between the two techniques was obtained when
the instantaneous thermodilution measurement was compared to the Doppler estimate
made from HPRF waveforms, and the vessel diameter was measured from a
transthoracic image using the leading edge method.
The differences between measurements by Doppler and thermodilution did not
increase with increasing cardiac output (Graphs lb to 12b, Pages 245 - 256).
Summary statistics of the differences expressed as a percentage of the thermodilution
measurement are detailed in Table 8.
Aortic diameter at the sino-tubular junction measured from transthoracic
echocardiography was significantly greater than the same diameter from
transoesophageal echocardiography and the aortic annulus diameter from transthoracic
113
echocardiography. The aortic diameter at the valve annulus was significantly less than
all other estimates (Table 9). There were no significant changes to any of the aortic
measurements with either dobutamine at 2 |ig.kg"1.min"1 or 4 pg.kg-fmin"1 (Table 10).
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Table 5 : Product - moment correlation coefficients and probability values for the
relationship between transoesophageal Doppler estimations of cardiac output and those
obtained by thermodilution. N = number of estimates, r = correlation coefficient, Graph
refers to figure number of the appropriate scatter plot of Doppler against thermodilution
measurements in Appendix Chapter 4.
High pulse repetition frequency mode
2-D measurement N r P Graph
Instantaneous thermodilution
Leading edge (transthoracic) 95 0.94 0.00000 la
Centre wall (transoesophageal) 95 0.93 0.00000 2a
Valve annulus (transthoracic) 95 0.90 0.00000 3a
Mean of 3 thermodilution
Leading edge (transthoracic) 95 0.93 0.00000 4a
Centre wall (transoesophageal) 95 0.93 0.00000 5a
Valve annulus (transthoracic) 95 0.90 0.00000 6a
Continuous wave mode
2-D measurement N r p Graph
Instantaneous thermodilution
Leading edge (transthoracic) 95 0.90 0.00000 7a
Centre wall (transoesophageal) 95 0.89 0.00000 8a
Valve annulus (transthoracic) 95 0.89 0.00000 9a
Mean of 3 thermodilution
Leading edge (transthoracic) 95 0.91 0.00000 10a
Centre wall (transoesophageal) 95 0.92 0.00000 11a
Valve annulus (transthoracic) 95 0.90 0.00000 12a
115
Table 6: Summary statistics of differences between cardiac output measurements by
Doppler echocardiography and those obtained by thermodilution in eight anaesthetised
horses. S.D. = standard deviation of differences, MIN = maximum underestimation of
thermodilution estimate, MAX = maximum overestimation of thermodilution estimate.
All values are in litres per minute. Total number of estimates = 95.
High pulse repetition frequency mode
2-D measurement mean S.D. MIN MAX
Instantaneous thermodilution
Leading edge (transthoracic) 3.7 3.7 -10.8 13.3
Centre wall (transoesophageal) 1.1 4.2 -12.4 10.2
Valve annulus (transthoracic) -0.9 5.2 -17.3 8.9
Mean of 3 thermodilution
Leading edge (transthoracic) 3.3 3.9 -10.8 13.7
Centre wall (transoesophageal) 0.7 4.2 -12.4 10
Valve annulus (transthoracic) -1.3 5.3 -17.3 8.1
Continuous wave mode
2-D measurement mean S.D. MIN MAX
Instantaneous thermodilution
Leading edge (transthoracic) 7.2 5.3 -8.4 22.7
Centre wall (transoesophageal) 4.1 4.7 -15.4 17.9
Valve annulus (transthoracic) 1.4 4.8 -16.1 11.5
Mean of 3 thermodilution
Leading edge (transthoracic) 7.1 5.0 -5.0 19.8
Centre wall (transoesophageal) 4.0 4.4 -10.2 15.0
Valve annulus (transthoracic) 1.3 4.8 -12.2 10.2
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Table 7: Confidence intervals for the bias (mean difference between techniques) and
limits of agreement between Doppler and thermodilution methods of cardiac output
measurement. Limits of agreement are mean difference +/- 1.96 x the standard
deviation of the difference. All values are in litres per minute. Total number of
estimates = 95.
High pulse repetition frequency mode





Leading edge (transthoracic) 3.7 3.0 - 4.5 -3.7 - 11.1
Centre wall (transoesophageal) 1.1 0.2 - 1.9 - 7.3 - 9.5
Valve annulus (transthoracic) -0.9 -2.0 - 0.2 - 11.3 - 9.5
Mean of 3 thermodilution
Leading edge (transthoracic) 3.3 2.5 - 4.1 -4.5 - 11.1
Centre wall (transoesophageal) 0.7 -0.2 - 1.6 -7.7 - 9.1
Valve annulus (transthoracic) -1.3 -2.4 - 2.1 -11.9 - 9.3
Continuous wave mode





Leading edge (transthoracic) 7.2 6.1 - 8.3 -3.4 - 17.8
Centre wall (transoesophageal) 4.1 3.1 - 5.0 -5.4 - 13.5
Valve annulus (transthoracic) 1.4 0.4 - 2.4 -8.1 - 10.9
Mean of 3 thermodilution
Leading edge (transthoracic) 7.1 6.1 - 8.1 -2.9 - 17.1
Centre wall (transoesophageal) 4.0 3.0 - 4.9 -4.9 - 12.8
Valve annulus (transthoracic) 1.3 0.3 - 2.3 -8.2 - 10.8
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Table 8: Difference between Doppler derived estimates of cardiac output and those
obtained by thermodilution, expressed as a percentage of the thermodilution
measurement. Total number of estimates = 95.
High pulse repetition frequency mode
2-D measurement Mean % Maximum % Maximum %
difference overestimation underestimation
Instantaneous thermodilution
Leading edge (transthoracic) 18 65 15
Centre wall (transoesophageal) 8 56 22
Valve annulus (transthoracic) 1 49 32
Mean of 3 thermodilution
Leading edge (transthoracic) 16 68 17
Centre wall (transoesophageal) 6 58 23
Valve annulus (transthoracic) 0 41 33
Continuous wave mode
2-D measurement Mean % Maximum % Maximum %
difference overestimation underestimation
Instantaneous thermodilution
Leading edge (transthoracic) 31 94 18
Centre wall (transoesophageal) 19 75 33
Valve annulus (transthoracic) 9 51 38
Mean of 3 thermodilution
Leading edge (transthoracic) 30 81 16
Centre wall (transoesophageal) 19 70 25
Valve annulus (transthoracic) 9 51 38
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Table 9: Median, maximum and minimum values in cm of aortic diameters obtained
from transthoracic and transoesophageal 2-D echocardiography in 8 horses during
0.9% end tidal halothane anaesthesia.
Vessel Leading edge Centre wall Annulus
Diameter (transthoracic) (transoesophageal) (transthoracic)
Median 7.23bc 7. 10ac 6.6 lab
Maximum 7.74 7.58 7.20
Minimum 6.70 6.53 6.30
abc
significantly different measurement of aortic diameter from that obtained at other sites
(p <0.01 using a Kruskal-Wallis test):
a different from vessel diameter measured from transthoracic echocardiography using
the leading edge to leading edge method.
b different from vessel diameter measured from transoesophageal echocardiography
using the Centre wall to Centre wall method.
c
different from aortic valve annulus diameter measured from transthoracic
echocardiography using the trailing edge to leading edge method.
Table 10: Median value (range in parentheses) of aortic diameter (cm) before and
during dobutamine infusion. Kruskal-Wallis test revealed no significant differences in
any vessel diameters during the infusion periods. P values are recorded in right hand
column. 1 = 0.9% halothane, 2 = 0.9% halothane after 15 minutes infusion of 2 pg.kg"
kmin"1 dobutamine, 3 = 0.9% halothane after 15 minutes infusion of 4 pg.kg'kmin"1
dobutamine






























Estimations of cardiac output by Doppler echocardiography showed a close
linear relationship with measurements obtained by thermodilution. The correlation
between the Doppler technique and thermodilution in the present study is higher than
that determined for man in similar studies using transoesophageal echocardiography. In
the human studies blood flow across the mitral and pulmonary valves, not the aortic
valves, were most commonly used to obtain velocity spectra for measurement of VTI
(Gorcsan, Diana, Ball and Hattler, 1992; Muhiudeen, Kuecherer, Lee, Cahalan and
Schiller, 1991; LaMantia, Carter, Davis and Ezekowitz, 1990; Ellis, Runyon-Hass,
Lichtor and Roizen, 1967). Mitral and pulmonary blood flows were chosen because of
superior alignment with the ultrasound beam from an oesophageal transducer. The
poor correlations obtained in these studies (0.65 - 0.80) may reflect difficulties in
measurement of the mitral and pulmonary valve areas (Sahn, 1985). In biped species
the descending aorta runs parallel to the oesophagus, therefore it is difficult to align
aortic blood flow and ultrasound from an oesophageal transducer. One group of
workers compared cardiac output calculations from human aortic blood flow profiles
obtained by transoesophageal echocardiography with measurements by thermodilution
(Perrino, Fleming and LaMantia, 1990). Due to the wide angle of incidence between
the beam and the descending aorta, the device had to be calibrated by calculating a
constant from a second transcutaneous Doppler transducer placed in the suprasternal
notch. Although these workers obtained a correlation of 0.91 between the two
techniques and limits of agreement within 26% of the mean cardiac output, the
technique is not widely used, probably due to the cumbersome calibration process
(Perrino, Fleming and LaMantia, 1991).
In horses the anatomical relationship of aorta and oesophagus differs from
humans and a transducer within the oesophagus can be aligned perfectly with the
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ascending aorta. This probably explains why the agreement and linear relationships
obtained by transoesophageal techniques in horses is better than for previously reported
human studies. The correlations obtained in the equine transoesophageal studies are
similar to those obtained in numerous human studies using transthoracic
echocardiography (Dubin, Wallerson, Cody and Devereux, 1990; Ihlen, Amlie, Dale,
Forfang, Nitter-Haige, Simonsen and Myhre, 1984; Nishimura, 1984; Huntsman,
Stewart, Barnes, Franklin and Colocousis, 1983). Cardiac output estimations using
transthoracic Doppler echocardiography are now widely used in human medicine
(Haites, McLennan, Mowat and Rawles, 1984), and it is generally accepted that the
estimates derived from Doppler echocardiography agree as well with the standard
methods (Fick principle, thermal and dye dilution) as the standard methods agree with
themselves (Schuster and Nanda, 1984).
Similar studies have been performed in standing horses when cardiac output
estimations from aortic velocity spectra derived by transthoracic echocardiography were
compared with measurements made by thermodilution (Long, Young, Jones, Darke and
Utting, 1992). Overall the linear relationship and limits of agreement of the two
techniques were consistently worse from the transthoracic studies in standing horses
than was found in the present transoesophageal studies in anaesthetised horses. Poor
alignment with aortic blood flow would consistently underestimate volumetric flow, but
have little effect upon the limits of agreement. In the previous transthoracic studies in
standing horses the narrowest limits of agreement were -12.89 - 11.83 L.min"1 (Long,
1993) compared to -3.70 - 11.10 L.min"1 from the present studies. Both these values
were obtained when vessel area was calculated using an aortic diameter obtained from a
transthoracic 2-D image. Since the technique of vessel area measurement was common
to both Doppler methods, the narrower limits of agreement in the transoesophageal
study must reflect more consistent alignment with blood flow in individual horses. The
reference long axis 2-D image obtained from transoesophageal echocardiography that
121
was used to guide placement of the Doppler sample volume was obtained repeatably in
every horse and the image did not appear to vary between individuals. Marked inter-
subject variation in correlation between transthoracic Doppler measurements of cardiac
output and those from the thermodilution and Fick methods has been reported
previously in humans (Christie, Sheldahl, Tristani, Sagar, Ptacin and Wann, 1987).
This variability remained when flow area was removed from the calculation of cardiac
output. Other workers have also noted variation in alignment between ultrasound beam
and aorta in individual patients during transthoracic echocardiography (Angelsen and
Brubakk, 1976; Sequeira, Light, Cross and Raftery, 1976). Within-subjects
measurement error also occurs in transthoracic echocardiography as the transducer must
be re-aligned with blood flow for each measurement. In transoesophageal
echocardiography, once in position, the transducer remains stationary in the
oesophagus.
Further errors may have occurred due to movement of conscious horses; small
movements between the transducer and the thoracic wall, e.g. associated with
ventilation, have a marked effect on the position of the sample volume which is located
18 cm from the skin surface. Although large changes in alignment would be obvious to
the operator from visual and audible changes in the spectra, small alterations in
angulation may have been more difficult to detect. In the present transoesophageal
studies the spectra were recorded from the oesophagus of an anaesthetised horse during
apnoea. This should have eliminated the alignment errors caused by motion and may
explain the narrower limits of agreement associated with the transoesophageal
technique.
There is a high prevalence of dysrhythmias in conscious horses; sinus
arrhythmia, second degree atrioventricular (AV) block and sinus blocks are common
(Hamlin, Klepinger, Gilpin and Smith, 1972). Blocked beats will increase the loss of
thermal indicator causing overestimation of cardiac output by thermodilution. This may
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have resulted an errors in the previous transthoracic studies. In the present study
Horses 4 and 8 had marked sinus arrhythmia during infusion of dobutamine. These
animals appeared most frequently as outlying points in graphs lb - 12b (Appendix
Chapter 4, Page 244), Since the time base of a single thermodilution measurement is
short, it is possible for cardiac output to be over or underestimated, depending at what
stage in the arrhythmia the measurement is made (Mackenzie, Haites and Rawles,
1986). In many of the human studies it is stated that patients who were not in normal
sinus rhythm were excluded from the study groups (Gorcsan, Diana, Ball and Hattler,
1992; Ryan, Page, Bouchier-Hayes and Cunningham, 1992). Such stringent exclusion
criteria cannot be applied to adult Thoroughbred horses. In the present study data were
only excluded from the one horse which developed iatrogenic atrial fibrillation.
However it is possible that other more benign rhythms such as mild sinus arrhythmia or
second degree atrioventricular block may have affected the accuracy of both the
thermodilution and Doppler echocardiographic techniques in both the present and
previous studies.
In the previous studies using the transthoracic approach in standing horses
(Long, 1993) the best correlation coefficient, lowest bias and narrowest limits of
agreement between techniques were obtained when the ascending aortic diameter was
measured by the leading edge method. This method of measurement of vessel diameter
also gave the closest agreement with thermodilution in the present transoesophageal
study. Similar correlation coefficients and limits of agreement and a lower bias between
thermodilution and transoesophageal-derived Doppler measurements were obtained
when aortic diameter was measured from a 2-D transoesophageal image. It can be
concluded therefore that transoesophageal echocardiography provides a suitable 2-D
image for derivation of aortic area for cardiac output determinations in anaesthetised
horses. This is convenient, as the same transducer can be used for acquisition of data
for both flow and cross-sectional area.
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In the present study estimates of cardiac output derived from the aortic diameters
obtained by both transthoracic and transoesophageal echocardiography overestimated
cardiac output when compared with thermodilution, a finding which has previously
been reported in human studies (Ryan, Page, Bouchier-Hayes and Cunningham, 1992;
Ihlen, Amlie, Dale, Forfang, Nitter-Haige, Simonsen and Myhre, 1984).
Mathematical considerations dictate that the vessel should be measured at the
same anatomical location as the flow velocity. However in humans and dogs the flow
velocity has been shown to be constant at different centre-line positions in the aorta
(Ihlen, Amlie, Dale, Forfang, Nitter-Haige, Simonsen and Myhre, 1984; Fisher, Sahn,
Friedman, Larson, Valdez-Cruz, Horowitz, Goldberg and Allen, 1983), indicating that
velocity measured by Doppler echocardiography is relatively insensitive to the vertical
location of the Doppler sample volume. A study in thoracotomised dogs confirmed this
hypothesis, the vertical position of the sample volume making no significant difference
to the agreement between aortic flow by pulsed Doppler echocardiography and the
volumetric flow produced by the roller pump providing the artificial circulation
(Brubakk and Givold, 1985).
It has been suggested that because the left ventricle ejects through a narrow
valve orifice into a much larger aortic root, the inelastic aortic annulus effectively
restricts flow to its cross sectional area, and the area through which most of the flow
occurs is less than the anatomical aortic root area. As a result the area of the aortic valve
annulus has been proposed to provide the best estimate of the true flow area (Ihlen,
Amlie, Dale, Forfang, Nitter-Haige, Simonsen and Myhre, 1984). This hypothesis
may explain why, in the present studies, when the aortic annulus measurement was
used to derive aortic diameter, the value of cardiac output obtained, more closely
approximated that derived from the thermodilution technique. Despite this, the
correlation between techniques was poorer and the limits of agreement more widely
separated than when the sino-tubular junction measurement was used. This probably
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reflects greater difficulties in imaging the aortic annulus compared to the sino-tubular
junction in individual horses. Errors in measurement of vessel diameter are magnified
because the derived radius is then squared in the calculation of flow area. Poorly
aligned or inconsistent images of the vessel which cause inaccurate diameter
measurements will cause large errors in flow calculation. In the present studies
although the calculations using measurements of the aorta at the sino-tubular junction
considerably overestimated cardiac output measured by thermodilution, the narrower
limits of agreement and closer linear relationship with the thermodilution technique
render the use of the sino-tubular junction area preferable in anaesthetised horses.
An in-vitro study in thoracotomised dogs (Loeber, Goldberg, Marx, Carrier and
Emery, 1987) showed that the areas of both aorta and pulmonary artery could vary
during systole by up to 12%. This is in contrast to the inelastic fibrous aortic valve
annulus the area of which is fixed during systole (Ihlen, Amlie, Dale, Forfang, Nitter-
Haige, Simonsen and Myhre, 1984). If the same situation occurs in the intact animal,
errors would be introduced into the flow calculation depending on the time in systole
that vessel diameter was measured. However in the study by Loeber, Goldberg, Marx,
Carrier and Emery (1987) the area changes only occurred under extreme conditions of
preload and afterload, so the significance of this effect in an anaesthetised horse is
unclear. The time that the maximum diameter occurs within the systolic cycle is also
contoversial; some workers demonstrated that it occurred early in systole coincident
with the upstroke of the pressure tracing (Greenfield and Patel, 1962). As a result
Stewart, Jiang, Mich, Pandian, Guerrero, and Weyman (1985) concluded that most
volumetric flow should occur when the aortic area is at its maximum dimension. In
their dog model Loeber, Goldberg, Marx, Carrier and Emery (1987) showed that
maximal vessel distension occurred in mid - late systole, but because maximal
distension was transient Goldberg, Allen, Marx and Donnerstein (1988) suggested that
it is unnecessary to measure the area at the point of maximal distension specifically. In
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human cardiology it has become a convention to derive aortic area from a single systolic
diameter measurement (Stewart, Jiang, Mich, Pandian, Guerrero and Weyman, 1985),
and since the pulmonary artery is subject to greater cyclic variation it is recommended
that an averaged systolic diameter is obtained from 5 randomly selected cardiac cycles
(Hatle and Angelsen, 1985a). Since changes in aortic area during systole have not been
specifically studied in horses, to minimise any resultant errors during the present study,
vessel area was calculated from a mean diameter measured from 3 successive frames
during systole in a single cardiac cycle. This process was repeated for two other
cardiac cycles to obtain an average diamter measurement.
Stewart, Jiang, Mich, Pandian, Guerrero, and Weyman (1985) demonstrated
that the cross-sectional area of aortic, mitral and pulmonary valves increased with
increasing volumetric flow. In the present study aortic diameters were measured from
2-D images at each level of dobutamine infusion, but no significant increases in vessel
diameter were found. Failure to detect small changes in aortic area may reflect errors in
imaging causing failure to obtain true cross-sectional images of the aorta on multiple
occasions (Stewart, Jiang, Mich, Pandian, Guerrero, and Weyman, 1985). In the
present studies it is also possible that the change in volume flow produced by
dobutamine infusion in these horses was too small to produce a measurable change in
aortic diameter.
It is generally accepted that inaccuracy in determination of flow area is the major
source of error in the Doppler technique (Haites, McLennan, Mowat and Rawles, 1985;
Ihlen, Amlie, Dale, Forfang, Nitter-Haige, Simonsen and Myhre, 1984). Because of
difficulties in its accurate measurement, it has been suggested by some workers that
velocity time integral (VTI) alone can be used to reflect changes in stroke volume
(Haites, McLennan, Mowat and Rawles, 1985), since a strong relationship has been
demonstrated between the two variables (Huntsman, Stewart, Barnes, Franklin and
Colocousis, 1983; Sequeira, Light, Cross and Raftery, 1976). The product of VTI and
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heart rate (minute distance) has also been proposed as an accurate and repeatable
indicator of cardiac output (Moulinier, Venet, Schiller, Kurtz, Morris and Sebastian,
1991; McLennan, Haites, Mackenzie, Daniel and Rawles, 1986). McLennan and
coworkers (1986) showed that in vitro the method detected changes in flow rate of 33%
with 95% certainty, a sensitivity which is similar to that of the thermodilution technique
in vitro under conditions of pulsatile flow. Minute distance derived from Doppler
echocardiography has been used to assess responses to medical therapy in human
patients (Elkayam, Gardin, Berkley, Hughes and Henry, 1983). In the present studies
no statistically significant differences in aortic diameter were found at different cardiac
output levels so that omission of vessel area from flow calculations in anaesthetised
horses may be worthy of consideration.
Because thermodilution has been shown to overestimate volumetric flow in
pulsatile models (Mackenzie, Haites and Rawles, 1986), it is possible that estimates of
cardiac output obtained by transoesophageal echocardiography considerably
overestimate true flow in horses. Jarvis, Woliner and Steffey (1992) evaluated a
commercial thermodilution computer for continuous flows in-vitro between 8 and 50
L.min"1. They reported that the technique underestimated true flow when an injectate of
30 - 40 mis was used and volumetric flow exceeded 25 L.min'. If this occurs in-vivo
estimates of cardiac output derived from transoesophageal echocardiography may be
closer to true cardiac output than the positive bias suggests. Unfortunately Jarvis and
coworkers did not evaluate the computer's performance during pulsatile flow, and this
may have influenced their result considerably (Mackenzie, Haites and Rawles, 1986).
The thermodilution measurement device used in the present studies was different to the
model used by Jarvis and co-workers and it has been demonstrated by Mackenzie,
Haites, and Rawles (1986) that measurements made by 3 different commercial devices
could differ by up to 2 L.min1 during measurement of a 5 L.min1 pulsatile flow.
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Continuous wave Doppler echocardiography has been used for computation of
aortic flow in humans, using both transthoracic (Huntsman, Stewart, Barnes, Franklin
and Colocousis, 1983; Nishimura, 1984) and transoesophageal techniques (Perrino,
Fleming and LaMantia, 1990; Gorcsan, Diana, Ball and Hattler, 1992). Most early
studies in the medical literature were performed using CW insonation as accuracy of
range gated Doppler was poor until the advent of fast Fourier transform analysis
(Nishimura, 1984). In human medicine the size of the ultrasound transducer needed for
HPRF Doppler studies limited access to the suprasternal window which provided most
accurate alignment with aortic blood flow. In the CW mode, maximum velocity is used
to obtain the velocity time integral. The spectra produced from CW studies are complex
since they are formed from velocity information from all along the depth of the beam. It
is therefore possible that the maximum velocity comes from a site other than the aorta.
Theoretically though the maximum velocity should occur at the narrowest point in the
circulation, which in the case of the aorta should be the valve annulus. It is for this
reason that cardiac output calculations from CW spectra usually incorporate aortic area
derived from the annulus diameter (Hatle and Angelsen, 1985a). It has been shown
that maximum velocity is less sensitive to poor angulation than the modal velocity, used
in the HPRF studies (Brubakk and Givold, 1985), and this may explain why some
authors found better agreement between Doppler and thermodilution when CW rather
than HPRF insonation was used (Fenger, Bertone and Bonagura, 1991). In the present
study the magnitude of bias was increased when spectra were derived using CW
Doppler echocardiography. Since maximum velocity is used to obtain VTI this is not
surprising; although if the flow velocity profile is flat, the spatial mean velocity should
be close to spatial maximum velocity in central core of blood flow (Ihlen, Amlie, Dale,
Forfang, Nitter-Haige, Simonsen and Myhre, 1984). In the present study the limits of
agreement between Doppler and thermodilution measurements were wider when the
CW mode of insonation was used. The reason for this unclear, since use of the
maximum velocity should produce a positive bias, but have no effect on the agreement
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between the two techniques. Since the transoesophageal echocardiography probe was
not moved between alternate HPRF and CW estimates the wider limits of agreement
cannot be attributed to altered alignment. It is possible that in some individuals the CW
technique detected a maximum velocity that came from the left ventricular outflow tract
or from accelerated flow around the aortic arch.
In this study there was no difference in agreement between the Doppler methods
and thermodilution regardless of whether comparison was made with a single
thermodilution measurement or a mean of three measurements. This probably reflects
the more stable baseline of cardiac output and heart rate in anaesthetised compared to
conscious horses (Long, 1993).
Most human studies have compared the Doppler and thermodilution methods in
patients in intensive care wards or cardiac catheterisation laboratories, so that agreement
has generally been assessed at resting levels. Rose, Nanna, Rahimtoola, Elkayam,
McKay and Chandraratna (1984) showed that agreement between Doppler estimates of
cardiac output obtained from aortic velocity spectra and thermodilution deteriorated
when patients were given dobutamine. In dogs aortic blood velocity becomes turbulent
after isoprenaline infusion (Falsetti, Caroll, Swope and Chen, 1977), if this occurs in
other species it may explain increased errors in the Doppler technique when inotropic
agents are infused. Decreases in the agreement between Doppler and thermodilution
techniques after dobutamine infusion was not observed in transoesophageal studies in
anaesthetised horses (Appendix Chapter 4: graphs lb - 12b, Page 244), but increased
error has been observed in standing horses after dopamine and dobutamine infusion
(Long, 1993).
Conclusions
These studies show that transoesophageal Doppler echocardiography provides a
useful alternative to thermodilution for measurement of cardiac output in anaesthetised
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horses. This non-invasive technique offers a number of advantages over
thermodilution. It avoids the need for cardiac catheterisation and allows continuous and
prolonged monitoring of cardiac output to be performed. The best agreement with the
thermodilution method was obtained using HPRF Doppler echocardiography to
measure aortic blood flow velocity, with aortic area calculated from its diameter
measured at the sino-tubular junction.
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FIGURES FOR CHAPTER 4
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Figure 21: Dilution curve obtained from an anaesthetised horse
The upper trace indicates pulmonary artery pressure measured from the
distal port of the thermodilution catheter. Note the baseline fluctuations in
pulmonary artery pressure which correspond to the inspiratory cycle of the
ventilator.
Mechanical ventilation was stopped immediately before the cardiac output
estimations were made, evidenced by the absence of baseline fluctuations in
pulmonary artery pressure during the apnoeic period.
The lower trace is taken from the thermistor in the pulmonary artery, whilst
a thermodilution measurement is performed. Acceptable dilution curves had
a smooth outline, with a characteristically steep ascent and a slower return
to baseline.
Note also the small fluctuations in baseline pulmonary artery temperature
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Figure 22: High pulse repetition frequency (HPRF) Doppler study of
aortic blood flow velocity obtained by transoesophageal
echocardiography
The small 2 D image above shows the Doppler sample volume (two red
dots) aligned with the long axis of the aorta (AO). The pulmonary artery
(PA) is also imaged in oblique cross section.
The slide was taken when the spectral Doppler measurement menu of the
Vingmed CFM 700 was active. The green line around the left hand spectra
has been manually traced around the brightest part of the velocity envelope,
using the keyboard tracker ball. Note minimal lateral dispersion of the
HPRF spectra indicating that flow is laminar at the point of insonation.
The user is prompted to indicate the start of the next spectra, allowing the
Vingmed CFM 700 to calculate heart rate, and then complete the left hand
panel by inserting the measured and computed values, velocity time interval
(VTI), heart rate (HR) and cardiac output (CO). Before calculating CO the
user is prompted to input vessel diameter.
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Figure 23: Continuous wave (CW) Doppler study of aortic blood flow
velocity obtained by transoesophageal echocardiography
The small 2-D image above shows a colour flow Doppler study of aortic
blood flow. Aliasing of the colour flow signal has occurred in the central
core of blood at aortic valve level; blood velocity has been coded in blue,
as if it were flowing away from the transducer.
Because velocity data is derived from sampling the whole length of the
aorta and left ventricular outflow tract, there is increased spectral dispersion
compared to the envelopes derived from HPRF insonation in Figure 22.
To derive velocity time integral, the tracker ball is used to trace around the
outside of each envelope, thus measuring the area under the maximum
velocity, not the modal velocity as in Figure 22.
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Figure 24: Transoesophageal long axis view of the aorta and left
ventricular outflow tract
Standard view used to obtain a transoesophageal derived aortic diameter for
cardiac output estimation.
Note the lateral broadening of the echoes from the left lateral wall of the
aorta. This occurs when tissue interfaces lie parallel to the ultrasound
beam. To measure aortic diameter the calipers were placed in the middle of
the echoes representing the anatomical boundaries of the aorta. The vertical
level of caliper placement was at the sino-tubular junction at approximately
the same level as the Doppler sample volume. The measurement was
always made at right angles to the long axis of the vessel.
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Figure 25: Right parasternal long axis view of the aorta obtained by
transthoracic echocardiography
Image used to obtain an aortic vessel diameter from the sino-tubular
junction using transthoracic echocardiography.
The green line has been drawn using the electronic calipers of the Vingmed
CFM 700. The line indicates the aortic diameter measured by the leading
edge to leading edge method. The measurement is made at right angles to
the long axis of the aorta.
Note the sharp definition of the vessel walls compared to those in Figure
24. Resolution is improved because the tissue interfaces are now
perpendicular to the ultrasound beam.
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Figure 26: Right parasternal long axis view of the left ventricular
outflow tract obtained by transthoracic echocardiography
View used to obtain the aortic valve annulus measurement from
transthoracic echocardiography.
The green line drawn using the electronic calipers indicates this
measurement. The diameter was measured from the trailing edge of the
upper bright echo in the intraventricular septum to the leading edge of the
echo at the insertion of the aortic valve into the fibrous annulus.
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CHAPTER 5
SENSITIVITY OF DOPPLER DERIVED INDICES OF LEFT
VENTRICULAR FUNCTION TO ADMINISTRATION OF INOTROPIC
AND VASODILATOR AGENTS IN ANAESTHETISED HORSES.
INTRODUCTION
The data presented in Chapter 3 showed that indices of left ventricular
performance derived from transoesophageal echocardiography could be obtained
reliably from anaesthetised Thoroughbred horses. The repeatability of these indices
was similar to that of the maximum rate of rise of left ventricular pressure (LVdp/dt,raJ.
The studies of Chapter 4 demonstrated that estimates of cardiac output derived from
aortic blood velocity spectra agreed well with simultaneous estimates of cardiac output
made by thermodilution. This agreement was not affected by administration of
dobutamine over a range of cardiac outputs of 15 to 75 L.min', and it was concluded
that the Doppler technique was as sensitive to haemodynamic changes as the invasive
method.
Validation of transoesophageal Doppler echocardiography for assessment of left
ventricular function in anaesthetised horses depends on demonstration of the sensitivity
of Doppler measurements to changes in contractility in the face of changes in preload
and afterload. The indices of cardiac performance measured by transoesophageal
echocardiography are obtained during left ventricular ejection, and as described by Van
den Bos, Elzinger, Westerhof and Noble (1973) they might be expected to be more
affected by changes in afterload than indices obtained during isovolumic contraction.
In the following studies afterload and cardiac contractility were manipulated by
the administration of three drugs dobutamine, dopexamine and dopamine, and data
were recorded from the anaesthetised horses by transoesophageal echocardiography and
direct intracardiac pressure recording. The selected drugs possess differing
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adrenoreceptor activities, resulting in differing effects on cardiac contractility and
loading conditions. In the following paragraphs the actions of adrenoceptors and the
receptor affinities of the three sympathomimetic amines studied are reviewed.
MECHANISMS OF ACTION OF SYMPATHOMIMETIC AGENTS
Distribution and actions of Pi adrenoreceptors
In the earliest classification of adrenoreceptor subtypes all cardiac (3
adrenoreceptors were classified as subtype Pi, whilst vascular and bronchial [3
receptors were classified as P2 adrenoreceptors (Lands, Arnold, McAuliff, Ludicna and
Frown, 1967). This simple classification was later modified when radioligand binding
studies demonstrated the presence of cardiac P2 adrenoreceptors (Brodde, 1988). P
adrenoreceptors are functionally coupled to adenyl cyclase and by increasing
concentrations of cyclic adenosine monophosphate they augment contractility by
increasing availability of intracellular calcium (Calvey and Williams, 1982). Pi
adrenoreceptor stimulation increases the rate of change and amplitude of Phase 0 of the
cardiac action potential and increases pacemaker firing rate (Smith, Braunwald and
Kelly, 1992). P adrenoreceptor agonists also promote extra-systoles, which may result
from accelerated closure of the channels carrying the outward potassium currents, and
an accelerated repolarisation back to the resting levels, shortening the action potential
(Milnor, 1990b). The Pi subtype of adrenoreceptors have been implicated in the
generation of arrhythmias associated with some catecholamines (Opie, 1995; Katz,
Lord and Eakins, 1967).
Distribution and actions of P2 adrenoreceptors
Large numbers of P2 adrenoreceptors are located in the arterial vascular smooth
muscle of skeletal muscle of all species. Stimulation of these receptors results in
vasodilation which reduces afterload and increases stroke volume (Lokhandwala and
Hegde, 1991). Recent radioligand binding studies have also demonstrated the
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coexistence of p2 adrenoreceptors with Pi receptors in the human heart (Brodde,
1988). In vitro studies have established that the P2 cardiac subtype also acts via adenyl
cyclase to increase cyclic adenosate monophosphate, and the stimulation of these
receptors contribute to the inotropic and chronotropic actions of some catecholamines
(Kaumann, Hall, Murray, Wells and Brown, 1991). There is no conclusive evidence
that there is similar distribution of Pi and P2 subtypes in equine myocardium but a
similar distribution has been demonstrated in sheep (Borea, Amerini, Masini, Cerbai,
Ledda, Mantelli, Varani and Mugelli, 1992), which suggests that they may occur in
other species. There is also evidence that human Pi adrenoreceptors become selectively
down-regulated in patients with severe congestive heart failure, suggesting that
utilisation of P2 adrenoreceptor agonists in therapy of these patients provides a more
rational approach to treatment (Lokhandwala and Hegde, 1991; Opie, 1989).
Distribution and actions of a adrenoreceptors
Two subtypes of adrenoreceptors mediating pressor effects have been identified
in the vasculature of all species (Berkowitz and Schwinn, 1994). Alphai
adrenoreceptors are located at the neuroeffector junction and 0C2 adrenoreceptors ane
extra-junctional. Pre-junctional 0C2 adrenoreceptors are also situated at noradrenergic
nerve terminals where their stimulation results in inhibition of further noradrenaline
release (Lokhandwala and Hegde, 1991; Starke and Docherty, 1982).
Distribution and actions of Dopamine 1 (DAi) adrenoreceptors
DAi adrenoreceptors are found predominantly in the arterial smooth muscle of
renal, mesenteric, coronary and cerebral vascular beds. DAi receptor agonists cause
vasodilation which selectively increases blood flow at these sites. In addition activation
of renal tubular DAi receptors causes natriuresis and diuresis (Brown, Dixon, Farmer,
Hall, Humphries, Ince, O'Connor, Simpson and Smith, 1985).
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Distribution and actions of Dopamine 2 (DA2) Receptors
DA2 receptors are pre-junctional and are located on the terminals of peripheral
sympathetic nerves. When stimulated they mediate a reduction of noradrenaline release,
which can result in generalised reduction of sympathetic tone throughout the
cardiovascular system (Smith and O'Connor, 1988).
MECHANISMS FOR INDIRECT SYMPATHOMIMETIC ACTIVITY
Inhibition of uptake 1
After being released from the adrenergic nerve terminal noradrenaline is in part
broken down by a local enzyme catechol-O-methyl transferase, and in part actively
taken back into the nerve terminal (uptake 1). If this active uptake is inhibited the active
compound noradrenaline persists in the synaptic cleft and causes a sustained
sympathomimetic effect which is referred to as being indirect (Smith and O'Connor,
1988).
Tyramine-like activity
Bound noradrenaline is stored in intracytoplasmic vesicles in the noradrenergic
nerve terminal. Arrival of action potentials at the terminal unbind the noradrenaline and
release it from the vesicles to diffuse out of the nerve terminal. Agents with tyramine-
like activity are able to enter the nerve terminal via uptake 1 and then displace
endogenous noradrenaline from the storage vesicles (Smith and O'Connor, 1988).
Baroreflex activation
Stimulation of P2 and DAi adrenoreceptors mediating vasodilation, may cause
hypotension which reduces the acivity of aortic and carotid sinus baroreceptors. As a
result there is increased firing of sympathetic nerves and increased output of
noradrenaline from the adrenal medulla which results in vasoconstriction and mild
inotropy (Brodde, 1988)
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REPORTED CARDIOVASCULAR ACTIONS OF DRUGS ADMINISTERED
Dobutamine
Dobutamine is a synthetic catecholamine that was developed by modifying the
chemical structure of isoproterenol (Tuttle and Mills, 1975). The resulting drug had
predominantly Pi activity but its affinity was not solely limited to the Pi receptor. The
commercial preparation is a racemic mixture of two isomers; [+] enantiomer is a potent
stimulant of P adrenoceptors whilst the [-] enantiomer is predominantly a potent a
adrenoceptor agonist (Ruffolo and Yaden, 1982). Radioligand binding studies have
shown that pi affinity predominates over of P2, and ai predominates over a2 (Smith,
Braunwald and Kelly, 1992; Williams and Bishop, 1981). Stimulation of Pi receptors
in cardiac muscle causes potent positive inotropic effects and a weaker positive
chronotropic effect (Vatner, McRitchie and Braunwald, 1974). In the vasculature there
is pharmacological and physiological antagonism of the actions of the two
stereoisomers at ai and P2 receptors (Williams and Bishop, 1981), resulting in
negligible net effects on blood pressure in dogs (Holloway and Frederickson, 1974).
When the drug is given to human patients in heart failure, dobutamine causes reduction
in systemic vascular resistance, as cardiac output rises and arterial pressure remains
relatively unchanged (Leier and Binkley, 1991; Bendersky, Chatterjee, Parmley,
Brundage and Ports, 1981; Berkowitz, McKeever, Croke, Jacobs, Loeb and Gunner,
1977). This is in contrast to its effects in anaesthetised horses, when infusion of the
drug produced elevation of arterial blood pressure (Donaldson, 1988; Swanson, Muir,
Bednarski, Skarda and Hubbell, 1985) and the drug has been advocated as a treatment
for intraoperative hypotension in this species (Trim, 1991; Muir and Bendarski, 1983).
Dopexamine
Dopexamine hydrochloride is a synthetic analogue of dopamine (Smith and
O'Connor, 1988). It possesses agonist properties at peripheral dopamine receptors
(DAi) and P2 adrenoreceptors, but has minimal affinity for a or pi adrenoreceptors
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(Brown, Dixon, Farmer, Hall, Humphries, Ince, O'Connor, Simpson and Smith,
1985). Its stimulant properties at DAi receptors and P2 adrenoceptors improve renal
blood flow and increase cardiac output secondary to afterload reduction (Smith, Hall,
Farmer and Simpson, 1987). Mild positive inotropy after dopexamine administration
has been attributed to stimulation of cardiac P2 adrenoceptors (Smith and O'Connor,
1988), but the work of Brodde (1988) suggested that the predominant mechanisms
resulting in enhanced contractility were indirect. Drug induced vasodilation caused
activation of aortic and carotid sinus baroceptors which increased sympathetic nerve
outflow. In addition inhibition of uptake 1 potentiated endogenous noradrenaline in the
synaptic cleft.
Afterload reduction and concomitant natriuresis by stimulation of renal DA
receptors confers specific advantages in the therapy of low output heart failure
(Lokhandwala and Hegde, 1991). In humans with congestive heart failure,
dopexamine increased cardiac output without undesirable increases in myocardial
oxygen consumption (Baumann, Gutting, Pfaferott, Ningel and Klein, 1988; Jaski and
Peters, 1988; Dawson, Thompson, Signy, Juul, Turnbull, Jenkins and Webb-Peploe,
1985). Dopexamine has been advocated for use in anaesthetised horses (Muir, 1992b),
where studies using specific antagonists have demonstrated its effects are similarly
mediated by DAi and p2 adrenoreceptors (Muir, 1992a).
Dopamine
Dopamine is an endogenous catecholamine and is an immediate biosynthetic
precursor of noradrenaline (Calvey and Williams, 1982). Dopamine has a mild
inotropic effect mediated by weak pi adrenoreceptor activity and indirectly by a
significant tyramine-like sympathomimetic action (Harrison, Levitt and Udenfriend,
1963). Dopamine also causes vasodilation by direct actions on coronary, cerebral,
renal and mesenteric DAi adrenoreceptors (Goldberg and Raifer, 1985; Yeh, McNay
and Goldberg, 1969). When doses of dopamine are increased vasoconstriction occurs
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in the arterioles and veins throughout all vascular beds (Hoffman and Lefkowitz,
1990). This global vasoconstriction is attributable to stimulation of a\ adrenoreceptors
and a direct effect on serotonin receptors in vascular smooth muscle (Gilbert and
Goldberg, 1975). In humans and dogs the effects of dopamine on vascular resistance
and arterial blood pressure are dose-dependent. At infusion rates below 2 p.gkg'min1
the predominant effect is lowered resistance in the renal, mesenteric, cerebral and
coronary vascular beds. At between 2 and 5 pgkg 'min'1 there is a positive inotropic
effect; cardiac output and contractility increase with minimal effects on heart rate and
either a reduction or no change in peripheral resistance (Goldberg, 1974). With higher
infusion rates in humans (5 - 10 figkg 'min') heart rate, arterial blood pressure and
peripheral vascular resistance increase and renal blood flow may decline.
Similar effects were observed when dopamine was infused at 0.5, 2.5 and 5
|igkg"'min"1 in anaesthetised horses, cardiac output being significantly increased with
doses of 2.5 and 5 (igkg'miri1 (Trim, Moore and White, 1985). Swanson and
coworkers (1985) showed that total peripheral resistance was significantly decreased at
5 ligkg 'min"1 and had returned to baseline at 10 |!gkg"lmin"1. Maximum rate of rise of
left ventricular pressure (LVdp/dt J and cardiac output (CO) increased with doses of 5
and 10 |igkg "miri1 leading these authors to conclude that the haemodynamic effects of
dopamine was similar in horses to other species (Swanson, Muir, Bednarski, Skarda
and Hubbell, 1985).
AIMS
The main purpose of this study was to determine the sensitivity of Doppler
derived indices of left ventricular function during alterations in afterload and inotropy.
The studies were designed to test the hypothesis that drug-induced changes in the left
ventricle's afterload and contractility would be accurately measured using
transoesophageal Doppler echocardiography. Preload also influences ejection phase
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and isovolumic indices of cardiac performance and can be manipulated by rapid
intravenous fluid administration to elevate central venous pressure, or caval occlusion to
reduce ventricular filling pressure. However in the following studies preload was not
altered because of the difficulties in infusing fluid fast enough to significantly increase
blood volume in horses and the need for surgical access to the vena cava.
Dobutamine, dopamine and dopexamine, have been advocated for the treatment
of intra-operative hypotension in anaesthetised horses (Muir, 1992b; Donaldson, 1988;
Trim, Moore and White, 1985). These studies enabled assessment of the primary
effects of exogenous catecholamines in horses that had been premedicated with a long
acting a2 adrenoreceptor agonist before induction of anaesthesia. Currently in the UK
long-acting a2 adrenoreceptor agonists, romifidine and detomidine, are commonly
employed with ketamine to induce general anaesthesia in horses (Johnston, Taylor,
Holmes and Wood, 1995). The modulating effects of a residual background of a2
adrenoreceptor agonist activity on the actions of exogenously administered
catecholamines in horses is unknown. Previous studies used only small doses of the
short acting agent xylazine before anaesthesia was induced using a barbiturate (Muir,
1992b; Swanson, Muir, Bednarski, Skarda and Hubbell, 1985). As romifidine and
detomidine are known to have residual cardiovascular effects for up to 120 minutes
after administration to conscious horses (Young, Long, Clutton, Molony and Darke,
1994), both drugs are likely to modulate the effects of agents administered during a
subsequent general anaesthetic. Comparison of the results in the present studies with
those of previous studies may help define the modulating influence of the a2
adrenoreceptor agonist agents on exogenously administered catecholamines.
Despite widespread clinical use of dobutamine and dopamine in equine clinical
anaesthetic practice no studies have been found which detail their haemodynamic effects
during prolonged periods of infusion. A further aim of this study was to use the
available echocardiography and invasive techniques to evaluate the haemodynamic
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effects of a single dose of these drugs when administered for 1 hour to horses
anaesthetised with halothane after induction of anaesthesia with romifidine and
ketamine. The longevity of their haemodynamic effects were assessed over a 30 minute
period after the infusion was discontinued.
MATERIALS AND METHODS
Horses and preparation
Seven horses (1-6 and 8) were the subjects of this study. Horse 7 was
excluded due to thrombosis of the raised carotid artery (see page 38). Each horse was
anaesthetised and instrumented for transoesophageal echocardiography as described
previously (see page 47). After a long axis view of the left ventricular outflow tract and
aorta was obtained, high pulse repetition frequency (HPRF) Doppler echocardiographic
measurements of aortic blood velocity were performed.
The heart was catheterised and calibrated strain gauge transducers were placed
in the ascending aorta and left ventricle (see page 53). General anaesthesia was
maintained with halothane at an end-expired concentration of 0.9% for 60 minutes
before data were collected. Intermittent positive pressure ventilation was performed by
a mechanical ventilator to maintain arterial PaC02 between 35 and 45 mmHg. Each
horse was anaesthetised on three occasions and 1 month elapsed between anaesthetic
episodes.
Data collection
Control data was collected after an end-tidal halothane concentration of 0.9%
had been maintained for 60 minutes. Data were recorded during suspension of artificial
ventilation. The ventilator was turned off immediately at the end of the inspiratory
phase of it's cycle and the recording facilities were activated to coincide with the second
'p' wave of the base-apex electrocardiogram after ventilation stopped. Twenty seconds
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of pressure data from each strain gauge transducer was collected and stored on the hard
disk of the Macintosh computer. This was then analysed later using the analysis
programme described previously (see page 56). The average mean, systolic and
diastolic pressures for the aortic transducer and the average left ventricular systolic
pressure and heart rate were computed by the programme. The left ventricular end-
diastolic pressure was measured using electronic calipers (see page 57). The left
ventricular pressure waveform was differentiated to obtain maximum rate of rise of left
ventricular pressure.
All Doppler derived data were obtained from video taped images of the Doppler
echocardiographic studies recorded simultaneously with the blood pressure data. The
measurements were made planimetrically by a single observer using electronic calipers.
Measurements from the aortic blood flow spectra comprised; velocity time integral
(VTI), maximum acceleration (dv/dtmax), maximum velocity (Vmax), left ventricular
ejection time (ET) and pre-ejection period (PEP).
Data from the velocity spectra of five consecutive cardiac cycles, coinciding
with the start of blood pressure data acquisition, were averaged for each data point.
Cardiac output was calculated using the equation:
Cardiac output = VTI x aortic cross sectional area x heart rate
Aortic cross sectional area was calculated using the equation:
Aortic cross sectional area = 3.14 x (radius)2
Aortic diameter was measured from a 2-D standard transoesophageal image, of
the sino-tubular junction using the centre wall to centre wall method (Figure 24). To
derive the radius, three measurements were taken during systole from three consecutive
cardiac cycles and an average figure calculated. The 2-D images were recorded onto
video tape immediately before each data collection period.
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Experimental protocol
Dobutamine hydrochloride (Dobutrex46), dopamine hydrochloride (Inotropin47)
and dopexamine hydrochloride (Dopacard48) were adminstered to each horse during one
anaesthetic episode in a randomised sequence. Five hundred milligrams of each drug
were dissolved in 1L of 0.9% saline solution. The 500 gg.mk1 solution was freshly
prepared before each study. Use of a standard concentration ensured that each
individual horse received the same volume of fluid regardless of the drug being
administered. After control data had been collected 4 pg.kg-fmin"1 of the
catecholamine was infused for sixty minutes. The infusion was delivered by an
infusion pump through a 13 gauge teflon catheter placed in the jugular vein. The
accuracy of the infusion pump had been confirmed by timing delivery of known
volumes of fluid, after it had been programmed to deliver fluid at a rate similar to that
used in the study (240 mls.hr1). The intravenous infusion was continued for 60
minutes. Doppler echocardiographic and blood pressure data were collected 10, 20, 40
and 60 minutes after the infusion started and 10, 20 and 30 minutes after the end of
each infusion.
When administration of any drug produced disturbances to cardiac rhythm that
were considered a risk to the horse, the infusion was discontinued and the anaesthetic
episode terminated. No data from such discontinued studies were included in statistical
analyses. Any discontinued studies were repeated in the same horse using the same
inotrope, one month after the remaining studies for that animal had been completed.
After the final data had been recorded the cardiac catheters and transoesophageal
echocardiography probe were removed from the horse. Haemostasis was achieved by
46 Dobutrex, 250mg in 20 ml solution, Eli Lilley and Company Limited , Kingsclere Road,
Basingstoke, Hampshire, UK.
47
Inotropin , 200mg in 5ml solution, Dupont Pharmaceuticals Limited, Avenue One, Letchworth
Garden City, Hertfordshire, UK.
48 Dopacard Powder, Fisons Pharmaceutical Division, Bakewell Road, Loughborough, Leicestershire,
UK.
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manual pressure on the raised carotid artery, and a firm bandage was applied to the area
before winching the horse into a paddded recovery area. After the endotracheal tube
was removed supplemental oxygen was supplied at 15 L.mkr1 to each horse through a
flexible narrow bore nasopharyngeal tube. Recovery to a standing posture was
observed continuously for each horse.
Statistical analysis
Haemodynamic variables for each recording time point in the study were
compared both with the value obtained during the control period and the preceeding
value in the series using a paired Wilcoxon test. A probability of < 0.05 was
considered to be significant.
RESULTS
Table 11 shows the median percentage change from control values after 60
minutes of drug administration for all measured haemodynamic variables. Dobutamine
caused the highest percentage change from control values for all measured blood
pressures, infusion of dopamine produced the least effect on these variables and the
effects of dopexamine administration were intermediate. Dobutamine also caused the
greatest fall in the systolic time intervals PEP and ET. The greatest percentage increase
in cardiac output occurred after infusion of dopexamine. Dobutamine caused the lowest
overall increase in both cardiac output and in the related Doppler variable VTI. All three
drugs significantly increased heart rate during the 60 minute intravenous infusion, but
after 60 minutes the heart rate was significantly elevated above control values for
dobutamine and dopexamine only. Of the three drugs only dobutamine caused
significant increases in aortic and left ventricular systolic pressures.
Maximum aortic acceleration (dv/dt,mx) was as sensitive as maximum rate of rise
of left ventricular pressure (LVdp/dt^J in reflecting the changes in cardiac performance
associated with administration of dobutamine and dopexamine. Dopamine infusion
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caused a slightly greater effect on dv/dt^ than LVdp/dt^ (Table 11). Maximum aortic
velocity (V^J also increased during inotrope infusion and followed similar trends with
individual drug administration as did dv/dt^ and LVdp/dt,nax. The percentage change in
VniM was smaller than for the other two variables, so although it responded to alterations
in left ventricular performance, it appears to be less sensitive than dv/dt^ and
LVdp/dW
Two studies were terminated early as a result of supraventricular tachycardia.
In both cases dysrhythmia occurred during infusion of dobutamine. Horse 8 developed
numerous ventricular ectopic beats followed by a supraventricular tachycardia after 20
minutes of infusion. Immediately before the supraventricular tachycardia developed the
systolic arterial blood pressure exceeded 240 mmHg and LVdp/dt^ was 2047
mmHg.s"1. The same study with dobutamine was repeated uneventfully eight weeks
later, and the data included in the analysis. Horse 6 developed junctional tachycardia 6
minutes after beginning the dobutamine infusion (Figure 27 and Figure 28). The same
rhythm developed when the infusion was administered on a second occasion. Data
from horse 6 is therefore missing from the analysis of all dobutamine data. In both
animals heart rate had returned to normal sinus rhythm within 10 minutes of stopping
dobutamine administration.
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HAEMODYNAMIC EFFECTS OF INDIVIDUAL INFUSIONS
Dobutamine
The haemodynamic effects of dobutamine are recorded in Table 12 and
Appendix Chapter 5: Dobutamine, Graphs 1-13 (Pages 258 - 265). Heart rate was
significandy less at 10 minutes after the infusion commenced than dring the control
period, and only became significantly greater than control values after 60 minutes of
infusion. Dobutamine infusion significantly increased LVdp/dt^, Vmax, and dv/dt^ at
10, 20, 40 and 60 minutes. There was a marked cumulative effect of the infusion on
LVdp/dtn^ and dv/dtmax, demonstrated by Graphs 2 and 6 (Pages 259 and 261). Left
ventricular and aortic blood pressures were increased during infusion of dobutamine.
From Graphs 11-13 (Page 264 - 265) the effect of the infusion on all the measured
blood pressures had begun to reach a plateau after 20 minutes of infusion. Dobutamine
also increased left ventricular end-diastolic pressure. The infusion caused progressive
shortening of the pre-ejection period and ejection time. Cardiac output and velocity time
integral were not significantly increased above control values until 40 minutes of
infusion (Graphs 9 and 10, Page 262).
The downstroke of the aortic velocity spectra developed a notch within 20
minutes of commencing dobutamine infusion in all horses (Figure 29). The notch
persisted throughout the infusion, but had disappeared 10 minutes after it was
discontinued. Marked spectral dispersion in the early downstroke of the velocity
spectra of Horses 2, 4, 5 was also noted associated with administration of the
catecholamine (Figure 30).
After discontinuing the infusion there was a progressive return of
haemodynamic variables towards normal (Table 13), although heart rate, LVdp/dt^,
Vniax, VTI, cardiac output, left ventricular systolic pressure and systolic and mean aortic
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pressure all remained elevated above control values 30 minutes later. Ejection time had
returned to control values 10 minutes after the infusion had been turned off, but then it
continued to increase beyond the control value. Ejection time was still significantly
longer than its control value at the time the final data was collected (Graph 8, Page
262).
Dopexamine
The haemodynamic effects of dopexamine are recorded in Table 14 and
Appendix Chapter 5: Dopexamine, Graphs 1-13 (Pages 266 - 273). Heart rate was
higher than control values after 10 minutes of infusion, and was maintained at this
elevated level throughout the remainder of drug administration (Graph 1, Page 267).
Dopexamine caused progressive increases in LVdp/dt^, dv/dt,nax, and cardiac output
similar to dobutamine (Table 14). VTI also showed a cumulative effect during the
infusion period, which reached statistical significance between the 20 and 40 minute
values (Graph 9, Page 271). Infusion of dopexamine caused no significant changes in
systolic, mean and diastolic aortic blood pressure (Graphs 11-13, Pages 272 - 273).
Left ventricular end-diastolic pressure also remained unchanged (Graph 4, Page 268).
Dopexamine had little effect on left ventricular systolic pressure although it was
significantly elevated above control values at 20 minutes (Graph 3, Page 268). In
common with dobutamine, dopexamine reduced pre-ejection period (Graph 7, Page
270), but in direct contrast, dopexamine significantly increased left ventricular ejection
time (Graph 8, Page 270). Ejection time increased progressively throughout the
infusion and continued to increase for ten minutes after the infusion was discontinued.
Ejection time was still significantly greater than control values 30 minutes after the
infusion was discontinued. The remaining haemodynamic variables showed a gradual
return towards pre-infusion values during the 30 minute period after drug
administration stopped (Table 15), although LVdp/dtmM, Vmax, VTI, and cardiac output
still remained higher than control values when the final data was collected.
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A notch in the downstroke of the aortic velocity spectra of Horses 1, 4, and 6
was observed from twenty minutes of infusion, but spectral dispersion in the early
deceleration period was not a feature associated with dopexamine infusion (Figure 31).
Dopamine
The haemodynamic effects of dopamine are recorded in Table 16 and Appendix
Chapter 5: Dopamine, Graphs 1-13 (Pages 274 - 281). There was a small increase in
heart rate which occurred within 10 minutes of drug administration and was maintained
throughout the remaining infusion (Graph 1, Page 275). Infusion of dopamine had
minimal effects on LVdp/dt,^, although there was a small but statistically significant fall
10 minutes after the infusion began (Graph 2, Page 275). There was a small but
significant cumulative increases in dv/dt^ up to 40 minutes of the 60 minute infusion
(Graph 6, Page 277). Systolic, diastolic and mean aortic blood pressure was lower than
control values for the first 20 minutes of infusion (Table 5). Systolic and diastolic
aortic pressures returned to control values by 40 minutes (Graph 11 and 13, Pages 280
and 281) and mean pressure had returned at 60 minutes (Graph 12, Page 280). After
the infusion was discontinued there was a tendency for mean, systolic and diastolic
aortic blood pressures of some animals to increase, although this increase was only
statistically significant after 10 minutes (Table 17). Left ventricular systolic pressure
showed a similar tendency to decrease for the first 20 minutes after dopamine infusion
commenced, but it exceeded control levels at 60 minutes. This increase continued for
20 minutes after dopamine was discontinued (Graph 3, Page 276). Infusion of
dopamine caused no change in left ventricular end diastolic pressure. Cardiac output
and VTI were significantly increased during dopamine infusion (Graph 9 and 10, Page
279). Infusion of dopamine caused small but significant decreases in PEP and small
but significant increases in ET (Graph 7 and 8, Page 278).
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Dopamine infusion caused minimal changes to the aortic velocity spectra in all
horses. The spectra widened but did not change shape and spectral dispersion was not
observed (Figure 32).
Prolonged infusion of dopamine in Horse 1 altered CO, VTI, ET and PEP in a
different manner to all other horses in the group. These variables followed similar
trends as in the other horses at the 10 and 20 minute data collection points, however at
40 minutes CO, and VTI were half their preceding value, PEP had increased to 0.34 s,
whilst ET had fallen to 0.34 s. These effects continued after the infusion was
discontinued after 60 minutes. Cardiac output fell to it's lowest level 10 minutes after
stopping the infusion and was still 12 L below it's control value after 30 minutes.
SIDE-EFFECTS
Dobutamine
Supraventricular and junctional tachycardia were observed in two horses at an
infusion rate of 4 pg.kg-fmhr1. The dysrhythmia occurred on a two separate
occasions in one animal, but the drug was administered uneventfully on a second
occasion in the other horse.
Dopexamine
During administration of dopexamine profuse sweating occurred in every horse. The
sweating began within 10 minutes of the start of the infusion and by twenty minutes
sweat was pooling between the thighs and forming discrete drops in five out of seven
horses (Figure 33). The volume of fluid lost in sweating could not be quantified, but in
the worst affected cases the theatre floor became saturated despite attempts to catch fluid
accumulating on the padded bed. Copious urination was noted in horses 1, 2, 3 and 4
during anaesthesia. In six horses, recovery from anaesthesia was associated with
excitement and violent shivering. These responses were not seen during recovery after
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dopamine or dobutamine administration. Colic occurred in 2 horses after dopexamine:
Horse 2 was found in colic, 3 hours after an excitable recovery. The horse had been
returned to her stable one hour after standing, but was found flank watching and rolling
two hours later. Auscultation revealed an absence of intestinal borborygmi and a heart
rate of 45 beats per minute. Rectal examination was normal. The mare was treated
with 4.4 mg.kg1 phenylbutazone49 by slow intravenous injection. She responded
quickly and no further signs of colic were observed. Horse 8 showed signs of colic in
the recovery box, immediately after regaining consciousness he became excited, began
rolling and showed bouts of violent colic for the next 2 hours. Intestinal sounds were
absent, and heart rate was less than 50 bpm. Phenylbutazone was administered after
rectal examination had revealed no abnormalities. The horse appeared dull over the
following 12 hours, but no further signs of severe abdominal discomfort were
observed.
Dopamine
In most horses the arterial blood pressure fell during the early part of dopamine
infusion despite increases in CO. This may be of concern if the drug is being employed
to overcome hypotension in anaesthetised horses. One horse showed a reduction in CO
and VTI after 40 minutes of dopamine infusion at 4 pg.kg-kmin1.
49 Equipalazone Injection, Arnolds Veterinary Products, Cartmel drive, Harlescott, Shrewsbury, UK.
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DISCUSSION
THE SENSITIVITY OF MAXIMUM ACCELERATION, MAXIMUM VELOCITY AND
MAXIMUM RATE OF RISE OF LEFT VENTRICULAR PRESSURE TO INOTROPIC
INTERVENTION
Maximum rate of rise of left ventricular pressure (LVdp/dt^J is used almost
exclusively for measurement of myocardial contractility in horses and was selected in
the following studies as the invasive standard of contractility measurement for
comparison with the Doppler phase indices of left ventricular function.
This study shows that the indices of ventricular function derived from
transoesophageal echocardiography are as sensitive to changes in left ventricular
performance in anaesthetised horses as LVdp/dt,nax, the index derived from direct
measurement. Specifically dv/dt^ was as sensitive as LVdp/dt^ in detecting changes
in inotropy when percentage change from control values was used to gauge sensitivity.
Maximum aortic velocity also changed in response to catecholamine administration but
the magnitude of the changes were less than for dv/dt^, reflecting reduced sensitivity
to the drugs administered in this study.
Influence of ventricular loading conditions
Maximum rate of rise of left ventricular pressure occurs in the isovolumic period
of systole before the aortic valve has opened. Theoretically LVdp/dt^ is independent
of afterload, but is influenced directly by preload (Milnor, 1990c), since increased
venous return increases end-diastolic fiber length and promotes more forceful
contraction by the Frank Starling mechanism. Maximum aortic acceleration and Vmax
occur after the aortic valve has opened i.e. they are cardiac ejection phase indices, and
as a result are both afterload and preload dependent. Because of this it is widely held
that ejection phase indices are unable to differentiate changes in contractility from
changes in ventricular load (Bedotto, Eichhom and Grayburn, 1989). In the present
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studies contractility and afterload were manipulated by drugs expected to have different
effects on inotropy and ventricular loading conditions. From the percentage changes
which occurred in dv/dt^ and LVdp/dt^ it appears that the two indices are equally
sensitive to changes in cardiac performance, despite LVdp/dt^ occurring in the
isovolumic period and dv/dt^ occurring during ejection.
Afterload
Maximum rate of rise of left ventricular pressure has been demonstrated to be
afterload dependent (Mason, 1969; Wallace, Skinner and Mitchell, 1963), despite being
obtained during the isovolumic period. This is contrary to the theoretical considerations
of Van den Bos, Elzinger, Westerhof and Noble (1973). This effect may explain the
significant fall in LVdp/dt^ after 10 minutes of dopamine infusion and the lack of
significant increases in LVdp/dt^ above its control level for the rest of the dopamine
infusion in the present studies. The fall in LVdp/dt^ at 10 minutes implies that either
dopamine is acting as a negative inotrope, which is unlikely, or that the effect on
LVdp/df^ has been attenuated by a simultaneous alteration in left ventricular loading
conditions. Throughout most of the dopamine infusion left ventricular end-diastolic
pressure was increased implying that left ventricular preload had been augmented, an
effect that that might be expected to increase LVdp/dt,rax. Dopamine infusion caused
aortic blood pressure to fall in the anaesthetised horses in this study, despite significant
increases in cardiac output, suggesting that afterload was reduced by drug
administration. A similar effect has been demonstrated in humans by Borow and
colleagues (1992) who showed that LVdp/dt^ showed markedly disparate responses to
dopamine infusion in human patients with dilated cardiomyopathy. These workers
demonstrated that when aortic diastolic pressure fell after dopamine, the aortic valve
opened before true LVdp/dt^ was attained. As a result left ventricular pressure
potential was not fully developed, and the maximum rate of pressure rise was
underestimated.
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In the present studies dv/dt^ showed a slightly greater percentage change in
response to dopamine infusion than LVdp/dt^ which might imply less dependence of
the latter on ventricular afterload. However afterload reduction has been demonstrated
to increase dv/dt^ and (Wallmeyer, Wann, Sagar, Czakanski, Kalbfleish and
Klopfenstein, 1988; Bedotto, Eichhorn and Grayburn, 1989), an effect promoting
changes opposite to those on LVdp/dt^. Because dopexamine also reduces systemic
vascular resistance the increases in LVdp/dt^ that occurred during infusion of the drug
may have been attenuated, whilst the changes in the ejection phase indices may have
been augmented by afterload reduction.
Preload
Both ejection phase and isovolumic indices of ventricular performance are
affected by end diastolic fiber length. In these studies it was decided not to alter preload
directly due to practical problems. However any changes in preload caused by the drug
treatments in the studies would be expected to affect all indices similarly. Since the
indices were measured simultaneously it is therefore valid to make direct comparisons
of their inotropic sensitivity. Changes in preload are also diffficult to quantify, as
preload cannot be measured directly. However left ventricular end-diastolic pressure is
frequently used as an index of left ventricular preload (Milnor, 1990c), since most
evidence suggests that left ventricular compliance is not altered by inotropic stimuli or
halothane (Prys-Roberts, Gersh, Baker and Reuben, 1972).
In the present studies 40 minutes after commencing dopexamine infusion there
were significant decreases in left ventricular end-diastolic pressure which would have
attenuated any increases in dv/dt^, LVdp/dt,n;« and Vmax. During dobutamine infusion
left ventricular end-diastolic pressure was significantly increased, inferring that the
increases in LVdp/dt™,, dv/dt,I1M and seen with this drug were augmented by the
effect of increased preload and do not reflect changes in inotropy alone.
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Load dependence: Conclusions
There have been several studies attempting to assess the load dependence of
LVdp/dt^, dv/dt,I1M and Vmax (Harrison, Clifton, Berk and DeMaria, 1989; Gardin,
1989; Wallmeyer, Wann, Sagar, Kalbfleisch and Kloppfenstein, 1986; Quinones,
Gaasch and Alexander, 1976; Mahler, Ross, O'Rourke and Covell, 1975; Mason,
Braunwald, Covell, Sonnenblick and Ross, 1971). The results are conflicting, some
workers claiming load independence for their respective index, only to have the
opposite finding proven by other workers using a different preparation. The present
studies show that the indices, dv/dtrnax and Vmax, derived from transoesophageal
echocardiography, are no more load dependent than LVdp/dt^, the conventional index
used in horses. Similar conclusions that the Doppler indices, dv/dt^ and V^, are 'as
sensitive as invasive indices to changes in contractility' have been made by other
workers in both humans and dogs (Gardin, 1989; Wallmeyer, Wann, Sagar,
Kalbfleisch and Kloppfenstein, 1986).
Heart rate dependence
In addition to dependence upon preload and afterload the indices of ventricular
performance, LVdp/dt^, dv/dt^ and are also influenced by heart rate (Wallmeyer,
Wann, Sagar, Kalbfleisch and Kloppfenstein, 1986; Bedotto, Eichhorn and Grayburn,
1989; Mason, 1969). In the present studies heart rate was increased by both
dopexamine and dopamine, and this may have augmented the increases in the
haemodynamic variables that occurred during the studies. Dobutamine caused heart rate
to fall after ten minutes of infusion which may also have influenced these variables at
this time.
VELOCITY TIME INTEGRAL AND CARDIAC OUTPUT
Estimates of cardiac output made from transoesophageal echocardiographic
studies agreed well with those obtained by thermodilution (Chapter 4). The present
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studies show that VTI and CO increased in response to dopexamine and dopamine and
to a lesser extent with dobutamine. The afterload dependence of these indices is clearly
illustrated in the present studies. Velocity time integral and CO were most increased by
dopexamine and dopamine, drugs with known afterload reducing properties. Velocity
time interval was not significantly increased by dobutamine infusion, despite the drug
causing the greatest increases in contractility, indicated by the largest increases in
LVdp/dt^, dv/dt,I1M and Vmax. Cardiac evaluation should include measurement of
cardiac output (Braunwald, 1971), but the limitations of equating increased cardiac
output directly to increased contractility are clearly demonstrated by these studies.
PRE-EJECTION PERIOD (PEP) AND EJECTION TIME <ET)
The three drugs studied had disparate effects on PEP and ET. All three drugs
decreased PEP, although the magnitude of the decrease was greatest for dobutamine.
Pre-ejection period comprises the electromechanical delay and the isovolumic
contraction period. Inotropic intervention should shorten the PEP by increasing the rate
of intraventricular pressure development. This can be modified by decreases in
diastolic aortic pressure, which leads to further reductions in PEP, by reducing the time
available for isovolumic contraction. Since dobutamine increased aortic diastolic
pressure the marked shortening of PEP associated with this drug is more likely to
reflect an increased rate of rise of intraventricular pressure (Talley, Meyer and McNay,
1971). Increased inotropy generally results in a reduction in ET because of increased
velocity and extent of fibre shortening (Lewis, Rittgers, Forester and Boudoulas,
1977). Predictably dobutamine caused ET to fall significantly, but it increased with
both dopamine and dopexamine infusions. These unexpected increases in ET are likely
to result from the marked increases in stroke volume which has been demonstrated to
accompany administration of both agents (Weissler, Peeler and Roahll, 1961). Ejection
time continued to increase for at least 20 minutes after dopexamine infusion was
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discontinued. This finding is difficult to explain from current knowledge of its actions.
Thirty minutes after the infusion was discontinued VTI was still elevated above the
control value, but was significantly less than the value after 60 minutes of infusion, yet
ET was significantly higher 30 minutes after the infusion had stopped than it had been
at any time during infusion. As a result the prolonged ET cannot be attributed to
increased stroke volume alone. The arterial blood pressure and left ventricular end-
diastolic pressures were unchanged, so no other evidence for alterations in afterload
and/or preload which might explain altered ejection dynamics was found.
It has been suggested that changes in systemic vascular resistance or mean
arterial blood pressure do not provide an adequate measure of afterload during
dopamine and dobutamine infusion in dogs (Borow, Lang, Neumann, Janzen and
Altman, 1986). If this also applies in horses, changes in afterload and hydraulic load of
the left ventricle cannot be discounted and may account for the altered ejection dynamics
30 minutes after dopexamine was discontinued. This sustained effect was also
observed after dopamine and dobutamine infusions when ET was also greater than the
control value 30 minutes after stopping both infusions. Again considerations of the
preload and afterload as assessed by left ventricular end-diastolic pressure and mean
aortic pressure fail to explain the increase in ET.
The altered dynamics may have resulted from changes in vascular inpedance
caused by an inbalance in the duration of receptor activities of the three drugs. All three
drugs have both peripheral vascular and cardiac effects and if the duration of the drugs'
inotropic actions are shorter than their vascular effects, this may explain the current
findings. In intact animals the autonomic nervous system modulates cardiac
contractility and heart rate in response to inotropic and vasodilator agents (Vatner,
Rutherford and Ochs, 1979). It is also possible that after prolonged infusion of
catecholamines there remains an altered balance of autonomic tone causing the observed
changes in the pattern of left ventricular ejection.
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INTEGRATED APPROACH TO THE MEASUREMENT OF VENTRICULAR
CONTRACTILITY
Binks and Jewell (1972) were of the opinion that no index will ever truly
provide a satisfactory measure of contractility in the intact animal. The present studies
support this suggestion. A better approach appears to be to judge contractility from
several indices of pressure, flow and cardiac dimensions, not from a single number
(Milnor, 1990c). Because of the large array of indices that are readily available from
transoesophageal Doppler echocardiography the technique has great potential for
evaluating the complex haemodynamic disturbances of the anaesthetised horse and for
monitoring its responses to therapy.
HAEMODYNAMIC EFFECTS OF INDIVIDUAL DRUGS
Cumulative effects of dopexamine and dobutamine
There is evidence from the present studies that continuous administration of 4
pg.kg-kmin1 dopexamine and dobutamine failed to illicit a maximum effect on a
number of haemodynamic variables within the 60 minute infusion period. Maximum
rate of rise of left ventricular pressure, CO, VTI and dv/dtniax all increased throughout
the infusion period. Dopexamine also caused progressive increases in left ventricular
ET, which continued after the infusion was discontinued.
Pharmacological studies in dogs have shown that the plasma half life of
dobutamine is 2 minutes and steady plasma levels of the catecholamine can be achieved
after 10 minutes of continuous infusion (Murphy, Williams and Kau, 1976). In human
medicine it is accepted that the half life of the catecholamines is less than five minutes
and their peak effects are achieved rapidly (Opie, 1995). Because of the rapid clearance
of the drugs their cardiovascular effects are short-lived, waning within 10 - 15 minutes
of stopping infusion (Leier and Binkley, 1991). This pharmacological data has been
directly transposed into veterinary medicine and it is generally accepted that the same
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situation occurs in horses (Muir, 1991). Most studies of the haemodynamic effects of
dobutamine or dopexamine in anaesthetised horses have utilised serially increasing
infusion rates (Muir, 1992b; Swanson, Muir, Bednarski, Skarda and Hubbell, 1985;
Wertz, Dunlop, Wagner, Heath and Chapman, 1991). In these studies a maximum of
15 minutes elapsed before data were collected and the infusion rate was again increased.
In the present studies the effect of the two drugs on heart rate and left ventricular and
aortic blood pressure had reached a plateau after 20 minutes. Stabilisation of blood
pressure after drug administration has been used to define the peak effect of intropic
agents or a "steady state" in many studies (Hinchcliffe, Mc Keever and Muir, 1991;
Bedotto, Eichhorn and Grayburn, 1989; Harrison, Clifton, Berk and DeMaria, 1989).
This assumption may explain why the cumulative effects of these drugs on other
haemodynamic variables in anaesthetised horses have not been reported previously.
The present studies show that the haemodynamic effects of dobutamine and
dopexamine persist longer than has been described in other species. This finding is
corroborated by the data of Muir (1992b) which indicated that LVdp/dt^ and CO had
not returned to baseline values 60 minutes after discontinuing a infusion of 20 pg.kg~
'.mhr1 of dopexamine. The studies of Trim, Moore and White (1985) also
demonstrate the persistance of haemodynamic effects following dopamine infusion.
These authors allowed 30 minutes to elapse between incremental infusions in
anaesthetised horses to allow the cardiac output to return to baseline values. However
examination of their data reveals that cardiac output remained significantly elevated 30
minutes after 2.5 and 5.0 pg.kg fmin"1 dopamine infusions and systemic vascular
resistance was still significantly below control values at this time.
The differences in pharmacokinetics of these drugs in anaesthetised horses,
conscious humans and dogs may be attributable to effects of general anaesthesia which
alters tissue and plasma clearance of the drugs or delays their removal from the
receptors. Haemodynamic variables failed to return to control levels 45 minutes after
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infusion of dobutamine was discontinued in anaesthetised dogs (Orchard, Chakrabarti
and Sykes, 1982). The authors attributed their findings to an action of dobutamine, or
a product of it's action that persisted for longer than 45 minutes, or they postulated that
improvement in haemodynamic variables had occurred unrelated to dobutamine infusion
resulting from a time related change in their experimental preparation. As the half life of
dobutamine was 2 minutes in conscious dogs (Murphy, Williams and Kau, 1976), they
attributed their findings to time-related changes in their animal model. A similar effect
cannot be ruled out in the present studies since it has been shown that the cardiac output
of horses anaesthetised by a constant halothane concentration increases from a low level
immediately after induction of anaesthesia to a plateau after around 2 hours (Steffey,
Kelly and Woliner, 1987; Steffey, Woliner and Dunlop, 1990). However the residual
increase in ejection time after dopexamine and dobutamine infusions did not occur in the
same horses after dopamine infusion, indicating that this effect is likely to result from
drug administration. Similarly there were no significant differences between the other
measured haemodynamic variables 30 minutes after dopamine infusion and their pre-
infusion control values. Since this study was performed in the same group of animals
after an identical anaesthetic protocol, it suggests that the residual effects after
dopexamine and dobutamine can be directly or indirectly attributed to the drugs
administered.
These studies indicate that inotropic and vasodilator agents do not necessarily
attain their peak effect after 10 - 15 minutes in anaesthetised horses, and that their
effects have not completely resolved within 30 minutes of discontinuing drug
administration.
SPECIFIC HAEMODYNAMIC EFFECTS OF DOBUTAMINE
In the present study, a sixty minute infusion of 4 pg.kgkmnr1 of dobutamine
significantly increased arterial blood pressure, dv/dt^, LVdp/df^ and Vmax. The effect
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of dobutamine on cardiac output was much smaller than either dopamine or dopexamine
administered to the same horses. These findings are in general agreement with other
studies carried out in horses (Swanson, Muir, Bednarski, Skarda and Hubbell, 1985).
However the effect of dobutamine on arterial blood pressure in horses differs from that
in humans and dogs, in which it has little pressor effect (Vainionpaa, Nuutinen, Mokka
and Tuononen, 1983; Vatner, McRitchie and Braunwald, 1974). Swanson, Muir,
Bednarski, Skarda and Hubbel (1985) found that their estimate of total peripheral
resistance was unchanged by dobutamine when the drug was given to anaesthetised
horses. In the present studies the increases in cardiac output and heart rate were small
despite the large increases in arterial blood pressure that occurred. These data suggest
that dobutamine did produce peripheral vascular effects, since in the absence of
increases in heart rate and stroke volume, increases in arterial blood pressure must be
mediated by an increase in systemic vascular resistance. A similar effect was described
by Hinchcliffe, McKeever and Muir (1991) when low doses of dobutamine
administered to conscious horses increased cardiac work, by increasing arterial blood
pressure without increasing cardiac output.
Human studies have shown that the increase in cardiac output that occurs with
dobutamine is associated with an increased stroke volume (Ihlen, Amlie, Dale, Forfang,
Nitter-Haige, Simonsen and Myhre, 1984). This contrasts findings in the present study
when dobutamine infusion failed to significantly alter VTI until 40 minutes after the
infusion commenced. Quantitatively the changes in VTI were much smaller than
occurred with dopexamine and dopamine, indicating that increased stroke volume was a
less prominent mechanism of dobutamine's activity in horses. A smaller increase in
VTI with dobutamine is explicable because the large increase in VIIM was offset by
significant decreases in left ventricular ET.
The different haemodynamic effects of dobutamine in anaesthetised horses
compared to dogs and humans may be explained by differences in the structure of
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peripheral vascular adrenoreceptors in horses. It is possible that these differences might
upset the normal balance of the vascular actions of the two stereoisomers which
constitute the racemic mixture of dobutamine. If the affinity of dobutamine for equine
a adrenoreceptors was predominant the mutual antagonism between the (-) enantiomer
and the (+) enantiomer in the vasculature could be disturbed, resulting in net
vasoconstriction. It is well known that the relative sensitivity to oc2 adrenoreceptors
agonists varies markedly between different species. Recently radioligand binding
studies have identified different (Xj adrenoreceptor subtypes in a variety of species, this
is likely to contribute to inter-species divergence in pharmacodynamic responses to a2
adrenoreceptor ligands (Daunt, Link, Chruscinski and Kobilka, 1994). Species
heterogenicity has also been demonstrated in a! adrenoreceptors (Berkowitz and
Schwinn, 1994), and it is therefore conceivable a similar effect could account for the
observed difference in pressor response with dobutamine in horses, dogs and humans.
In the present study infusion of dobutamine was associated with significant
increases in left ventricular end-diastolic pressure. Assuming that ventricular
compliance was normal it can be inferred that dobutamine increased left ventricular
preload. Some support for this is available from studies in calves in which dobutamine
caused venoconstriction and decreased venous capacitance (Binkley, Murray, Watson,
Myerowitz and Leier, 1991). Similar venoconstriction mediated by an a
adrenoreceptor mechanism was also demonstrated in dogs (Fuch, Rutlen and Powell,
1976). Increases in preload may have significantly contributed to the increases in
LVdp/dt^, dv/dt^, and Vmax which occurred with dobutamine infusion (Sonnenblick,
1962a), therefore the changes in these variables cannot be ascribed to increased
contractility alone.
During dobutamine infusion the down-stroke of aortic velocity spectra became
notched and spectral dispersion was evident during the deceleration component in a
number of animals. Spectral dispersion indicates that non-laminar flow is occurring
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within the vessel. Non laminar flow has been observed previously in the central core of
aortic blood flow after isoprenaline infusion in dogs (Falsetti, Caroll, Swope and Chen,
1977). These workers also noted that the turbulence existed throughout the deceleration
component of the aortic blood flow. Deceleration is a more disorganised process than
acceleration, so that deceleration instability with associated spectral broadening is
characteristic of flows in great arteries (Weyman, 1994c). Since dobutamine increases
both inotropy and lusitropy and increases Vmax, deceleration must increase. This may
explain the increased spectral broadening which occurred during dobutamine
administration, and to a lesser extent during administration of dopexamine.
The notching on the down-stroke of the aortic velocity envelope has not been
reported previously in horses. Additional momentum must have been imparted to the
blood, or opposition to blood flow must have suddenly decreased, for velocity during
the deceleration phase to suddenly increase. It is possible that there is recruitment of
cardiac contractile elements at this time, or a sudden increase in developed tension.
This explanation seems unlikely since most studies suggest that there is almost
synchronous activation of the left ventricular contractile mass and that left ventricular
ejection is "more like striking a piston with a mallet than like squeezing blood out of a
chamber" (Rushmer, 1964). An alternative explanation lies in a change in ventricular-
vascular coupling induced by dobutamine infusion. Dobutamine infusion has been
shown to have beneficial effects on ventricular-vascular coupling in human patients
with congestive heart failure (Binkley, VanFossen, Nunziata, Unverferth and Leier,
1990). In these patients increased stroke volume was accompanied by complimentary
changes in the aortic impedance spectrum which optimally matched it to the increased
contractile state of the ventricle, maximising the efficiency of power transfer to the
circulation. The characteristics of hydraulic impedance are greatly influenced by body
shape and this phenomenon has been used to explain the different aortic pressure wave
profiles observed in different species (Nichols and O'Rourke, 1990a). Differences in
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early wave reflectance caused by peripheral vasodilation or changes in ventricular
ejection time can induce a mismatch between the early minimal value of impedance
modulus and the maximal values of flow harmonics, a relationship which is necessary
to optimise cardiovascular efficiency (Nichols and O'Rourke, 1990a). Sharp
reductions in ejection time occur with dobutamine infusion which may be accompanied
by alterations in vascular resistance in horses. It is possible that the sudden increase in
flow velocity during the deceleration period corresponds to a sudden reduction in
impedance modulus at a later stage in ventricular ejection.
Similar notching of pulmonary arterial flow velocity waveforms have been
observed in human patients with pulmonary hypertension (Martin-Duran, Larman,
Trugena, Vasquez De Prada, Ruano, Torres, Figuero, Pajaron and Nistal, 1986).
Similar findings were also obtained when pulmonary hypertension was induced in dogs
(Matsuda, Sugishita, Yamaguchi, Tamura and Ita, 1981). These authors suggested that
the flow pattern was altered by changes in stroke volume and peripheral wave reflection
resulting from right ventricular pressure overload, altered ejection dynamics and
increased right ventricular outflow impedance. This may be a similar mechanism to that
responsible for the notching of the aortic velocity waveforms observed in the present
studies
Arrhythmogenicify of dobutamine
Tachydysrhythmia occurred in two horses during dobutamine infusion. This is
in contrast to previous reports of the use of dobutamine in anaesthetised horses.
Swanson, Muir, Bednarski, Skarda and Hubbel (1985) noted that heart rate fell after
infusions of 2.5 and 5 pg.kg-fmin1 but had returned to baseline after a 10 qg.kg-
fmin1 infusion in a study examining serial increasing infusions of dobutamine.
Donaldson (1988) reported a 28% incidence of dysrhythmia after 1.7 qg-kg-fmin"1
was administered to horses anaesthetised for elective surgery. These dysrhythmias
were exclusively associated with reduction in heart rate. In the present study after 20
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minutes of an infusion of 4 pg.kg-fmin1 there was a significant decrease in heart rate,
similar to the findings of Swanson, Muir, Bednarski, Skarda and Hubbel (1985)
however drug administration was not continued beyond 6 minutes in horse 6 as
supraventricular tachycardia developed in this animal at this time on two separate
occasions. Horse 7 developed supraventricular tachycardia after 20 minutes during
dobutamine infusion, but this data was not included in the results as the infusion was
administered uneventfully on another occasion.
The appearance of tachydysrhythmia in two horses in the present study may be
attributable to the adrenoreceptor agonist, romifidine, administered as a premedicant
agent. It has been documented that a related drug, xylazine, decreases the dose of
adrenaline necessary to produce tachydysrhythmias in dogs (Muir, Werner and Hamlin,
1975). However the chemical structure of romifidine differs from that of xylazine by
the presence an imidazole ring (Gasthuys, Parmentier, Goossens and DeMoor, 1990).
Studies have demonstrated that a related drug, dexmedetomidine, had antiarrhythmic
properties in halothane anaesthetised dogs. (Hayashi, Sumikawa, Maze, Yamatodani,
Kamibayashi, Kuro and Yoshiya, 1991). The antiarrhythmic properties of this drug
have been attributed to the presence of an imidazole ring in the parent compound
(Hayashi and Maze, 1994). Specific studies investigating the arrhythmogenicity of the
oc2 adrenoreceptor agonists have not been reported in horses and it is possible that the
situation with romifidine is complex.
The threshold for arrhythmogenesis with dobutamine infusion is known to
decrease in response to vagotomy in horses (Light, Hellyer and Swanson, 1992) and
dogs (Bednarski and Muir, 1983), which infers that the parasympathetic nervous
system modulates responses to dobutamine infusion. Modulation of parasympathetic
tone by the long acting a2 adrenoreceptor agonist is an alternative explanation for the
increased arrhythmogenicity seen with dobutamine infusion in the present study.
Romifidine has a potent vagal stimulatory effect in conscious horses (Young, Long,
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Clutton, Molony and Darke, 1994), but the modulating effect of the drug on
parasympathetic activity in anaesthetised horses is currently unknown. The present
studies suggest that romifidine, administered as a premedicant drug, may alter the
cardiovascular responses to infused catecholamines in certain individuals.
Dobutamine showed less arrythmogenic potential in dogs than did isoprenaline,
noradrenaline or dopamine (Tuttle and Mills, 1975; Holloway and Frederickson,
1974). Failure of dobutamine to significantly increase arterial blood pressure in dogs
and humans is believed to contribute to its low arrhythmogenic potential (Holloway and
Frederickson, 1974). Increases in arterial blood pressure result in greater developed
tension in the contracting myocardium which is known to increase purkinje cell
automaticity (Muir, 1977; Moore, Morse and Price, 1964). In horses infusion of
dobutamine elevates arterial blood pressure (Light, Hellyer and Swanson, 1992; Muir,
1992b; Donaldson, 1988; Swanson, Muir, Bednarski, Skarda and Hubbell, 1985).
Interestingly in the present study, in the two horses which developed tachycardia with
dobutamine infusion, the arterial blood pressure increased to much higher values than in
the other animals immediately before the arrhythmia commenced. Romifidine is known
to cause peripheral vasoconstriction and resultant increases in arterial blood pressure in
conscious horses (Young, Long, Clutton, Molony and Darke, 1994), it is possible that
residual activity of romifidine at peripheral a adrenoceptors may have been
responsible for a greater effect of dobutamine on arterial blood pressure resulting in the
appearance of arrhythmia in 2 of these animals at much lower infusion rates than has
been observed previously.
SPECIFIC HAEMODYNAMIC EFFECTS OF DOPEXAMINE
Infusion of 4 pg.kgfmin1 dopexamine increased cardiac output and stroke
volume without affecting arterial blood pressure. The drug also increased LVdp/dt^,
V max and dv/dt max suggesting that it increased cardiac contractility, findings that are
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consistent with those of Muir (1992b). The cardiovascular effects of dopexamine in
anaesthetised horses mirror that in humans (Baumann, Gutting, Pfaferott, Ningel and
Klein, 1988; Jaski and Peters, 1988; Dawson, Thompson, Signy, Juul, Turnbull,
Jenkins and Webb-Peploe, 1985) and the drug appears to have an ideal haemodynamic
profile for the treatment of low cardiac output in horses. However the side effects
noted in the present study may preclude its use in clinical equine anaesthesia.
Side-effects of dopexamine
Increased urine output is expected from a drug known to increase renal blood
flow and promote natriuresis (Smith and O'Connor, 1988). The copious sweating seen
in the present studies was not reported by Muir (1992b), neither has it been reported in
other species. Dopamine and dobutamine did not produce a similar response in the
horses in the present studies inferring that it is unlikely to arise from Pi, DA! or a
adrenoreceptor stimulation. Dopexamine is an agonist at p2 receptors (Biro, Douglas,
Keon and Taichman, 1988; Brown, Dixon, Farmer, Hall, Humphries, Ince, O'Connor,
Simpson and Smith, 1985) and direct stimulation of p2 receptor subtypes may be
responsible for the profuse sweating noted in these studies. Intravenous administration
of the p2 adrenoreceptor agonist drug, clenbuterol, to anaesthetised horses also caused
profuse sweating (Bartram, Young, Diamond, Gregg and Jones, 1993), providing
additional evidence that a p2 adrenergic mechanism might be involved. That sweating
was not observed in the studies by Muir (1992b) may be explained as follows: The
protocol used differed from the present study in the drugs used to induce anaesthesia.
The dose of a2 adrenergic agonist agent administered in the present studies as a
premedicant agent was high, to allow induction of anaesthesia with ketamine. The long
duration of action of romifidine would ensure it's continued presence during the
inotrope infusion. Romifidine, in common with other a2 adrenergic agonist drugs, is
known to cause sweating after intravenous administration in conscious horses (Hall and
Clarke, 1992). In the study by Muir (1992b) a low dose of the shorter acting a2
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adrenergic agonist drug, xylazine, was used to facilitate cardiac catheterisation, the
effects of this drug are more likely to have waned by the time anaesthesia was induced.
It is possible that the combined actions of romifidine and dopexamine were responsible
for the profuse sweating seen in the present studies.
The excitement and shivering observed during recovery from anaesthesia in a
high proportion of horses also appears to be unique to this species. One study in
humans reported tremors and chest pain in 20% of conscious human patients during
infusion of dopexamine (Dawson, Thompson, Signy, Juul, Turnbull, Jenkins and
Webb-Peploe, 1985). Shivering may have occurred secondary to sweating; as the wet
horse recovered in the colder environment of the recovery box, evaporation of surface
moisture could reduce surface, then core temperature to a threshold that provoked
shivering. Two of the horses that were noted to have had excitable recoveries showed
signs of colic, which probably contributed to their poor quality recoveries. The 3
geldings urinated immediately after standing after dopexamine had been administered.
Abdominal discomfort caused by a full bladder may have adversely influenced quality
of recovery in these patients.
The most serious side-effect observed in these studies was colic seen in 2/7
animals, both horses responded to medical treatment over about 4 hours, but during the
recovery period the likelihood of self trauma was high in horse 8. If either horse had
undergone surgery for fracture repair, the colic that resulted could have compromised
the surgical outcome. The mechanism of the gastrointestinal pain observed in these
horses was uncertain and similar side-effects were not reported in the studies by Muir
(1992b). Decreased intestinal motility, as evidenced by absence of intestinal
borborygmi at clinical examination, could have resulted from a direct effect of
dopexamine, or from a combination of dopexamine and the romifidine, a drug known
to reduce intestinal motility (Hall and Clarke, 1992). Dehydration of gut contents
caused by the profuse sweating that accompanied dopexamine infusion may also have
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contributed to gastrointestinal dysfunction. Regardless of the aetiology, if the colic
observed in these studies is typical, it represents a serious complication to
administration of dopexamine and could preclude its clinical use.
SPECIFIC HAEMODYNAMIC EFFECTS OF DOPAMINE
Infusion of 4 pg.kg^.min"1 of dopamine increased cardiac output and stroke
volume in these anaesthetised horses whilst their arterial blood pressure tended to fall.
Maximum rate of rise of left ventricular pressure, V max and dv/dt mai were minimally
affected by dopamine infusion implying that at the dose rate employed in these studies
the drug was increasing cardiac output primarily through afterload reduction. This is in
agreement with the studies of Goldberg (1974) who showed a similar haemodynamic
effect when infusion rates of between 2 and 5 (xg.kg kmin1 were employed in humans.
The following studies are consistent with the conclusions of Swanson, Muir,
Bednarski, Skarda and Hubbel (1985) namely that the haemodynamic effect of
dopamine was similar in horses to other species.
INOTROPIC THERAPY FOR ANAESTHETISED HORSES
Of the three drugs under investigation dobutamine appeared to be most
efficacious in increasing inotropy, but the least effective in increasing aortic blood flow.
In equine anaesthesia support of mean arterial blood pressure has become an
increasingly important goal (Hubbel, 1991), largely as a result of the work of two
groups who showed that induced arterial hypotension in anaesthetised horses was
associated with post-operative myopathy (Lindsay, Robinson, Brunson and Majors,
1989; Grandy, Steffey, Hodgson and Woliner, 1987). Retrospective clinical surveys
have also linked occurrence of post-operative lameness to intra-operative hypotension
(Richey, Hollans, McGrath, Dodman, Marshall, Court, Norman and Seeler, 1990;
Klein, 1978). Pressures within Triceps brachii exceeding 60 mmHg have been
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measured in the dependent fore-limbs of anaesthetised horses using wick catheters
(Lindsay, McDonell and Bignell, 1980). This led to the hypothesis that postoperative
myopathy was similar to the compartmental syndrome seen in man, when increasing
pressure within a closed fascial compartment leads to a vicious circle of ischaemia,
muscle damage and further increases in intracompartmental pressure (Mubarak and
Hargens, 1983). It has been demonstrated experimentally that blood flow to muscle is
decreased if internal pressure exceeds 50 mmHg, and flow reduces to 95% of normal
when internal pressure exceeds 80 mmHg (Sheridan and Matsen, 1957). In other
studies pressures greater than 30 mmHg have been shown to cause muscle damage
(Rorabeck and MacNab, 1975). This data has been used to explain the muscle damage
which can result from equine anaesthesia, and it has been suggested that a pressure
difference of at least 30 mmHg must be maintained between mean arterial blood
pressure and maximum intracompartmental pressure (Taylor, 1992). Advocates of this
simplistic hypothesis have suggested that since intracompartmental pressures as high as
60 mmHg have been measured in anaesthetised horses in the laboratory (White and
Suarez, 1986; Lindsay, McDonell and Bignell, 1980), to maintain a perfusion presure
of 30 mmHg, mean arterial blood pressure must be maintained in excess of 90 mmHg
(Taylor, 1992).
Despite the widespread and increasing use of dobutamine in clinical equine
anaesthesia a reduction in the incidence of myopathy has not been reported. Young and
Taylor (1993) failed to demonstrate a statistically significant decrease in the incidence of
myopathy following the use of dobutamine, despite clearly demonstrating that the drug
reduced the incidence of hypotension. They suggested that the cases of myopathy that
occurred after the routine use of dobutamine were not as severe, as had been observed
previously and attributed their aetiology to poor positioning. Unfortunately the cases in
the Young and Taylor series were separated, not only by routine use of dobutamine, but
also by a period of up to seven years. In this time advances in equine surgery have also
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occurred, including increasing use of less invasive methods such as arthroscopy,
refinement of techniques and surgical skills and more routine use of analgesia. It is
likely that these factors also affect the outcome of equine anaesthesia, or the severity of
any problems which do occur. Until prospective blind studies are conducted, a cause-
effect relationship between low arterial blood pressure and postoperative lameness in
clinical anaesthesia will be neither conclusively demonstrated nor disproved.
In some of the veterinary anaesthetic literature increased arterial blood pressure
is often assumed to equate to increased cardiac output (Taylor, 1992; Klein, 1978).
This assumption is not surprising since halothane anaesthesia has been shown to reduce
cardiac output and blood pressure in horses, whilst not greatly affecting systemic
vascular resistance (Steffey and Howland, 1978; Eberly, Gillespie, Tyler and Fowler,
1968). Dobutamine is known to increase cardiac index in humans and dogs, whilst
having minimal effects on systemic vascular resistance, so when the drug is
administered to anaesthetised horses it is logical to assume that when arterial blood
pressure increases increased cardiac output is likely to be the cause. The present studies
demonstrate that in anaesthetised horses arterial blood pressure may increase after
dobutamine without accompanying increases in cardiac output. In fact in certain
individuals, cardiac output fell, if a barorececeptor response to increased arterial blood
pressure induced bradycardia or second degree heart block.
In the present studies dopexamine and dopamine increased cardiac output to a
much greater extent than dobutamine. The fit Thoroughbred horses involved in these
studies were anaesthetised for at least 3 hours during each procedure and their mean
aortic blood pressures were often below the levels that would be considered the "safe"
threshold. Interestingly it was also shown that the mean arterial pressure measured
from the upper-most facial and great metatarsal arteries in horses in left lateral
recumbency did not bear a constant relationship to mean aortic pressure (Clutton,
Young and Long, 1994). In these studies mean pressures in the facial and metatarsal
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areries were 13. 5 mmHg (standard deviation = 7.4 mmHg) and 17.8 mmHg (standard
deviation = 6.5 mmHg) lower than mean aortic pressure respectively. In anaesthetised
horses measurements of arterial blood pressure are generally made from these
peripheral arteries, and their intraluminal pressures are then used as a basis for
therapeutic decisions. In our studies mean pressures as low as 40 mmHg were
regularly recorded from these arteries during dopamine and dopexamine infusions, yet
all horses recovered after at least 3 hours of general anaesthesia with no evidence of
muscle damage. Whilst low arterial blood pressure was associated with the
development of myopathy in the studies of Lindsay, Robinson, Branson and Majors
(1989) and Grandy, Steffey, and Miller (1987), lameness was not detected in the
present studies in fit healthy animals when facial artery pressures were reduced to
similar levels for a similar period. Our animals were positioned on a padded surface
with the lower thoracic limb pulled forward and the upper limbs supported
perpendicular to the sternum, a position which has been shown to reduce
intracompartmental pressures (White and Suarez, 1986). This may have reduced the
tendency for muscle damage in the present study, although Grandy, Steffey, and Miller
(1987), used the same positioning and obtained 100% incidence of obvious muscle
dysfunction after a similar period of hypotension. It is possible that the duration of
hypotension in the present study was insufficient to create the problems detected by the
other workers. However with a 100% incidence of muscle damage detected by both
groups it might be expected that one or more horses should have been at least mildly
affected by lameness, in these studies. From the interquartile ranges of mean aortic
pressure shown in Tables 14 to 17 individual horses had aortic blood pressures within
the 55 - 66 mmHg range for at least 3.5 hours. As mean aortic pressures tend to exceed
mean facial artery pressures, a higher proportion of the group probably fell into the
hypotensive category of Lindsay, Robinson, Branson and Majors (1989) and Grandy,
Steffey, Hodgson and Woliner (1987).
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In the studies of Lindsay, Robinson, Brunson and Majors (1989) and Grandy,
Steffey, Hodgson and Woliner (1987) inspired halothane concentration was increased
until mean facial artery pressure was in the range 55 and 65 mmHg. Halothane causes
a dose dependent depression in cardiac output (Steffey and Howland, 1978), resulting
in the low values of cardiac indices reported in the hypotensive period, 23.2 - 29.2
ml.kg-Lmin1 (Grandy, Steffey, Hodgson and Woliner, 1987) and 19.5 ml.kg'Lmin-1
(Lindsay, Robinson, Brunson and Majors, 1989). In the present studies end-tidal
halothane concentration did not exceed 0.9% and the cardiac index ranged from 53.9 -
78.9 ml.kg'Lmin"1 (dopamine) and 52.0 - 99.8 ml.kgLmin1 (dopexamine). This
questions the hypothesis of whether low mean arterial pressure was the single
aetiological cause of the severe muscle damage produced in the early studies. The
assumption that driving pressure is paramount in maintaining muscle perfusion has
been widely accepted and has led to the increasing use of dobutamine in modern equine
anaesthetic practice. It has been demonstrated in these studies that in the early stages of
infusion in anaesthetised horses dobutamine may reduce cardiac output, despite mean
arterial blood pressure increasing. In clinical usage, after arterial blood pressure has
increased to an acceptable value, the drug is often discontinued. Lower doses of the
drug, 0.5 - 2.0 lig.kg'kmin-1, are generally employed in the clinical situation and as a
consequence of infusion bradydysrhythmias commonly result (Donaldson, 1988). It is
unlikely, therefore, that used in this manner dobutamine would significantly increase
cardiac output. If low blood pressure as a result of halothane overdose in the early
foundation studies occurred secondary to low cardiac output, it is possible that low
cardiac output contributed to the production of the devastating lamenesses reported by
these workers. If this is the case, it may explain why routine use of dobutamine in
clinical equine anaesthesia has not greatly improved its outcome. It is also possible that
the haemodynamic effects produced in the anaesthetised horses in the laboratory were
not representative of the clinical situation, as the dose of halothane administered greatly
exceeded that normally used in general surgery. Clearly the mechanisms underlying
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changes in muscle pressure and perfusion which result in muscle damage in
anaesthetised horses are not yet fully understood. The established pressure-based
theories of muscle perfusion, whilst attractive in their simplicity, are not adequate to
explain the mechanisms of muscle dysfunction in this species. Attemps to ellucidate the
relationship of driving pressure and blood flow to muscle represents an exciting area for
future investigations.
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FIGURES FOR CHAPTER 5
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Figure 27: Aortic velocity spectra recorded from Horse 6 during
infusion of 4 pgkg^min"1 dobutamine.
Six minutes after commencing infusion of dobutamine the heart rate of
Horse 6 accelerated into a junctional tachycardia (rate 150 bpm). The
rhythm was short-lived and returned to normal sinus rhythm within 5
minutes of stopping dobutamine administration.
This slide shows the transition from normal sinus rhythm to junctional
tachycardia. Note the reduction in amplitude and area under the velocity
spectra (VTI) as the accelerated rhythm begins.
The study was repeated on a second occasion, and tachycardia reccurred
approximately the same time after beginning the infusion.
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Figure 28: Aortic velocity spectra from Horse 6 during sustained
junctional tachycardia.
The spectra are reduced in amplitude (< 0.8 ms-1) and duration. Marked
spectral dispersion is evident in the downstroke of the envelope.
185
SAWKJJ! " S 4 m- ««»"<!!«>wtTWB
fllvr 1.39 «/« .* F$ | „ '
flngl.i I .* MBD
l.,pf rr>wl 1
lapthi 113 aa *llci HI
COHfl'flt fl» HALOTHAHE ;jf
* J MMmmJrnym*
•:tw.. jaaan, .ffag. jaa, .w:1—*
"let 34 A -*»«•(,,c<) ,[I •"«' \SB."I •" A£h w» J
TE taap: 34.8 C
Dtpthi 139 aa
29RCC91K
I0BUTAN1HC (I HIHUTC8 — ,
*, IF Z
Z 4 fp» friati 1




Figure 29: Aortic velocity spectra obtained from Horse 1 before (upper)
and after (lower) 60 minutes of 4 pgkg^min-1 dobutamine
infusion
Notice the velocity scale has been increased from 1.0 to 1.5 ms"
indicating that maximum velocity (Vn>ax) has increased. The upstroke of the
spectra is steeper representing an increase in maximum acceleration
(dv/dtmaj) The downstroke of the spectra has become notched. Pre-ejection
period (PEP) and ejection time (ET) have both reduced.
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Figure 30: Spectral dispersion in the early downstroke of the aortic flow
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Figure 31: Aortic velocity spectra obtained from Horse 1 before (upper)
and after (lower) 20 minutes of 4
infusion
pgkg^min-1 dopexamine
The velocity scale has been increased from 1.0 to 1.5 ms_1, indicating that
maximum velocity (Vmax) has increased. The upstroke of the spectra is
more steep representing an increase in maximum acceleration (dv/dtmax).
The downstroke of the spectra became notched. Pre-ejection period (PEP)
has reduced and ejection time has increased. Infusion of dopexamine was
associated with large increases in cardiac output, evidenced by the
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Figure 32: Aortic velocity spectra obtained from Horse 1 before (upper)
and after (lower) 40 minutes of 4 pgkgYmin-1 dopamine
infusion
Notice that there has been only a small increase in maximum velocity (V^)
and maximum acceleration (dv/dtmax). The overall shape of the spectra is
unchanged. The area under the velocity profile (VTI) is larger because of a
significantly increased ejection time (ET)
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Figure 33: Horse 1 during infusion of 4 pgkg^min"1 dopexamine.
Dopexamine was associated with pronounced sweating in all horses. This
slide was taken 20 minutes after the start of infusion in Horse 1.
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GENERAL DISCUSSION
Transoesophageal echocardiography has been demonstrated to be a valuable
technique for assessment of left ventricular function in anaesthetised horses. The
number of two dimensional (2-D) images obtainable from transoesophageal
echocardiography in horses is limited compared to the large number of reference views
available in humans. This probably results from the greater distance between the
oesophagus and the heart, and the differences in thoracic anatomy between biped and
quadruped species. However a long axis view of the left ventricular outflow tract and
aorta was repeatably obtained by transoesophageal echocardiography in horses, and the
alignment of the ultrasound beam with ascending aortic blood flow was ideal for
Doppler echocardiography. Doppler echocardiographic studies of aortic blood flow
velocity obtained from the oesophageal probe were suitable for measurement of indices
of left ventricular performance.
In transoesophageal echocardiography the ultrasound transducer is fixed in the
oesophagus and controlled from a site distant from the patient, it is thus ideally suited
for use in the operating theatre. The technique is minimally invasive and appears to be
well tolerated in healthy thoroughbred horses. Cardiac catheterisation is not required,
removing the risks that have previously restricted haemodynamic monitoring to the
laboratory. Transoesophageal echocardiography will allow haemodynamic monitoring
to be performed in client-owned animals, so that the interactions between general
anaesthesia and surgery can be evaluated in horses presented for both elective and
emergency procedures.
Chapter 3 of this work showed that the repeatability of the indices of left
ventricular performance derived from Doppler echocardiography were similar to those
derived from cardiac catheterisation. Overall the repeatability of blood pressure and
Doppler derived data were poor compared to those obtained previously for conscious
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horses and humans. This suggests that general anaesthesia interferes with normal
homeostatic control of cardiovascular performance in horses.
Transoesophageal echocardiography provides a non-invasive alternative to
thermodilution method for measurement of cardiac output in anaesthetised horses. The
technique affords a number of advantages over the traditional method, avoiding the
need for cardiac catheterisation and allowing continuous prolonged monitoring to be
performed. In these studies the limits of agreement and linear relationships between
Doppler derived estimations of cardiac output and those derived from thermodilution
exceeded those obtained when thermodilution was compared to transoesophageal
echocardiography in humans and transthoracic echocardiography in conscious horses.
The improved agreement probably reflects superior, and more repeatable, alignment of
the ultrasound beam with aortic blood flow.
Chapter 5 of this work showed that the Doppler derived index of cardiac
performance, maximum aortic acceleration (dv/dt^J, was as sensitive as the maximum
rate of rise of left ventricular pressure (LVdp/dt^J in detecting the changes in cardiac
performance produced by administration of dobutamine, dopexamine and dopamine.
Maximum aortic velocity (VmM) also changed with catecholamine infusion, but the
magnitude of the changes were less than for LVdp/dt^ and dv/dt,nax, reflecting reduced
sensitivity to the drugs administered. Despite being derived during ventricular ejection,
dv/dtII1M and VmM were no more load dependent than LVdp/dt^, an index obtained
during isovolumic systole. Velocity time interval (VTI) and the systolic time intervals
(PEP and ET) also showed sensitivity to catecholamime infusion, supporting the
suggestion that cardiac performance is better judged from as complete a set of data as
possible, rather than from a single variable. Because transoesophageal
echocardiography provides a number of indices of ventricular performance it has great
potential for evaluating the complex haemodynamic disturbances of the anaesthetised
horse.
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Further information can be provided by 2-D echocardiography which permits
measurement of chamber volumes and the non-invasive assessment of preload.
Integration of 2-D and Doppler echocardiography data should provide more complete
assessment of cardiac performance and represents an exciting area for future
investigations. Although the depth of intracardiac structures in horses currently limits
the 2-D information available from transoesophageal echocardiography, advances in
ultrasound technology and probe design may overcome this limitation.
Chapter 5 also called into question the hypothesis that low mean arterial blood
pressure was associated with muscle dysfunction in anaesthetised horses. These
studies showed that when cardiac index was high, post-anaesthetic lameness did not
occur, despite prolonged periods of hypotension in horses anaesthetised with
halothane. These findings suggest that fundamental mechanistic studies are now
required to elucidate the relationship of pressure and flow in determining muscle
perfusion. Ideally the intracompartmental pressure hypothesis should be tested by
simultaneous measurement of muscle blood flow by techniques such as Laser Doppler
flowmetry. The relationship between central and peripheral arterial pressures, cardiac
output and muscle blood flow must be determined before rational preventative therapy
for post-operative lameness and morbidity can be established. Because there is a higher
incidence of morbidity and mortality associated with general anaesthesia in horses,
improvements in our monitoring capabilities by the techniques provided by cardiac
ultrasound must increase our understanding of the complex haemodynamic disturbances
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APPENDIX FOR CHAPTER 3
In all box and whisker plots the central horizontal lines in the boxes
represent the median value.
The upper and lower horizontal box boundaries are the upper and lower
quartiles.
The vertical whiskers are drawn from the smallest, or largest data point,
within 1.5 interquartile ranges from either quartile
Outlying points are shown by a point.
Special data points (e.g. crosses or elipses) are used to indicate far outlying
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In all box and whisker plots the central horizontal lines in the boxes
represent the median value.
The upper and lower horizontal box boundaries are the upper and lower
quartiles.
The vertical whiskers are drawn from the smallest, or largest data point,
within 1.5 interquartile ranges from either quartile
Outlying points are shown by a point. Special data points (e.g. crosses or
elipses) are used to indicate far outlying data, more than three
interquartile ranges from the upper, or lower, quartile
* Indicates a significant difference from control values (p < 0.05) by a
paired Wilcoxon Test
A Indicates a significant difference from the preceding value (p < 0.05) by
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In all box and whisker plots the central horizontal lines in the boxes
represent the median value.
The upper and lower horizontal box boundaries are the upper and lower
quartiles.
The vertical whiskers are drawn from the smallest, or largest data point,
within 1.5 interquartile ranges from either quartile
Outlying points are shown by a point. Special data points (e.g. crosses or
elipses) are used to indicate far outlying data, more than three
interquartile ranges from the upper, or lower, quartile
* Indicates a significant difference from control values (p < 0.05) by a
paired Wilcoxon Test
A Indicates a significant difference from the preceding value (p < 0.05) by
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In all box and whisker plots the central horizontal lines in the boxes
represent the median value.
The upper and lower horizontal box boundaries are the upper and lower
quartiles.
The vertical whiskers are drawn from the smallest, or largest data point,
within 1.5 interquartile ranges from either quartile
Outlying points are shown by a point. Special data points (e.g. crosses or
elipses) are used to indicate far outlying data, more than three
interquartile ranges from the upper, or lower, quartile
* Indicates a significant difference from control values (p < 0.05) by a
paired Wilcoxon Test
A Indicates a significant difference from the preceding value (p < 0.05) by
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Feasibility of transoesophageal echocardiography for
evaluation of left ventricular performance in anaesthetised
horses
LESLEY E. YOUNG, KAREN J. BLISSITT, R. E. CLUTTON, V. MOLONY* and P. G. G. DARKEt
Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, Easter Bush, Near Roslin,
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Summary
TYansoesophageal Doppler echocardiography was performed
in 7 Thoroughbred horses anaesthetised with halothane. The
procedure was performed on 4 occasions under standard
conditions. On one occasion dobutamine hydrochloride was
infused at 4 pg/kg/min for 20 min. Recordings of aortic blood
velocity, obtained using high pulsed repetition frequency
Doppler echocardiography (HPRF), were used to derive
maximum acceleration (dv/dtm„J, maximum velocity (V„, ),dx max
left ventricular ejection time (ET), pre-ejection period (PEP),
velocity time integral (VTI) and cardiac output (CO).
The coefficient of variation and 95% confidence intervals
were narrower for the Doppler variables than for those
obtained from cardiac catheterisation. For each horse the
anaesthetic to anaesthetic repeatability of the Doppler indices
of left ventricular function, exceeded that of maximum rate of
rise of left ventricular pressure (LVdp/dtmax). The horse to
horse variability was significant for heart rates Vmax,
dv/dtmax, and VTI. After dobutamine infusion there were
signifcant changes in all measured variables except heart rate,
VTI and CO. The % change that occurred exceeded the
predicted 95% confidence intervals for single measurements
in all significantly affected variables. This suggests Doppler
indices of cardiac performance may be useful to assess
changes in haemodynamic function.
Passage of the probe into the oesophagus was not
associated with serious adverse effects. Mild serous nasal
discharge was visible for up to 24 h after the horses recovered
from anaesthesia. Mild nasal haemorrhage occurred on 5
occasions during probe insertion. It is concluded that
transoesophageal Doppler echocardiography provides a
minimally invasive, continuous method for monitoring left
ventricular systolic performance in anaesthetised horses.
Introduction
Transoesophageal ultrasonography was first developed in human
cardiology to enable cardiac imaging of patients with obesity,
pulmonary disease or prosthetic valves (Frazin et al. 1976). The
close anatomical proximity of the oesophagus to the heart enabled
the use of near-focused, high frequency transducers, resulting in
*Present address: Department of Preclinical Veterinary Studies,
Royal (Dick) School of Veterinary Studies, Summerhall Square,
Edinburgh, UK.
*Present address: Wordsworth Bam, Bicknoller, Taunton,
Somerset.
superior images of many intracardiac structures (Schluter et al.
1982). In transoesophageal echocardiography the transducer is
fixed in the oesophagus and controlled from a site distant to the
patient; and the technique is, therefore, ideal for the intensive care
unit or operating theatre (Bjerke 1992).
Measurement of aortic blood flow velocity enables left
ventricular systolic performance to be assessed. It has been shown
that the peak acceleration and maximum velocity of blood flow in
the ascending aorta are sensitive indices of left ventricular
contractile function (Rushmer 1964; Lambert et al. 1983). Studies
performed in dogs in which noninvasive Doppler measurements
were compared with conventional invasive indices of contractility
have shown a close correlation over a range of contractile states and
over a wide range of preload and afterload (Wallmeyer et al. 1988).
Doppler echocardiography plots blood velocity against time
in targeted areas of the heart and great vessels. Peak velocity and
maximum acceleration are readily obtained from blood velocity
spectra recorded from the aortic root during ventricular ejection.
These indices, derived from transthoracic echocardiography, have
been used to evaluate ventricular function in dogs (Brown 1992)
and adult horses, and are sensitive to changes in inotropic state
(Young et al. 1993).
Integration of the velocity-time curve gives an area which
represents the summated distance travelled by the blood with each
heartbeat, the velocity time integral (VTI). If the VTI is
multiplied by the cross sectional area of the vessel and the heart
rate, a measure of cardiac output is obtained (Haites et al. 1984).
When transthoracic echocardiography was used to obtain the
aortic velocity recordings, cardiac output estimations compared
favourably with thermodilution measurements in man (Huntsman
et al. 1983), dogs (Bonagura et al. 1990) and horses (Long et al.
1992). Doppler echocardiography is now available on commercial
transoesophageal ultrasound transducers and has been used for
intraoperative measurement of cardiac output in man (Haude et
al. 1989; Gorcsan et al. 1992; Ryan et al. 1992).
General anaesthesia in horses is known to produce cardiac
depression and systemic hypotension (Eberly et al. 1968;
Gillespie et al. 1969) and this has been linked to the development
of post operative morbity and lameness (Grandy et al. 1987;
Lindsay et al. 1989; Richey et al. 1990). Steffey and Howland
(1978) showed that the equine cardiovascular system is more
susceptible to the depressant effects of halothane than that of
other species. The assessment of cardiac performance in horses
has been restricted to measurement of cardiac output (Muir et al.
1976) or intracardiac and arterial pressures (Brown and Holmes
1979). However, use of these techniques is limited to research
applications due to risks associated with cardiac catheterisation
(Cournand 1975; Schlipf et al. 1994). The need for a noninvasive
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Fig 1: Equine transoesophageal probe. A 3.0 MHz, dynamically steered,
annular phased array transducer, mounted at the distal end of a 150 cm
human colonoscope. Note that the end has been stiffened, so that the
controls are no longer operational and an external lubrication system
has been applied.
Fig 2: Standard 2-D view of the left ventricular outflow tract and
aorta, obtained by transoesophageal echocardiography (AO = aorta,
PA = pulmonary artery, LVOT = left ventricular outflow tract).
technique to evaluate cardiac function in horses led the authors to
investigate transoesophageal echocardiography. The aims of this
particular study were to examine the feasibility of
transoesophageal echocardiography in anaesthetised adult horses,
and assess the repeatability of the derived indices of left
ventricular performance. The sensitivity of the Doppler indices to
inotropic intervention was also assessed by administration of the
Pi adrenoreceptor agonist, dobutamine.
Materials and methods
Echocardiography
A transoesophageal probe, suitable for use in horses, was
developed by Vingmed Sound (Horten, Norway) in association
with the Royal (Dick) School of Veterinary Studies. The probe
was used in conjunction with a Vingmed CFM 700 ultrasound
machine (Diasonics, Sonotron, Bedford, UK). The images were
obtained using a 3.0 MHz transducer mounted at the end of a 150
cm human colonoscope (Fig 1). The transducer was a
mechanically steered, 6 ringed annular phased array, with
dynamic focussing. The ultrasound system had the capacity for
Fig 3: Colourflow mapping applied to the aorta to facilitate placement
of the Doppler sample volume. The flash of red colour shows flow from
the left ventricular outflow tract to the aorta during systole. The lighter
shades of red represent a central core of faster flowing blood in the
centre of the vessel. The timing of this frame is represented by the ECG
in the far right of the figure (AO = aorta, PA = pulmonary artery,
LVOT = left ventricular outflow tract).
Fig 4: Pulse-wave Doppler study of aortic blood flow. The frozen 2-D
image, used to position the sample volume can be seen in the top of the
figure. The velocity scale in m/s is depicted on the right of the figure.
Blood is flowing towards the ultrasound transducer and is depicted
above the baseline.
two-dimensional (2-D) and M-mode imaging, colour flow
mapping and spectral Doppler (HPRF) and continuous wave
(CW) modes.
The maximum depth for 2-D and M-mode imaging was 24 cm.
The frame update rate was between 19 and 55 frames/s, dependent
upon the sector angle selected and the imaging depth. The
maximum depth for colour flow mapping and spectral Doppler
studies was 20 cm. Spectral Doppler studies were conducted using
the transducer in HPRF mode, with ultrasound emitted at a
frequency of 2.5 MHz.
The first equine transoesophageal transducer was similar to a
standard human transoesophageal probe. The distal end was
flexible for 15cm beyond the transducer, which could be rotated,
using the endoscopic controls. Flexibility of the end of the probe
is important in human cardiology to allow acquisiton of the
multiple standard transoesophageal images (Fisher et al. 1991).
However, during early studies, advancing the probe against












Fig 5: Diagram representing the ventricular outflow velocities recorded
by Doppler echocardiography. Peak velocity (V J is measured in m/s.
Peak acceleration (dv/dttmJ, in m/s/s, is measuredfrom the middle of the
upstroke of the spectral envelope to the peak velocity. The area under the
curve (VTI) is measured in cm and is derived by integrating below a line
traced around the brightest line of the spectral envelope (modal
velocity). PEP is measured from the start of the 'Q' wave of the ECG to
the start of ejection. The pre-ejection period (PEP) and the ejection time
(ET) are both measured in seconds.
resistance in the horses' pharynx caused it to bend and retroflex
before entering the oesophagus. This resulted in irreversible
damage. This complication, although rare, has also been reported
in man (Kronzon 1992). Subsequent pilot studies showed that
suitable transoesophageal images were obtained in horses with the
endoscopic controls in the locked position. The end of the probe
was then stiffened using heat seal material (Fig 1). To facilitate
lubrication of the oesophagus and to ensure good
echocardiography contact, a length of vinyl tubing
(800/101/250/800, Portex, Hythe, UK) was affixed to the body of
the colonoscope by adhesive tape (Sleek, Smith and Nephew
Medical Limited, Hull, UK). Before insertion the tubing was pre-
filled with lubricating fluid (Vet-Lubigel, Millpledge, Retford,
Herts, UK).
Horses and preparation
Seven Thoroughbred horses (4 mares and 3 geldings), aged 3-6
years and weighing 490-600 kg were used in the study. The
horses were healthy, housed indoors, and kept in moderate work.
No less than 3 months before these studies began, a 3 cm portion
of the right carotid artery in the mid-cervical area was raised to a
subcutaneous position with the horses under general anaesthesia.
Food, but not water, was withheld from the horses from 0800 h
of the day preceding the study. In a padded induction area 100
pg/kg romifidine (Sedivet, Boehringer Ingelheim (Vetmedica),
Bracknell, UK) were administered i.v. through a pre-placed
jugular catheter. Anaesthesia was induced by administration of
2.2 mg/kg bwt ketamine (Vetalar, Parke Davis, Pontypool, UK).
The trachea was intubated with a 25 or 30 mm cuffed
endotracheal tube which was adapted to allow collection of gas
from its distal end. Anaesthesia was subsequently maintained by
halothane. Initially the horses breathed spontaneously from a
large animal circle system.
Each horse was anaesthetised on 4 separate occasions,
separated by a period of not less than 28 days
Transoesophageal probe insertion
Within 15 min of induction of anaesthesia, with the horses in
lateral recumbency, the transoesophageal probe was inserted into
the uppermost nostril and advanced through the ventral nasal
meatus into the pharynx. Once the probe reached the pharynx, the
endotracheal tube was removed. One operator then placed a hand
into the pharynx through the horse's mouth, which was held open
using a Varnell's gag. From this postion the end of the probe
could be guided into the oesophagus and advanced at the nares by
a second operator. The endotracheal tube was then reintroduced
and its cuff inflated. As soon as the airway was secure, 60 ml of
lubricating fluid was introduced through the lubrication tubing.
The probe was then advanced down the oesophagus until the
endoscopic controls reached the nostrils.
General anaesthetic protocol
The horse was transferred to a padded operating table and
respiration was controlled using intermittent positive pressure
ventilation (Large Animal Control Center, Drager, Germany).
Ventilation rate and tidal volume were adjusted to maintain
arterial partial pressure of C02 (PaC02) between 35 and 45
mmHg. Halothane concentration was measured from end-expired
TABLE 1: Mean values and coefficients of variation of measured haemodynamic variables derived from pooled data (7
anaesthetised Thoroughbreds in 4 separate anaesthetic episodes). Intraclass correlation coefficient is also shown (where
applicable P<0.05 in ANOVA)
Intraclass
Mean Coefficient of 95% CI as % of correlation
(n=28) variation mean value coefficient
Heart rate (beats/min) 28 14% 20% 0.43
Maximum aortic velocity Vmax (m/s) 0.84 11% 23% 0.75
Maximum aortic acceleration dv/dt (m/s/s) 5.12 23% 22% NA
Pre-ejection period PEP (s) 0.23 12% 17% NA
Ejection time (ET) (s) 0.51 9% 15% NA
Velocity time integral VTI (cm) 24.8 14% 19% 0.47
Cardiac output (l/min) 27.8 14% 24% NA
Aortic systolic pressure (mmHg) 78 18% 35% NA
Aortic mean pressure (mmHg) 66 20% 42% NA
Aortic diastolic pressure (mmHg) 55 22% 45% NA
Maximum rate of rise of LV pressure (mmHg/s) 246 26% 52% NA
CI = confidence interval; n = number of measurements; NA = Not applicable.
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TABLE 2: Mean values of measured haemodynamic variables in individual horses (H) from 4 separate episodes of 0.9% end-tidal
halothane anaesthesia (values in parenthesis indicate coefficient of variation)
H1 H2 H3 H4 H5 H6 H7
Heart rate (beats/min) 28.0 26.7 29.7 37 28.2 27.5 30.5
(14%) (8%) (6%) (7%) (5%) (14%) (8%)
Maximum aortic velocity Vmax (m/s) 0.93 0.86 0.75 0.80 0.84 0.87 0.86
(8%) (5%) (8%) (14%) (5%) (8%) (15%)
Maximum aortic acceleration dv/dt (m/s/s) 5.91 5.62 4.64 5.1 4.74 5.71 4.14
(37%) (18%) (17%) (13%) (14%) (22%) (14%)
Pre-ejection period PEP (s) 0.22 0.21 0.24 0.22 0.24 0.22 0.26
(18%) (14%) (4%) (9%) (13%) (9%) (8%)
Ejection time (ET) (s) 0.49 0.56 0.48 0.51 0.53 0.50 0.48
(8%) (11%) (13%) (2%) (6%) (6%) (8%)
Velocity time integral VTI (cm) 26.8 29.5 21.1 23.7 26.2 24.8 21.3
(10%) (12%) (9%) (13%) (11%) (5%) (7%)
Cardiac output (l/min) 27.6 29.06 23.0 32.4 27.1 28.1 26.7
(13%) (10%) (11%) (8%) (10%) (14%) (17%)
Aortic systolic pressure (mmHg) 77 75 76 84 67 76 89
(19%) (21%) (17%) (19%) (21%) (12%) (13%)
Aortic mean pressure (mmHg) 64 63.2 65 72 58 66 77
(20%) (30%) (18%) (24%) (22%) (13%) (14%)
Aortic diastolic pressure (mmHg) 53 51.8 54 61 47 54 65
(22%) (32%) (20%) (27%) (23%) (14%) (16%)
Maximum rate of rise of LV pressure (mmHg/s) 238 225 242 289 206 278 244
(32%) (24%) (18%) (33%) (29%) (17%) (22%)
gas sampled from the end of the endotracheal tube, using an
anaesthetic gas monitor (Servo Gas Monitor 120, Siemens pic,
Cumberauld, UK). The out-of-circuit vaporiser was continually
adjusted throughout the procedure to maintain an end-tidal
halothane concentration of 0.9%. A base-apex electrocardiogram
(ECG) was displayed on an oscilloscope (Datascope 500,
Datascope Medical Company Ltd, Cambridge, UK).
Transoesophageal probe postioning
The transoesophageal ultrasound probe was positioned by slowly
withdrawing it, until a standard long-axis view of the aorta, left
ventricular outflow tract, and pulmonary artery (Fig 2) was
obtained. The probe occasionally had to be rotated to bring this
image into view. Once optimal alignment along the long-axis of
the aorta was obtained, colour flow mapping of aortic blood flow
was performed (Fig 3). The Doppler sample volume was then
placed in the centre of the vessel above the aortic valve in the area
where the colour flow Doppler study had revealed the fastest flow
of blood (Blissitt et al. 1995). Once the sample volume had been
positioned, the colour flow Doppler image was frozen, allowing
the transducer to be dedicated to the acquisition of Doppler
information. Adequate alignment with aortic blood flow was
assumed from the clarity of the audible signal and when a
complete velocity envelope containing minimal spectral
dispersion was obtained (Fig 4).
Intravascular pressure measurement
Left ventricular and aortic pressure measurements were made
using strain gauge transducers (Gaeltec Ltd, Dunvegan, Skye,
UK), mounted on a size 8F, woven Dacron catheter. One
manometer was sited at the distal end, and one 12 cm more
proximal. The bridge excitation voltage from each manometer
was monitored with a high gain amplifier (Series 5000,
Lectromed, Letchworth Garden City, UK). The output from each
high gain amplifier was recorded simultaneously by 1 channel of
a 4 channel chart recorder and a data acquisition system on a
Macintosh 11VI microcomputer. Each transducer was calibrated
against 100 mmFIg, using a mercury manometer before being
inserted and again on removal. In this study for both transducers,
zero lay within 2.5 mmHg of their pre-insertion zero reading with
95% confidence. Recorded pressures were not adjusted when
baseline drift occurred.
Catheters were introduced into the the left heart through an 8
French introducer (Haemaquet, Bard Ltd, Crawley, UK) placed in
the raised right carotid artery. The catheter was advanced through
the introducer until the pressure traces recorded indicated the
distal transducer was located in the left ventricle and the proximal
transducer in the aorta. Pressure data was displayed throughout
each study on the chart recorder and on the screen of the
microcomputer.
Data collection and measurement
Data was collected after 60 min of anaesthesia maintained at
0.9% end-tidal halothane concentration. In anaesthetic episode 3,
after initial data collection, dobutamine hydrochloride (Dobutrex,
Eli Lilley and Co, Basingstoke, UK) was infused at 4 pg/kg
bwt/min. Additional data was collected at 20 min and the infusion
was discontinued. Mechanical ventilation was stopped at each
measurement point and data was therefore recorded during
apnoea. In each recording period, 20 s of pressure data from each
strain gauge transducer was stored on the hard disk of the
microcomputer. This was analysed off-line using a purpose
written analysis programme (Labview 2.2.1, National
Instruments, Texas, USA). The average mean, systolic and
diastolic pressures for the aortic transducer were derived. The left
ventricular pressure waveform was differentiated to obtain
maximum rate of rise of left ventricular pressure (Lvdp/dtmax).
Average heart rate was also determined from the left ventricular
pressure waveform.
Doppler velocity spectra were recorded onto VHS videotape
for analysis. All Doppler derived data was measured by a single
observer by manual planimetry using electronic callipers.
Measurements from the spectra comprised; velocity time integral
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TABLE 3: Mean values of measured haemodynamic variables in 7 anaesthetised Thoroughbreds after 60 min of 0.9% end-tidal
halothane concentration in each of 4 separate anaesthetic episodes (values in parenthesis indicate coefficient of variation)
Episode 1 Episode 2 Episode 3 Episode 4
Heart rate (beats/min) 31 (14%) 29 (14%) 28 (13%) 30 (14%)
Maximum aortic velocity Vmax (m/s) 0.82 (12%) 0.89 (9%) 0.88 (5%) 0.78 (12%)
Maximum aortic acceleration dv/dt (m/s/s) 4.69 (16%) 5.89 (31%) 5.18 (10%) 4.74(19%)
Pre-ejection period PEP (s) 0.22 (14%) 0.24 (12%) 0.24 (13%) 0.24 (4%)
Ejection time (ET) (s) 0.51 (8%) 0.51 (10%) 0.48 (6%) 0.53 (11%)
Velocity time integral VTI (cm) 24.6 (14%) 25.1 (16%) 24.8 (10%) 24.5 (19%)
Cardiac output (l/min) 28.4 (9%) 28.6 (17%) 26.6 (18%) 27.0 (11%)
Aortic systolic pressure (mmHg) 78 (18%) 76 (19%) 75 (15%) 82 (20%)
Aortic mean pressure (mmHg) 68 (20%) 64 (21%) 62 (20%) 72 (22%)
Aortic diastolic pressure (mmHg) 55 (22%) 53 (22%) 51 (20%) 61 (24%)
Maximum rate of rise of LV pressure (mmHg/s) 257 (26%) 237 (34%) 234 (18%) 257 (26%)
(VTI), maximum acceleration (dv/dt,^), maximum velocity
(Vmax), left ventricular ejection time (ET) and pre-ejection period
(PEP) (Fig 5). Five consecutive velocity spectra, coinciding with
the period of blood pressure data acquisition, were averaged for
each anaesthetic episode. Cardiac output was calculated using the
equation:
Cardiac output = VTI x aortic cross sectional area x heart rate
Aortic cross sectional area was calculated using the equation:
Aortic cross sectional area = 3.14 x (radius)2
Aortic radius was measured from a 2-D standard transoesophageal
image (Fig 2), using the leading edge to leading edge method
(Wyatt et al. 1983). The vessel was measured above the sinus of
Valsalva at the vertical level of the Doppler sample volume. To
obtain the radius, 3 measurements were taken during systole from 3
consecutive cardiac cycles and an average figure obtained. These 2-
D images were recorded onto videotape immediately before the
spectral Doppler recordings. Heart rate was derived from left
ventricular pressure measurements recorded by the Macintosh 11VI.
Statistical analysis
Differences between anaesthetic episodes and horses were
assessed using analysis of variance. When the f ratio was
significant (P<0.05) an estimate of the day to day variability and
within horse variability was determined by calculating the
intraclass correlation coefficient, using the method described by
Sokal and Rohlf (1969). In this method the added variance
between groups, sA2, is first calculated using the equation:
n
sA2 = measure of the variability between individual horses, (an
estimate of the variance due to error-free variability of
different horses)
sB2 = the between group mean square (measure of the variance
between horses)
sw2 = the within group mean square (measure of the variance in
individual horses)
n = number of horses
The intraclass correlation coefficient (rt) is calculated from the
equation
s 2 - s 2bW A
The intraclass correlation coefficient represents the fraction of
the overall variability of the measurement that arises due to
variability between individual horses. It therefore varies from 0 to
1. The more repeatable a measurement is in an individual the
closer rj will be to 1.
Coefficient of variation was calculated for each variable from
pooled data by dividing the mean value by the standard deviation
and expressing the result as a percentage. Ninety-five %
confidence intervals for the error-free (or true) value of a
measured variable in a single subject was calculated using the
methods described by Moulinier et al, (1991). The square root of
sw2 is used to obtain the standard deviation (s.d.) within
individuals.
95% confidence interval for
= 2 x s
a single measurement w
sw = s.d. within individuals.
This value was then expressed as a percentage of the mean. The
percentage difference between 2 measurements in a single
individual must therefore exceed the 95% confidence interval, if
the observed difference reflects a real change (P<0.05)
Measurements before and after dobutamine infusion were
compared using a paired Student's t test. A probability of less
than 0.01 was considered significant.
Results
The probe was placed in the oesophagus successfully in each
horse on every occasion. The stiffened distal portion of the
colonoscope made it difficult to place in the ventral meatus.
Inadvertent introduction into the middle meatus resulted in nasal
haemorrhage on 5 occasions. Haemorrhage was usually short
lived and had always resolved before the horse recovered from
anaesthesia. If the probe entered the middle meatus, resistance
was detected before it reached the pharynx. When this occurred
the probe was withdrawn and reintroduced into the ventral nasal
meatus.
Once the oesophageal probe was fully inserted the standard 2-
D view (Fig 1) was always obtained within 5 min. The required
view was obtained at a depth of 130-145 cm in all horses studied,
a depth that was repeatable for each horse. A long-axis view of
the left atrium and left ventricular inflow was also observed, but
this was not specifically studied. Spectral Doppler recordings
taken from aortic blood flow were of uniform high quality, only
minor adjustment or rotation of the probe being required to
maintain clear audible signals and velocity spectra.
Table 1 shows the pooled data for all measured variables.
There were significant differences for heart rate, and VTI
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TABLE 4: Measured variables before and 20 min after infusion of 4 pg/kg bwt/min dobutamine hydrochloride. Change expressed
as percentage of control values (mean value and standard deviation in parenthesis)
Control Dobutamine % Change from control
Heart rate (beats/min) 28 (3.5) 29 (4.7) 1%
Maximum aortic velocity Vmax (m/s) 0.88 (0.04) 1.15 (0.21 )a 39%
Maximum aortic acceleration dv/dt (m/s/s) 5.18 (0.61) 14.7 (4.7)a 175%
Pre-ejection period PEP (s) 0.24 (0.03) 0.1 (0.03)a -60%
Ejection time (ET) (s) 0.48 (0.03) 0.42 (0.04)a -12%
Velocity time integral VTI (cm) 24.8 (0.05) 26.3 (3.0) 7%
Cardiac output (l/min) 26.6 (4.7) 28.4 (4.12) 7%
Aortic systolic pressure (mmHg) 75 (11.4) 127 (25.9)a 59%
Aortic mean pressure (mmHg) 62 (12.2) 106 (22)a 67%
Aortic diastolic pressure (mmHg) 51 (10.5) 83 (16.8)a 55%
Maximum rate of rise of LV pressure (mmHg/s) 234 (43.1) 856 (303)a 250%
Statistically significant difference from control values P<0.01. Tested using a paired Student's ftest.
only. Table 2 shows data from each anaesthetic episode averaged
for each horse, the coefficient of variation reflects variability
within individual horses. In Table 3 the data are averaged for all
horses for each anaesthetic episode. The coefficients of variation
therefore reflect the between horse variability.
Table 4 shows the variables before and after administration of
dobutamine, and the percentage change from control values.
Aortic dv/dt,^, V,^, LV systolic and end-diastolic pressures,
mean, systolic and diastolic aortic pressures and LVdp/dtmax, were
all significantly increased from control values. Left ventricular ET
and PEP were significantly decreased. There was no significant
change in heart rate or VTI, or the related variable CO.
Discussion
The present study shows that transoesophageal echocardiography
is well tolerated in anaesthetised Thoroughbred horses and
although the number of 2-D images obtained was limited
compared to human studies, a long-axis view of the left
ventricular outflow tract and aorta was always obtained. The axial
alignment of the aorta and left ventricular outflow tract with the
ultrasound beam in this view was ideal for Doppler
echocardiography. High quality velocity spectra, which were
suitable for derivation of ejection phase indices of left ventricular
function, were readily obtained using high pulse repetition
frequency Doppler insonation. Management of the horses in the
study was controlled with respect to diet, exercise and
environment. Anaesthetic technique was standardised, and
intraoperative arterial blood gas tensions were maintained within
fixed limits. The effects of these sources of variance on the
measured haemodynamic variables within each study, should
therefore have been minimised.
All measured variables showed marked overall variation,
indicated by coefficients of variation greater than 10% and wide
95% confidence intervals (Table 1). Since variation in a biological
measurement made on a particular animal on different occasions
dictates its sensitivity for detecting serial changes, allowance must
be made for this when it is proposed to use the measurement to
detect responses to treatment. Variation between individuals also
influences the normal range of a measurement and must be
defined, if the measurement is to be used to help define disease or
abnormal function. For physiological data these two sources of
variation can be of differing relative importance. When
haemodynamic data are considered, the situation is complex
because measurement errors can also contribute additional
sources of variation to biological data. As a result reliability of
any new measurement technique is an important consideration.
In this study significant differences in measured variables
between individual horses was assessed using analysis of
variance. Statistically significant differences were detected in
heart rate, Vmax and VTI. The intraclass correlation coefficient, r(,
has been used as an index of measurement technique reliability
(Landis and Koch 1977). It provides a number between 0-1, for
which 1 which indicates perfect repeatability. Moulinier et al.
(1991) performed a very similar study of day to day reliability of
Doppler derived VTI measurements in 7 conscious human
volunteers kept under tight environmental control. They used
transthoracic echocardiography to obtain the aortic velocity
spectra and also measured heart rate and arterial blood pressure. If
calculation of the correlation coefficient, rj described by
Moulinier et al. (1991) is used on data from the present study, the
values obtained for heart rate are very similar (0.60 cf 0.57), but rt
for VTI was considerably higher in the Moulinier study (0.87 cf
0.51). Similarly arterial blood pressure values were much more
repeatable in human subjects compared to anaesthetised horses.
If the errors in blood pressure measurement are similar in both
studies it can be concluded that general anaesthesia in horses
interferes with normal homeostatic control of arterial blood
pressure. A similar effect may also be responsible for the
increased variation of VTI, an index which reflects stroke volume.
In the present study, heart rate, V^, and VTI were the only
variables for which significant differences were detected between
individual horses. The source of this variation is more clearly
illustrated in Table 2 . The coefficients of variation of heart rate,
in 2 horses (Horses 1 and 6) show much higher individual
variation than the rest of the group. Horse 1 was noted to have
second degree atrioventricular block and a heart rate of 22 during
anaesthetic episode 2. In the other 3 episodes, the horse was in
normal sinus rhythm with a rate of 30 beats/min. Dysrhythmias
have important effects on indices of myocardial contractility and,
in this horse, were probably responsible for aberrant high values
for dv/dtmax and LVdp/dtj^ and their very high coefficients of
variation. In Horse 6 the high coefficient of variation was not
associated with a single anaesthetic episode. Marked variation of
heart rate between horses is illustrated by Horse 4 who
persistently maintained a higher heart rate in all anaesthetic
episodes.
The main source of error in the measurement of linear
velocity by Doppler echocardiography arises from poor alignment
of the ultrasound beam with the direction of blood flow. The
measured velocity of blood flow is proportional to the cosine of
the angle between the direction of blood flow and the insonating
beam. If this angle is less than 18° this gives a maximum error of
± 5% in velocity measurement. The standard 2-D image obtained
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hy transesophageal echocardiography in horses permitted good
alignment with anatomical structures (Fig,2)-. Alignment in the
ulhet plane is difllcull lo assess, hut tfie clarity of the audible
signals indicated that the beam was well aligned to blood flow. It
is therefore considered unlikely that poor alignment provided a
significant source of error in the present study.
Operator errors associated with measurement of the Doppler
indices are a possible source of error in this study, but most
variation was associated with variables derived from aortic and left
ventricular pressure measurement. The high fidelity
micromanometers and the recording system used were calibrated
frequently and are considered to have measured pressure accurately.
Since the greatest coefficient of variation and widest 95%
confidence intervals are associated with the index of left ventricular
contractility LVdp/dtmax, it is probable that ventricular performance
indices derived simultaneously from Doppler echocardiography are
also subject to a similar amount of true physiological variation. In
this study the coefficient of variation and 95% confidence intervals
are narrower for the Doppler variables than for those obtained by
cardiac catheterisation. Doppler indices of ventricular performance
are ejection phase indices, occurring after the aortic valve has
opened. In contrast LVdp/dt,,,^ is an isovolumic index of left
ventricular contractility. This difference may explain the different
variability found for these indices.
Ideally the error of a new measurement technique can be
established by first comparing it with a pre-existing technique
taken to be an absolute standard. Transoesophageal Doppler
derived cardiac output measurements have been compared with
simultaneous measurements made by thermodilution in
anaesthetised Thoroughbred horses (Long et al. 1994), the 2
techniques showed good agreement and the results of this study
will be published in full later. The remaining Doppler derived
variables, dv/dtmax, Vmax, ET, PEP and VTI have not been
compared directly with measurements made by other techniques.
Peak aortic velocity, acceleration and LVdp/dtmax were
demonstrated to have similar inotropic sensitivity to dobutamine
infusions in a study in thoracotomised dogs (Lambert et al. 1983).
LVdp/dtmax is the most frequently used index for assessment of
myocardial contractility in horses (Brown and Holmes 1979;
Muir, 1992; Wagner et al. 1990). In the present study dobutamine
infusion caused significant increases in dv/dtmax, Vmax and
LVdp/dtmax. LVdp/dtmax showed the greatest percentage increase
in response to infusion of the inotrope, but the increases in
dv/dtmax and Vmax significantly exceeded their 95% confidence
intervals, indicating that all 3 variables show sufficient sensitivity
to dobutamine administration to be useful markers of ventricular
contractile performance. The 3 indices, LVdp/dtmax, dv/dtmax and
Vmax, all have differing sensitivities to changes in afterload. The
Doppler derived measurements, dv/dtmax and Vmax being ejection
phase indices are highly sensitive to afterload changes whereas
LVdp/dtmax, an isovolumic index is less influenced by afterload.
These differing sensitivities to ventricular loading may explain the
quantitative differences in variable response to dobutamine
infusion.
Maximum aortic acceleration (dv/dtmax) showed much higher
variation than the peak velocity (V,^). This is in agreement with
a study performed in experimental dogs (Wallmeyer et al. 1988).
In a study in man, Gardin et al. (1984) attributed this to technical
difficulties in defining dv/dt,^ from the velocity spectra. Peak
velocity is much easier to identify and small errors in identifying
dv/dtmax are magnified by differentiation (Figures 4 and 5).
Pre-ejection period and ET also showed sensitivity to
dobutamine infusion, both were reduced significantly from
preinfusion values. This reduction in PEP is expected when
ventricular contractility increases; the increased contractility
results in an increase in the rate of left ventricular pressure
generation during isovolumic systole, luminal pressure exceeds
aortic pressure faster, so that the aortic valve opens and ejection
commences sooner after electrical activation of the ventricle.
Increases in afterload and contractility reduce ventricular ejection
times (Braunwald 1988) and this may explain the significant falls
in ET after infusion of dobutamine.
In the present study, increased peak aortic velocity was
offset by reduction in ejection time (ET), as a result VTI, which
directly reflects stroke volume, remained unchanged. Although
arterial blood pressure was significantly increased by
dobutamine at 4 pg/kg^wt/min, cardiac output remained
unchanged after 20 min of infusion. These results are in
agreement with those from standing horses, when dobutamine
failed consistently to raise cardiac output despite elevating
cardiac contractility (Hinchcliffe et al. 1991; Young et al. 1993).
Increased arterial blood pressure, with no change in cardiac
output implies that systemic vascular resistance has increased.
This contrasts the drug's activity in man and dogs, when
augmentation of cardiac output is not accompanied by elevation
of arterial blood pressure or systemic vascular resistance (Tuttle
and Mills 1975; Bendersky et al. 1981).
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